<?xml version="1.0" encoding="UTF-8" standalone="yes"?><trialResultsOutput hits="10" offset="1" totalResults="6530"><Filters total="48"><Filter label="Trial Technologies" name="trialTechnologies" total="100"><FilterOption id="762" count="4098" label="Small molecule therapeutic"/><FilterOption id="585" count="3247" label="Oral formulation"/><FilterOption id="761" count="2607" label="Biological therapeutic"/><FilterOption id="648" count="2543" label="Intravenous formulation"/><FilterOption id="595" count="2349" label="Tablet formulation"/><FilterOption id="740" count="2139" label="Infusion"/><FilterOption id="746" count="1781" label="Solution"/><FilterOption id="751" count="1500" label="Film coating"/><FilterOption id="586" count="1476" label="Capsule formulation"/><FilterOption id="573" count="1360" label="Immunoglobulin-G"/><FilterOption id="898" count="1201" label="Formulation powder"/><FilterOption id="647" count="1182" label="Subcutaneous formulation"/><FilterOption id="85" count="1181" label="Protein recombinant"/><FilterOption id="750" count="995" label="Freeze drying"/><FilterOption id="169" count="851" label="Monoclonal antibody humanized"/><FilterOption id="1263" count="690" label="Immuno-oncology"/><FilterOption id="168" count="629" label="Monoclonal antibody human"/><FilterOption id="1652" count="515" label="Prodrug"/><FilterOption id="1647" count="482" label="Natural product"/><FilterOption id="594" count="472" label="Oral suspension formulation"/><FilterOption id="80" count="423" label="Peptide"/><FilterOption id="902" count="382" label="Orally disintegrating tablet"/><FilterOption id="805" count="380" label="Daily dosing"/><FilterOption id="589" count="366" label="Sustained release formulation"/><FilterOption id="175" count="358" label="Drug combination"/><FilterOption id="593" count="353" label="Oral liquid formulation"/><FilterOption id="651" count="306" label="Intramuscular formulation"/><FilterOption id="745" count="264" label="Suspension"/><FilterOption id="766" count="258" label="Parenteral formulation unspecified"/><FilterOption id="166" count="232" label="Chimeric monoclonal antibody"/><FilterOption id="180" count="206" label="Antibody fragment"/><FilterOption id="894" count="204" label="Liquid formulation"/><FilterOption id="348" count="195" label="PEGylated formulation"/><FilterOption id="743" count="178" label="Granule"/><FilterOption id="74" count="165" label="Glycoprotein"/><FilterOption id="84" count="164" label="Protein fusion"/><FilterOption id="66" count="156" label="Antibiotic"/><FilterOption id="616" count="147" label="Inhalant formulation"/><FilterOption id="128" count="133" label="Cell culture technique"/><FilterOption id="112" count="132" label="DNA technology"/><FilterOption id="90" count="129" label="Steroid"/><FilterOption id="596" count="126" label="Injectable formulation"/><FilterOption id="660" count="125" label="Oral sustained release formulation"/><FilterOption id="649" count="122" label="Intraperitoneal formulation"/><FilterOption id="667" count="122" label="Peptidomimetic"/><FilterOption id="207" count="117" label="Protein conjugated"/><FilterOption id="127" count="107" label="Cell culture"/><FilterOption id="852" count="106" label="Intravesical formulation"/><FilterOption id="599" count="105" label="Nanoparticle formulation injectable"/><FilterOption id="630" count="104" label="Stereochemistry"/><FilterOption id="680" count="102" label="Buccal formulation systemic"/><FilterOption id="701" count="101" label="Nucleoside synthesis"/><FilterOption id="641" count="99" label="Controlled release formulation"/><FilterOption id="171" count="91" label="Monoclonal antibody conjugated"/><FilterOption id="603" count="87" label="Systemic formulation unspecified"/><FilterOption id="611" count="86" label="Dermatological formulation"/><FilterOption id="723" count="85" label="Drug coating"/><FilterOption id="617" count="83" label="Aerosol formulation inhalant"/><FilterOption id="618" count="82" label="Powder formulation inhalant"/><FilterOption id="558" count="76" label="Transdermal formulation"/><FilterOption id="742" count="72" label="Pellet"/><FilterOption id="590" count="68" label="Enteric coated formulation"/><FilterOption id="51" count="66" label="Monoclonal antibody"/><FilterOption id="208" count="66" label="Protein conjugation"/><FilterOption id="159" count="64" label="Oligosaccharide"/><FilterOption id="620" count="62" label="Ophthalmic formulation"/><FilterOption id="167" count="60" label="Monoclonal antibody murine"/><FilterOption id="756" count="57" label="Pharmaceutical carrier"/><FilterOption id="1646" count="56" label="Injectable controlled release formulation"/><FilterOption id="598" count="56" label="Liposome formulation injectable"/><FilterOption id="662" count="56" label="Quick release formulation"/><FilterOption id="62" count="54" label="Virus recombinant"/><FilterOption id="559" count="50" label="Oral controlled release formulation"/><FilterOption id="661" count="50" label="Oral quick release formulation"/><FilterOption id="615" count="49" label="Aerosol formulation dermatological"/><FilterOption id="1164" count="49" label="Antibody drug conjugate"/><FilterOption id="102" count="48" label="Nucleotide and derivatives"/><FilterOption id="652" count="46" label="Intra-articular formulation"/><FilterOption id="807" count="45" label="Monthly dosing"/><FilterOption id="776" count="42" label="Oral gel formulation"/><FilterOption id="753" count="41" label="Microparticle formulation"/><FilterOption id="347" count="38" label="Intratumoral formulation"/><FilterOption id="236" count="38" label="Macrolide"/><FilterOption id="962" count="34" label="Biosimilar product"/><FilterOption id="170" count="34" label="Multivalent monoclonal antibody"/><FilterOption id="724" count="32" label="Radiolabeling"/><FilterOption id="103" count="31" label="Oligonucleotide"/><FilterOption id="806" count="31" label="Weekly dosing"/><FilterOption id="569" count="30" label="Oligonucleotide antisense"/><FilterOption id="901" count="30" label="Recombinant enzyme"/><FilterOption id="267" count="28" label="Multivalent antibody"/><FilterOption id="1" count="23" label="Antibody"/><FilterOption id="537" count="23" label="Chimeric antibody"/><FilterOption id="1669" count="23" label="Emulsion formulation"/><FilterOption id="731" count="23" label="Imaging"/><FilterOption id="111" count="22" label="Cloning technology"/><FilterOption id="659" count="21" label="Ophthalmic liquid formulation"/><FilterOption id="67" count="20" label="Antigen"/><FilterOption id="612" count="20" label="Emulsion dermatological"/><FilterOption id="142" count="20" label="Liposome formulation"/></Filter><Filter label="Indications" name="indications" total="100"><FilterOption id="3665" count="322" label="Metastatic non small cell lung cancer"/><FilterOption id="3657" count="301" label="Metastatic breast cancer"/><FilterOption id="2399" count="204" label="Adenocarcinoma"/><FilterOption id="3713" count="191" label="Advanced solid tumor"/><FilterOption id="837" count="174" label="Non-insulin dependent diabetes"/><FilterOption id="1069" count="169" label="Metastasis"/><FilterOption id="3658" count="158" label="Metastatic colorectal cancer"/><FilterOption id="291" count="148" label="Rheumatoid arthritis"/><FilterOption id="159" count="143" label="HIV-1 infection"/><FilterOption id="307" count="129" label="Squamous cell carcinoma"/><FilterOption id="49" count="125" label="Breast tumor"/><FilterOption id="153" count="125" label="Hepatitis C virus infection"/><FilterOption id="1828" count="122" label="Multiple myeloma"/><FilterOption id="3246" count="97" label="Hormone refractory prostate cancer"/><FilterOption id="3257" count="96" label="Stage IV melanoma"/><FilterOption id="213" count="88" label="Multiple sclerosis"/><FilterOption id="1185" count="85" label="Chronic obstructive pulmonary disease"/><FilterOption id="158" count="84" label="HIV infection"/><FilterOption id="3669" count="84" label="Metastatic pancreas cancer"/><FilterOption id="4250" count="81" label="Metastatic renal cell carcinoma"/><FilterOption id="1771" count="81" label="Transitional cell carcinoma"/><FilterOption id="3866" count="80" label="Metastatic ovary cancer"/><FilterOption id="3666" count="78" label="Metastatic stomach cancer"/><FilterOption id="14" count="77" label="Alzheimers disease"/><FilterOption id="1262" count="76" label="Non-small-cell lung cancer"/><FilterOption id="319" count="75" label="Non-Hodgkin lymphoma"/><FilterOption id="84" count="74" label="Crohns disease"/><FilterOption id="80" count="72" label="Coronary artery disease"/><FilterOption id="20" count="71" label="Pain"/><FilterOption id="3083" count="71" label="Peritoneal tumor"/><FilterOption id="1731" count="69" label="Acute myelogenous leukemia"/><FilterOption id="1749" count="68" label="Diffuse large B-cell lymphoma"/><FilterOption id="2243" count="68" label="Fallopian tube cancer"/><FilterOption id="3673" count="68" label="Metastatic head and neck cancer"/><FilterOption id="55" count="66" label="Cardiac failure"/><FilterOption id="1734" count="65" label="Chronic lymphocytic leukemia"/><FilterOption id="31" count="64" label="Asthma"/><FilterOption id="1745" count="64" label="Follicle center lymphoma"/><FilterOption id="337" count="63" label="Ulcerative colitis"/><FilterOption id="121" count="62" label="Factor VIII deficiency"/><FilterOption id="1767" count="62" label="Hepatocellular carcinoma"/><FilterOption id="3667" count="62" label="Metastatic esophageal cancer"/><FilterOption id="281" count="60" label="Psoriasis"/><FilterOption id="57" count="59" label="Cardiovascular disease"/><FilterOption id="799" count="59" label="Ovary tumor"/><FilterOption id="1261" count="58" label="Small-cell lung cancer"/><FilterOption id="1705" count="55" label="Endometrioid carcinoma"/><FilterOption id="224" count="55" label="Myocardial infarction"/><FilterOption id="255" count="53" label="Parkinsons disease"/><FilterOption id="17" count="52" label="Anemia"/><FilterOption id="1542" count="52" label="Atrial fibrillation"/><FilterOption id="2454" count="46" label="Glioblastoma"/><FilterOption id="3664" count="46" label="Metastatic prostate cancer"/><FilterOption id="3256" count="45" label="Stage III melanoma"/><FilterOption id="3466" count="42" label="Metastatic bladder cancer"/><FilterOption id="1272" count="42" label="Myelodysplastic syndrome"/><FilterOption id="238" count="41" label="Obesity"/><FilterOption id="299" count="40" label="Schizophrenia"/><FilterOption id="1735" count="39" label="Chronic myelocytic leukemia"/><FilterOption id="1781" count="38" label="Psoriatic arthritis"/><FilterOption id="318" count="38" label="Systemic lupus erythematosus"/><FilterOption id="119" count="37" label="Epilepsy"/><FilterOption id="1128" count="35" label="Neuroendocrine tumor"/><FilterOption id="245" count="35" label="Osteoarthritis"/><FilterOption id="3378" count="35" label="Soft tissue sarcoma"/><FilterOption id="427" count="35" label="Uterine cervix tumor"/><FilterOption id="2380" count="34" label="Bladder cancer"/><FilterOption id="552" count="34" label="Bleeding"/><FilterOption id="1080" count="34" label="Female infertility"/><FilterOption id="3510" count="34" label="Pulmonary artery hypertension"/><FilterOption id="1744" count="32" label="Mantle cell lymphoma"/><FilterOption id="3676" count="31" label="Ischemic stroke"/><FilterOption id="203" count="31" label="Lymphoma"/><FilterOption id="316" count="30" label="B-cell lymphoma"/><FilterOption id="623" count="30" label="Head and neck tumor"/><FilterOption id="325" count="30" label="Thromboembolism"/><FilterOption id="3258" count="29" label="Acute coronary syndrome"/><FilterOption id="1728" count="29" label="Acute lymphoblastic leukemia"/><FilterOption id="88" count="29" label="Cystic fibrosis"/><FilterOption id="3251" count="29" label="End stage renal disease"/><FilterOption id="3439" count="29" label="Partial seizure"/><FilterOption id="178" count="28" label="Hypertension"/><FilterOption id="65" count="28" label="Stroke"/><FilterOption id="398" count="27" label="Ankylosing spondylitis"/><FilterOption id="191" count="27" label="Influenza virus infection"/><FilterOption id="3003" count="27" label="Juvenile rheumatoid arthritis"/><FilterOption id="3147" count="27" label="Open angle glaucoma"/><FilterOption id="2376" count="27" label="Overactive bladder"/><FilterOption id="249" count="27" label="Pancreas tumor"/><FilterOption id="1102" count="26" label="Atopic dermatitis"/><FilterOption id="1228" count="26" label="Factor IX deficiency"/><FilterOption id="4898" count="26" label="Major depressive disorder"/><FilterOption id="152" count="25" label="Hepatitis B virus infection"/><FilterOption id="836" count="25" label="Insulin dependent diabetes"/><FilterOption id="725" count="25" label="Solid tumor"/><FilterOption id="1765" count="24" label="Cholangiocarcinoma"/><FilterOption id="574" count="24" label="Deep vein thrombosis"/><FilterOption id="276" count="24" label="Prostate tumor"/><FilterOption id="1078" count="23" label="Lung embolism"/><FilterOption id="1108" count="22" label="Glioma"/></Filter><Filter label="Endpoint Index" name="trialEndpointIndex" total="100"><FilterOption id="8489" count="299" label="Lung tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8481" count="269" label="Lung tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8712" count="242" label="Breast tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8719" count="236" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="8998" count="236" label="Breast tumor - Assessment of adverse events"/><FilterOption id="8713" count="230" label="Breast tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8505" count="204" label="Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"/><FilterOption id="8663" count="204" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8639" count="194" label="Lung tumor - Assessment of Safety and Tolerability"/><FilterOption id="15312" count="173" label="Solid tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="15287" count="166" label="Solid tumor - Assessment of adverse events"/><FilterOption id="8522" count="162" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of duration of response"/><FilterOption id="8738" count="159" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of duration of tumor response"/><FilterOption id="8514" count="154" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="8513" count="154" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="9153" count="148" label="Lung tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="7547" count="144" label="Lymphoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8996" count="137" label="Breast tumor - Assessment of Safety and Tolerability"/><FilterOption id="8640" count="135" label="Lung tumor - Assessment of Safety and Tolerability - Adverse events as graded by CTCAE/CTC"/><FilterOption id="8721" count="133" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="9247" count="127" label="HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="7538" count="127" label="Lymphoma - Assessment of Overall Survival (OS)"/><FilterOption id="7569" count="126" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="7879" count="125" label="Leukemia - Assessment of Overall Survival (OS)"/><FilterOption id="9122" count="124" label="Breast tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8430" count="124" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="9213" count="124" label="HIV infection - Assessment of Viral Load - Assessment of HIV RNA levels"/><FilterOption id="7680" count="124" label="Lymphoma - Assessment of adverse events"/><FilterOption id="15212" count="124" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"/><FilterOption id="8187" count="122" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of Objective/Overall Response Rate (ORR)"/><FilterOption id="8163" count="120" label="Colorectal tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="9215" count="119" label="HIV infection - Assessment of CD4 Cell Responses - Assessment of CD4 cell count/percentage"/><FilterOption id="8078" count="118" label="Leukemia - Assessment of adverse events"/><FilterOption id="8523" count="118" label="Lung tumor - Assessment of Disease Progression"/><FilterOption id="8720" count="115" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="8722" count="112" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Clinical Benefit Rate (CBR)"/><FilterOption id="7563" count="111" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="7611" count="109" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of tumor response rate (Duration of response)"/><FilterOption id="15207" count="108" label="Solid tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="15293" count="107" label="Solid tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="6863" count="106" label="Hepatitis C virus infection - Assessment of Viral Load/Viral Kinetics"/><FilterOption id="3900" count="102" label="Rheumatoid arthritis - DAS-28 (Disease Activity Score) Response"/><FilterOption id="8151" count="101" label="Colorectal tumor - Assessment of Overall Survival (OS)"/><FilterOption id="9218" count="101" label="HIV infection - Assessment of Immune Response"/><FilterOption id="3736" count="99" label="Hepatitis C virus infection - Assessment of Sustained Virologic Response (SVR)"/><FilterOption id="1503" count="96" label="Non-insulin dependent diabetes - Anthropometric Assessments - Assessment of body weight"/><FilterOption id="2622" count="91" label="Coronary artery disease - Assessment of Mortality/Death Rates - Cardiovascular mortality"/><FilterOption id="7908" count="90" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="1626" count="90" label="Non-insulin dependent diabetes - Assessment of Adverse Events"/><FilterOption id="1624" count="90" label="Non-insulin dependent diabetes - Assessment of Safety and Tolerability"/><FilterOption id="22595" count="89" label="End stage renal disease - Assessment of adverse events"/><FilterOption id="26033" count="88" label="Pain - Assessment of adverse events"/><FilterOption id="8555" count="87" label="Lung tumor - Assessment of Mortality/Death Rates"/><FilterOption id="8519" count="87" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Tumor Growth Control Rate (TGCR)"/><FilterOption id="8516" count="86" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Stable Disease"/><FilterOption id="15218" count="86" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of duration of tumor response"/><FilterOption id="10830" count="85" label="Ovary tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="4144" count="85" label="Rheumatoid arthritis - Assessment of adverse events"/><FilterOption id="8077" count="84" label="Leukemia - Assessment of Safety and Tolerability"/><FilterOption id="8651" count="83" label="Lung tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="6940" count="83" label="Melanoma - Assessment of Response Rates (RR) - Assessment of overall/objective response rate"/><FilterOption id="1359" count="83" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels - Change in HbA1c"/><FilterOption id="15285" count="83" label="Solid tumor - Assessment of Safety and Tolerability"/><FilterOption id="8744" count="82" label="Breast tumor - Assessment of Disease Progression"/><FilterOption id="8641" count="82" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of frequency and severity of adverse events"/><FilterOption id="7679" count="81" label="Lymphoma - Assessment of Safety and Tolerability"/><FilterOption id="9155" count="80" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="7045" count="80" label="Prostate tumor - Assessment of Overall Survival (OS)"/><FilterOption id="37159" count="79" label="Breast tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="7027" count="79" label="Melanoma - Assessment of adverse events"/><FilterOption id="1345" count="78" label="Non-insulin dependent diabetes - Glycemic Control Analysis - Assessment of fasting blood glucose"/><FilterOption id="8997" count="77" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of serious adverse events"/><FilterOption id="7564" count="77" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="6924" count="77" label="Melanoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="7360" count="77" label="Multiple myeloma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="6919" count="76" label="Melanoma - Assessment of Overall Survival (OS)"/><FilterOption id="7367" count="76" label="Multiple myeloma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="10828" count="74" label="Ovary tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8725" count="73" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Stable Disease"/><FilterOption id="8189" count="73" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of duration of response"/><FilterOption id="8508" count="73" label="Lung tumor - Assessment of Overall Response"/><FilterOption id="4139" count="73" label="Rheumatoid arthritis - Assessment of Safety and Tolerability"/><FilterOption id="7891" count="72" label="Leukemia - Assessment of Progression Free Survival (PFS)"/><FilterOption id="7049" count="72" label="Prostate tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="13352" count="71" label="Pancreas tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8759" count="70" label="Breast tumor - Patient Reported Outcomes/Quality of Life Assessments"/><FilterOption id="7909" count="69" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="7354" count="69" label="Multiple myeloma - Assessment of Overall Survival (OS)"/><FilterOption id="3883" count="69" label="Rheumatoid arthritis - American College of Rheumatology (ACR) 20 Response"/><FilterOption id="7489" count="68" label="Multiple myeloma - Assessment of Safety and Tolerability - Assessment of other adverse events"/><FilterOption id="13344" count="67" label="Pancreas tumor - Assessment of Overall Survival (OS)"/><FilterOption id="4000" count="67" label="Rheumatoid arthritis - Assessment of Inflammatory &amp; Oxidative Stress Markers - Assessment of C-reactive protein (CRP)/high sensitivity C-reactive protein (hs-CRP)"/><FilterOption id="3809" count="66" label="Hepatitis C virus infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="25874" count="66" label="Pain - Assessment of Intensity of Pain - Based on Visual analog scale[VAS]"/><FilterOption id="11717" count="65" label="Bladder cancer - Assessment of Overall Survival (OS)"/><FilterOption id="1358" count="65" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels"/><FilterOption id="13357" count="65" label="Pancreas tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"/><FilterOption id="10545" count="65" label="Renal cell carcinoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="15215" count="65" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="10540" count="64" label="Renal cell carcinoma - Assessment of Overall Survival (OS)"/></Filter><Filter label="Trial Drug Phase Highest" name="trialDrugPhaseHighest" total="12"><FilterOption id="L" count="4243" label="Launched"/><FilterOption id="C3" count="623" label="Phase 3 Clinical"/><FilterOption id="C2" count="526" label="Phase 2 Clinical"/><FilterOption id="DX" count="501" label="Discontinued"/><FilterOption id="PR" count="121" label="Pre-registration"/><FilterOption id="C1" count="104" label="Phase 1 Clinical"/><FilterOption id="NDR" count="103" label="No Development Reported"/><FilterOption id="R" count="63" label="Registered"/><FilterOption id="W" count="43" label="Withdrawn"/><FilterOption id="DR" count="34" label="Discovery"/><FilterOption id="S" count="11" label="Suspended"/><FilterOption id="CU" count="5" label="Clinical"/></Filter><Filter label="Trial Company Sponsor" name="trialCompaniesSponsor" total="100"><FilterOption id="23137" count="385" label="Novartis AG"/><FilterOption id="19446" count="358" label="Roche Holding AG"/><FilterOption id="18767" count="301" label="Pfizer Inc"/><FilterOption id="28355" count="273" label="GlaxoSmithKline plc"/><FilterOption id="15065" count="199" label="Bristol-Myers Squibb Co"/><FilterOption id="14190" count="198" label="AstraZeneca plc"/><FilterOption id="17810" count="191" label="Eli Lilly &amp; Co"/><FilterOption id="26178" count="172" label="F Hoffmann-La Roche AG"/><FilterOption id="14455" count="133" label="Bayer AG"/><FilterOption id="1144568" count="127" label="Novartis Pharma Services AG"/><FilterOption id="14881" count="123" label="Boehringer Ingelheim International GmbH"/><FilterOption id="1067538" count="123" label="Janssen Research &amp; Development LLC"/><FilterOption id="1072507" count="111" label="AbbVie Inc"/><FilterOption id="1091809" count="107" label="Janssen-Cilag International NV (BE)"/><FilterOption id="1059823" count="103" label="Merck Sharp &amp; Dohme Corp"/><FilterOption id="15331" count="101" label="Celgene Corp"/><FilterOption id="25599" count="100" label="Novartis Pharma AG"/><FilterOption id="1009547" count="100" label="Sanofi SA"/><FilterOption id="14109" count="94" label="Amgen Inc"/><FilterOption id="16450" count="93" label="Gilead Sciences Inc"/><FilterOption id="18614" count="87" label="Novo Nordisk A/S"/><FilterOption id="30062" count="80" label="AstraZeneca AB"/><FilterOption id="29218" count="77" label="AbbVie Deutschland GmbH &amp; Co KG"/><FilterOption id="15133" count="76" label="Bristol-Myers Squibb International Corp"/><FilterOption id="1121088" count="72" label="Novartis Farmaceutica SA"/><FilterOption id="1038736" count="63" label="PETHEMA Foundation"/><FilterOption id="19453" count="61" label="Genentech Inc"/><FilterOption id="22546" count="53" label="Boehringer Ingelheim GmbH"/><FilterOption id="1003983" count="51" label="Bayer HealthCare AG"/><FilterOption id="1013295" count="44" label="Astellas Pharma Inc"/><FilterOption id="13601" count="43" label="Abbott Laboratories"/><FilterOption id="1057369" count="43" label="La Paz University Hospital (Madrid)"/><FilterOption id="1119200" count="42" label="Sanofi-Aventis Research and Development"/><FilterOption id="1110770" count="41" label="Novartis Farma SpA"/><FilterOption id="17839" count="39" label="Eli Lilly SA"/><FilterOption id="23119" count="39" label="European Organisation for Research and Treatment of Cancer (EORTC)"/><FilterOption id="1050515" count="39" label="ViiV Healthcare Ltd"/><FilterOption id="15414" count="37" label="Chugai Pharmaceutical Co Ltd"/><FilterOption id="1005244" count="36" label="Biogen Inc"/><FilterOption id="22586" count="36" label="Boehringer Ingelheim Corp"/><FilterOption id="1042061" count="36" label="Spanish Breast Cancer Research Group"/><FilterOption id="1087775" count="35" label="Novartis Oncology"/><FilterOption id="24652" count="35" label="Shire plc"/><FilterOption id="1145220" count="32" label="GlaxoSmithKline Research &amp; Development Ltd"/><FilterOption id="18101" count="32" label="Merck KGaA"/><FilterOption id="27053" count="31" label="Glaxo Group Research Ltd"/><FilterOption id="1040862" count="31" label="Hospital General Universitario Gregorio Marañon"/><FilterOption id="20348" count="31" label="Teva Pharmaceutical Industries Ltd"/><FilterOption id="23780" count="30" label="Actelion Ltd"/><FilterOption id="1045910" count="30" label="Hospital Clinico San Carlos"/><FilterOption id="1122528" count="30" label="SCS Boehringer Ingelheim Comm.V"/><FilterOption id="20452" count="30" label="UCB SA"/><FilterOption id="19620" count="29" label="Eisai Inc"/><FilterOption id="17259" count="29" label="Ipsen"/><FilterOption id="1103352" count="28" label="Boehringer Ingelheim Espana Sa"/><FilterOption id="1044292" count="28" label="Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal"/><FilterOption id="17216" count="28" label="Incyte Corp"/><FilterOption id="15121" count="27" label="Bristol-Myers Squibb Belgium SA"/><FilterOption id="1079538" count="27" label="Instituto de Investigación Hospital Universitario La Paz"/><FilterOption id="22563" count="26" label="Boehringer Ingelheim Ltd"/><FilterOption id="1110884" count="25" label="Biogen Idec Research Ltd"/><FilterOption id="1020322" count="25" label="Daiichi Sankyo Inc"/><FilterOption id="24166" count="25" label="GlaxoSmithKline Biologicals"/><FilterOption id="19461" count="25" label="Hoffmann-La Roche Inc"/><FilterOption id="20556" count="25" label="Universidad Complutense de Madrid"/><FilterOption id="14112" count="25" label="Wyeth"/><FilterOption id="1003570" count="24" label="Janssen R&amp;D (Ireland)"/><FilterOption id="18008" count="24" label="MedImmune LLC"/><FilterOption id="16299" count="24" label="Sanofi Genzyme"/><FilterOption id="22554" count="23" label="Boehringer Ingelheim BV"/><FilterOption id="21991" count="23" label="Takeda Oncology"/><FilterOption id="14913" count="22" label="Eisai Ltd"/><FilterOption id="1035512" count="22" label="EMD Serono Inc"/><FilterOption id="17332" count="22" label="Johnson &amp; Johnson"/><FilterOption id="1095980" count="22" label="NOVARTIS FARMACEUTICA, S.A. DE C.V."/><FilterOption id="22598" count="22" label="Unilfarma Lda"/><FilterOption id="DOL1000131" count="21" label="Universidad Autonoma de Madrid"/><FilterOption id="22555" count="20" label="Boehringer Ingelheim Ellas AE"/><FilterOption id="27108" count="20" label="Glaxo SA"/><FilterOption id="1039423" count="20" label="Hospital Clinic of Barcelona"/><FilterOption id="1007052" count="20" label="Universidad Europea De Madrid"/><FilterOption id="1092773" count="19" label="Hospital Puerta de Hierro Majadahonda"/><FilterOption id="28611" count="18" label="Actelion Pharmaceuticals Ltd"/><FilterOption id="22545" count="18" label="Boehringer Ingelheim AB"/><FilterOption id="27847" count="18" label="Boston Scientific Corp"/><FilterOption id="13979" count="17" label="Alexion Pharmaceuticals Inc"/><FilterOption id="22549" count="17" label="Boehringer Ingelheim Austria GmbH"/><FilterOption id="1099195" count="17" label="Clínica IVI Madrid"/><FilterOption id="1042371" count="17" label="Spanish Oncology Genito-Urinary Group"/><FilterOption id="20300" count="17" label="Takeda Pharmaceutical Co Ltd"/><FilterOption id="1143375" count="16" label="AbbVie Pte Ltd"/><FilterOption id="21283" count="16" label="Astellas Pharma Europe BV"/><FilterOption id="1122527" count="16" label="Boehringer Ingelheim Finland Ky"/><FilterOption id="22556" count="16" label="Boehringer Ingelheim France SARL"/><FilterOption id="22590" count="16" label="Boehringer Ingelheim SA"/><FilterOption id="1046331" count="16" label="Fundacion SEIMC-GESIDA"/><FilterOption id="1084801" count="16" label="Medica Scientia Innovation Research"/><FilterOption id="1045284" count="16" label="Spanish Cooperative Group for Gastrointestinal Tumour Therapy"/><FilterOption id="1045513" count="16" label="Spanish Lung Cancer Group"/><FilterOption id="14199" count="16" label="Wyeth Pharmaceuticals"/></Filter><Filter label="Trial Recruitment Status" name="trialRecruitmentStatus" total="7"><FilterOption id="4" count="3378" label="Completed"/><FilterOption id="2" count="1385" label="Recruiting"/><FilterOption id="3" count="965" label="No longer recruiting"/><FilterOption id="6" count="596" label="Terminated"/><FilterOption id="1" count="99" label="Not yet recruiting"/><FilterOption id="12" count="82" label="Status not specified"/><FilterOption id="5" count="25" label="Suspended"/></Filter><Filter label="Trial Commercially Significant" name="trialIsCommerciallySignificant" total="2"><FilterOption id="YES" count="4243" label="Yes"/><FilterOption id="NO" count="2287" label="No"/></Filter><Filter label="Trial Indications Pioneer" name="trialIndicationsPioneer" total="100"><FilterOption id="3713" count="111" label="Advanced solid tumor"/><FilterOption id="3665" count="102" label="Metastatic non small cell lung cancer"/><FilterOption id="3657" count="77" label="Metastatic breast cancer"/><FilterOption id="2399" count="73" label="Adenocarcinoma"/><FilterOption id="1069" count="60" label="Metastasis"/><FilterOption id="3658" count="57" label="Metastatic colorectal cancer"/><FilterOption id="307" count="50" label="Squamous cell carcinoma"/><FilterOption id="3669" count="49" label="Metastatic pancreas cancer"/><FilterOption id="3866" count="41" label="Metastatic ovary cancer"/><FilterOption id="3673" count="39" label="Metastatic head and neck cancer"/><FilterOption id="3666" count="35" label="Metastatic stomach cancer"/><FilterOption id="1771" count="34" label="Transitional cell carcinoma"/><FilterOption id="3257" count="33" label="Stage IV melanoma"/><FilterOption id="3667" count="30" label="Metastatic esophageal cancer"/><FilterOption id="319" count="27" label="Non-Hodgkin lymphoma"/><FilterOption id="3466" count="26" label="Metastatic bladder cancer"/><FilterOption id="1262" count="26" label="Non-small-cell lung cancer"/><FilterOption id="4250" count="25" label="Metastatic renal cell carcinoma"/><FilterOption id="1767" count="24" label="Hepatocellular carcinoma"/><FilterOption id="1261" count="24" label="Small-cell lung cancer"/><FilterOption id="49" count="23" label="Breast tumor"/><FilterOption id="57" count="23" label="Cardiovascular disease"/><FilterOption id="2454" count="23" label="Glioblastoma"/><FilterOption id="1705" count="22" label="Endometrioid carcinoma"/><FilterOption id="3246" count="22" label="Hormone refractory prostate cancer"/><FilterOption id="427" count="22" label="Uterine cervix tumor"/><FilterOption id="1749" count="21" label="Diffuse large B-cell lymphoma"/><FilterOption id="1745" count="21" label="Follicle center lymphoma"/><FilterOption id="1828" count="21" label="Multiple myeloma"/><FilterOption id="3664" count="19" label="Metastatic prostate cancer"/><FilterOption id="224" count="19" label="Myocardial infarction"/><FilterOption id="837" count="19" label="Non-insulin dependent diabetes"/><FilterOption id="799" count="19" label="Ovary tumor"/><FilterOption id="3083" count="18" label="Peritoneal tumor"/><FilterOption id="291" count="18" label="Rheumatoid arthritis"/><FilterOption id="2243" count="17" label="Fallopian tube cancer"/><FilterOption id="1731" count="16" label="Acute myelogenous leukemia"/><FilterOption id="2380" count="16" label="Bladder cancer"/><FilterOption id="1734" count="16" label="Chronic lymphocytic leukemia"/><FilterOption id="159" count="15" label="HIV-1 infection"/><FilterOption id="793" count="14" label="Mouth tumor"/><FilterOption id="1765" count="13" label="Cholangiocarcinoma"/><FilterOption id="84" count="13" label="Crohns disease"/><FilterOption id="3676" count="13" label="Ischemic stroke"/><FilterOption id="3378" count="13" label="Soft tissue sarcoma"/><FilterOption id="337" count="13" label="Ulcerative colitis"/><FilterOption id="316" count="12" label="B-cell lymphoma"/><FilterOption id="203" count="12" label="Lymphoma"/><FilterOption id="1240" count="12" label="Mesothelioma"/><FilterOption id="3467" count="12" label="Metastatic renal cancer"/><FilterOption id="1128" count="12" label="Neuroendocrine tumor"/><FilterOption id="55" count="11" label="Cardiac failure"/><FilterOption id="2975" count="11" label="Ewing sarcoma"/><FilterOption id="623" count="11" label="Head and neck tumor"/><FilterOption id="2054" count="11" label="Hematological neoplasm"/><FilterOption id="1744" count="11" label="Mantle cell lymphoma"/><FilterOption id="1272" count="11" label="Myelodysplastic syndrome"/><FilterOption id="2726" count="11" label="Neuroblastoma"/><FilterOption id="725" count="11" label="Solid tumor"/><FilterOption id="3256" count="11" label="Stage III melanoma"/><FilterOption id="65" count="11" label="Stroke"/><FilterOption id="3258" count="10" label="Acute coronary syndrome"/><FilterOption id="14" count="10" label="Alzheimers disease"/><FilterOption id="1815" count="10" label="Bacterial pneumonia"/><FilterOption id="651" count="10" label="Cancer"/><FilterOption id="989" count="10" label="Colorectal tumor"/><FilterOption id="1080" count="10" label="Female infertility"/><FilterOption id="1108" count="10" label="Glioma"/><FilterOption id="3198" count="10" label="Larynx tumor"/><FilterOption id="1507" count="10" label="Pancreatic ductal adenocarcinoma"/><FilterOption id="3351" count="10" label="Papillary thyroid tumor"/><FilterOption id="794" count="10" label="Pharynx tumor"/><FilterOption id="3678" count="10" label="Urethral cancer"/><FilterOption id="760" count="9" label="Brain tumor"/><FilterOption id="3251" count="9" label="End stage renal disease"/><FilterOption id="153" count="9" label="Hepatitis C virus infection"/><FilterOption id="213" count="9" label="Multiple sclerosis"/><FilterOption id="1768" count="9" label="Nasopharyngeal carcinoma"/><FilterOption id="127" count="9" label="Stomach tumor"/><FilterOption id="318" count="9" label="Systemic lupus erythematosus"/><FilterOption id="552" count="8" label="Bleeding"/><FilterOption id="759" count="8" label="Central nervous system tumor"/><FilterOption id="80" count="8" label="Coronary artery disease"/><FilterOption id="161" count="8" label="Hodgkins disease"/><FilterOption id="20" count="8" label="Pain"/><FilterOption id="249" count="8" label="Pancreas tumor"/><FilterOption id="2448" count="8" label="Rhabdomyosarcoma"/><FilterOption id="398" count="7" label="Ankylosing spondylitis"/><FilterOption id="1516" count="7" label="Biliary cancer"/><FilterOption id="1735" count="7" label="Chronic myelocytic leukemia"/><FilterOption id="100" count="7" label="Diabetic nephropathy"/><FilterOption id="3003" count="7" label="Juvenile rheumatoid arthritis"/><FilterOption id="1078" count="7" label="Lung embolism"/><FilterOption id="1746" count="7" label="Marginal zone B-cell lymphoma"/><FilterOption id="3668" count="7" label="Metastatic lung cancer"/><FilterOption id="2637" count="7" label="Non-alcoholic steatohepatitis"/><FilterOption id="717" count="7" label="Seizure disorder"/><FilterOption id="1728" count="6" label="Acute lymphoblastic leukemia"/><FilterOption id="2193" count="6" label="Anal tumor"/><FilterOption id="1755" count="6" label="Anaplastic large cell lymphoma"/></Filter><Filter label="Registry Id" name="trialRegistries" total="31"><FilterOption id="1000" count="6328" label="CT.gov"/><FilterOption id="1001" count="4598" label="EudraCT"/><FilterOption id="1030" count="1027" label="RSRM CTR"/><FilterOption id="1006" count="710" label="JapicCTI"/><FilterOption id="1023" count="490" label="UKCRN"/><FilterOption id="1019" count="376" label="DRKS"/><FilterOption id="1004" count="311" label="WHO ICTRP"/><FilterOption id="1012" count="281" label="CTRI"/><FilterOption id="1035" count="262" label="Singapore HSA CTR"/><FilterOption id="1021" count="244" label="NMRR"/><FilterOption id="1033" count="167" label="Mexico CTR"/><FilterOption id="1039" count="150" label="CDE"/><FilterOption id="1009" count="148" label="HKClinicalTrials.com"/><FilterOption id="1038" count="105" label="PHRR"/><FilterOption id="1002" count="68" label="ISRCTN"/><FilterOption id="1011" count="52" label="ANZCTR"/><FilterOption id="1020" count="28" label="ReBec"/><FilterOption id="1010" count="20" label="CRiS"/><FilterOption id="1003" count="19" label="UMIN"/><FilterOption id="1008" count="12" label="Hong Kong CCTCTR"/><FilterOption id="1015" count="11" label="NTR"/><FilterOption id="1018" count="8" label="SLCTR"/><FilterOption id="1040" count="6" label="REec"/><FilterOption id="1016" count="4" label="PACTR"/><FilterOption id="1037" count="3" label="TCTR"/><FilterOption id="1032" count="1" label="Chile CTR"/><FilterOption id="1031" count="1" label="Estonia CTR"/><FilterOption id="1014" count="1" label="IRCT"/><FilterOption id="1013" count="1" label="RPCEC"/><FilterOption id="1026" count="1" label="SANCTR"/><FilterOption id="1024" count="1" label="TzCTR"/></Filter><Filter label="Trial Reason for Discontinuation" name="trialReasonForDiscontinuation" total="8"><FilterOption id="1" count="151" label="Lack of Efficacy"/><FilterOption id="2" count="125" label="Not Reported"/><FilterOption id="5" count="108" label="Patient Enrollment Issues"/><FilterOption id="4" count="103" label="Other"/><FilterOption id="8" count="64" label="Sponsor/Business Decision"/><FilterOption id="7" count="43" label="Safety Issues"/><FilterOption id="3" count="32" label="Operational Issues"/><FilterOption id="6" count="5" label="Planned, not Initiated"/></Filter><Filter label="Active Controls" name="trialActiveControls" total="100"><FilterOption id="3803" count="114" label="paclitaxel"/><FilterOption id="44383" count="108" label="carboplatin"/><FilterOption id="2953" count="92" label="docetaxel"/><FilterOption id="3199" count="87" label="gemcitabine"/><FilterOption id="12205" count="53" label="capecitabine"/><FilterOption id="6736" count="51" label="rituximab"/><FilterOption id="3536" count="46" label="pemetrexed disodium"/><FilterOption id="8047" count="45" label="bevacizumab"/><FilterOption id="3792" count="43" label="oxaliplatin"/><FilterOption id="6386" count="36" label="trastuzumab"/><FilterOption id="6050" count="33" label="metformin hydrochloride"/><FilterOption id="2871" count="26" label="irinotecan"/><FilterOption id="6408" count="25" label="vinorelbine"/><FilterOption id="10252" count="24" label="insulin glargine"/><FilterOption id="7310" count="24" label="ritonavir"/><FilterOption id="14163" count="23" label="adalimumab"/><FilterOption id="13928" count="23" label="enoxaparin sodium"/><FilterOption id="29016" count="23" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"/><FilterOption id="49219" count="23" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="44375" count="22" label="warfarin"/><FilterOption id="11961" count="21" label="erlotinib"/><FilterOption id="3072" count="21" label="etoposide phosphate"/><FilterOption id="7413" count="19" label="darbepoetin alfa"/><FilterOption id="15954" count="18" label="bortezomib"/><FilterOption id="3313" count="18" label="fulvestrant"/><FilterOption id="37370" count="17" label="azacitidine"/><FilterOption id="2784" count="17" label="letrozole"/><FilterOption id="47000" count="16" label="bendamustine"/><FilterOption id="8165" count="16" label="tiotropium bromide"/><FilterOption id="44401" count="16" label="vancomycin"/><FilterOption id="10388" count="15" label="cetuximab"/><FilterOption id="2836" count="15" label="clopidogrel"/><FilterOption id="7934" count="15" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="3081" count="15" label="exemestane"/><FilterOption id="23625" count="15" label="peginterferon alfa-2a"/><FilterOption id="70667" count="15" label="pembrolizumab"/><FilterOption id="15254" count="14" label="atazanavir"/><FilterOption id="12973" count="14" label="sunitinib"/><FilterOption id="4577" count="14" label="topotecan"/><FilterOption id="3669" count="13" label="mycophenolate mofetil"/><FilterOption id="29831" count="13" label="sorafenib"/><FilterOption id="4529" count="13" label="temozolomide"/><FilterOption id="3321" count="12" label="anastrozole"/><FilterOption id="32981" count="12" label="darunavir"/><FilterOption id="10172" count="12" label="efavirenz"/><FilterOption id="13340" count="12" label="everolimus"/><FilterOption id="11460" count="12" label="imatinib"/><FilterOption id="14493" count="12" label="tenofovir disoproxil fumarate"/><FilterOption id="10309" count="11" label="abiraterone"/><FilterOption id="2807" count="11" label="atorvastatin"/><FilterOption id="13022" count="11" label="epirubicin"/><FilterOption id="6156" count="11" label="fludarabine"/><FilterOption id="8832" count="11" label="glimepiride"/><FilterOption id="48181" count="11" label="lamivudine + abacavir, GlaxoSmithKline"/><FilterOption id="27572" count="11" label="lenalidomide"/><FilterOption id="4567" count="10" label="etanercept"/><FilterOption id="14336" count="10" label="fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"/><FilterOption id="10411" count="10" label="insulin aspart"/><FilterOption id="33591" count="10" label="lapatinib"/><FilterOption id="3616" count="10" label="meropenem"/><FilterOption id="54804" count="10" label="nivolumab"/><FilterOption id="4510" count="9" label="tacrolimus"/><FilterOption id="28773" count="8" label="eribulin mesylate"/><FilterOption id="6850" count="8" label="infliximab"/><FilterOption id="3360" count="8" label="interferon beta-1a, Biogen"/><FilterOption id="14681" count="8" label="lopinavir + ritonavir"/><FilterOption id="11519" count="8" label="mitoxantrone"/><FilterOption id="27696" count="8" label="pomalidomide"/><FilterOption id="72699" count="7" label="atezolizumab"/><FilterOption id="5999" count="7" label="ciclosporin, Novartis"/><FilterOption id="13239" count="7" label="decitabine"/><FilterOption id="3159" count="7" label="fluticasone propionate"/><FilterOption id="5148" count="7" label="liraglutide"/><FilterOption id="22395" count="7" label="ranibizumab"/><FilterOption id="5369" count="7" label="ribavirin"/><FilterOption id="42858" count="7" label="ustekinumab"/><FilterOption id="44384" count="6" label="ceftriaxone"/><FilterOption id="3353" count="6" label="insulin lispro"/><FilterOption id="36630" count="6" label="ipilimumab"/><FilterOption id="3474" count="6" label="lamivudine"/><FilterOption id="53227" count="6" label="obinutuzumab"/><FilterOption id="13460" count="6" label="oseltamivir"/><FilterOption id="43738" count="6" label="pazopanib"/><FilterOption id="9702" count="6" label="recombinant interferon beta-1a, Merck Serono"/><FilterOption id="4234" count="6" label="risedronate sodium"/><FilterOption id="44312" count="6" label="salmeterol"/><FilterOption id="10488" count="6" label="tolterodine"/><FilterOption id="15130" count="6" label="vinflunine"/><FilterOption id="59062" count="5" label="dolutegravir"/><FilterOption id="4728" count="5" label="emtricitabine"/><FilterOption id="53981" count="5" label="enzalutamide"/><FilterOption id="5267" count="5" label="leuprorelin acetate"/><FilterOption id="12978" count="5" label="moxifloxacin"/><FilterOption id="42299" count="5" label="ofatumumab"/><FilterOption id="3750" count="5" label="ondansetron"/><FilterOption id="21374" count="5" label="pegfilgrastim"/><FilterOption id="28532" count="5" label="pertuzumab"/><FilterOption id="44313" count="5" label="simvastatin"/><FilterOption id="4513" count="5" label="tamsulosin hydrochloride"/><FilterOption id="36332" count="5" label="ticagrelor"/></Filter><Filter label="Exclusion Criteria Index" name="trialExclusionCriteriaIndex" total="100"><FilterOption id="6258" count="238" label="Breast tumor - Subjects co-morbid with cardiovascular diseases/disorders"/><FilterOption id="5125" count="236" label="Lung tumor - Subjects with Evidence of Metastasis - Subjects with central nervous system metastases"/><FilterOption id="5132" count="225" label="Lung tumor - Subjects co-morbid with cardiovascular diseases/disorders"/><FilterOption id="5193" count="219" label="Lung tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="20282" count="217" label="Lung tumor - Subjects co-morbid with inflammatory disorders"/><FilterOption id="6247" count="211" label="Breast tumor - Subjects by disease severity - Subjects with Brain/Leptomeningeal metastases"/><FilterOption id="6294" count="207" label="Breast tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="10704" count="195" label="Solid tumor - Subjects with Co-morbid Conditions"/><FilterOption id="6272" count="186" label="Breast tumor - Subjects co-morbid with inflammatory disorders"/><FilterOption id="4702" count="176" label="Lymphoma - Subjects with Co-morbid Conditions"/><FilterOption id="5270" count="174" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="6554" count="169" label="Leukemia - Subjects with Co-morbid Conditions"/><FilterOption id="6393" count="167" label="Breast tumor - Subjects with History of/Scheduled to Receive Therapy"/><FilterOption id="6331" count="165" label="Breast tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="5365" count="165" label="Lung tumor - Protocol Specified Other Exclusion Criteria - Protocol specified exclusion criteria for females"/><FilterOption id="6328" count="163" label="Breast tumor - Subjects with History of/Scheduled for Anti-neoplastic Therapy"/><FilterOption id="5345" count="158" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"/><FilterOption id="6859" count="156" label="HIV infection - Pregnant or Breast Feeding Subjects"/><FilterOption id="5291" count="154" label="Lung tumor - Subjects with History of/Scheduled for Other Treatments"/><FilterOption id="6377" count="152" label="Breast tumor - Subjects with history of/planned radiotherapy"/><FilterOption id="5282" count="151" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for radiation therapy"/><FilterOption id="10761" count="151" label="Solid tumor - Subjects with Evidence of Metastasis - Subjects with brain/CNS metastasis"/><FilterOption id="5139" count="141" label="Lung tumor - Subjects co-morbid with Respiratory Diseases/Disorders - Subjects co-morbid with pulmonary diseases/disorders"/><FilterOption id="6252" count="133" label="Breast tumor - Subjects with Co-morbid Conditions"/><FilterOption id="6253" count="122" label="Breast tumor - Subjects with Co-morbid Conditions - Subjects with central nervous system diseases"/><FilterOption id="6845" count="121" label="HIV infection - Subjects with Co-morbid Conditions - Subjects co-morbid with hepatobiliary diseases/disorders"/><FilterOption id="20281" count="119" label="Lung tumor - Subjects with Co-morbid Conditions"/><FilterOption id="6756" count="118" label="Lung tumor - Subjects with History of/Scheduled for Other Cancer Therapies"/><FilterOption id="6260" count="115" label="Breast tumor - Subjects co-morbid with gastrointestinal diseases/disorders"/><FilterOption id="5349" count="115" label="Lung tumor - Subjects with Protocol Specified Compliance Status - Subjects unable/unwilling to comply with protocol requirements"/><FilterOption id="4692" count="115" label="Lymphoma - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="5128" count="113" label="Lung tumor - Subjects with Co-morbid Conditions - Subjects with central nervous system diseases/disorders"/><FilterOption id="20290" count="110" label="Breast tumor - Subjects with History of/Scheduled for Intervention/Surgery - Subjects with history of/scheduled for surgery"/><FilterOption id="6302" count="110" label="Breast tumor - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients - Subjects with hypersensitivity/contraindication to any investigational agents"/><FilterOption id="5269" count="110" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy"/><FilterOption id="20114" count="109" label="Pain - Subjects with Co-morbid Conditions - Subjects co-morbid with CNS disorders/diseases"/><FilterOption id="5149" count="107" label="Lung tumor - Subjects co-morbid with gastrointestinal diseases/disorders"/><FilterOption id="5163" count="105" label="Lung tumor - Subjects with Co-morbid Conditions - Subjects co-morbid with hepatobiliary diseases/disorders"/><FilterOption id="12316" count="105" label="Solid tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="5841" count="103" label="Colorectal tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="5826" count="101" label="Colorectal tumor - Subjects with Metastatic Colorectal Cancer - Subjects with brain metastases or leptomeningeal carcinomatosis"/><FilterOption id="10739" count="101" label="Solid tumor - Subjects with History of Other Non Anti-cancer Drugs/Agents"/><FilterOption id="20289" count="100" label="Breast tumor - Subjects with History of/Scheduled for Disease Specific Pharmacological Therapy - Subjects with history of biologic therapy"/><FilterOption id="5277" count="100" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for biological therapy"/><FilterOption id="4769" count="100" label="Lymphoma - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="5285" count="98" label="Lung tumor - Subjects with History of/Scheduled for Intervention/Surgery - Subjects with history of/scheduled for surgery"/><FilterOption id="6534" count="97" label="Leukemia - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="20112" count="95" label="Pain - Subjects with Co-morbid Conditions"/><FilterOption id="6783" count="93" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for immunotherapy"/><FilterOption id="6065" count="93" label="Multiple myeloma - Subjects with Co-morbid Conditions"/><FilterOption id="6261" count="92" label="Breast tumor - Subjects with Co-morbid Conditions - Subjects co-morbid with hepatobiliary diseases/disorders"/><FilterOption id="17519" count="91" label="End stage renal disease - Subjects co-morbid with cardiovascular diseases/disorders"/><FilterOption id="5344" count="89" label="Lung tumor - Protocol Specified Other Exclusion Criteria"/><FilterOption id="9810" count="89" label="Ovary tumor - Subjects with Co-morbid Conditions"/><FilterOption id="6259" count="88" label="Breast tumor - Subjects co-morbid with Respiratory Diseases/Disorders - Subjects co-morbid with pulmonary diseases/disorders"/><FilterOption id="5347" count="87" label="Lung tumor - Protocol Specified Other Exclusion Criteria - Subjects with abnormal laboratory values"/><FilterOption id="10378" count="87" label="Pancreas tumor - Subjects with Co-morbid Conditions"/><FilterOption id="5856" count="86" label="Colorectal tumor - Subjects co-morbid with inflammatory disorders"/><FilterOption id="5864" count="85" label="Colorectal tumor - Subjects co-morbid with cardiovascular diseases/disorders"/><FilterOption id="4810" count="85" label="Lymphoma - Subjects with History of Treatment with Non-chemotherapeutic Drugs"/><FilterOption id="5962" count="83" label="Colorectal tumor - Subjects with history of/scheduled to receive therapy for other indication"/><FilterOption id="6820" count="83" label="HIV infection - Subjects with Opportunistic/Other Infections"/><FilterOption id="4909" count="83" label="Prostate tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="10736" count="83" label="Solid tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of radiotherapy"/><FilterOption id="6767" count="82" label="Lymphoma - Lymphoma Subjects with Advanced Disease - Subjects with central nervous system involvement of lymphoma"/><FilterOption id="6361" count="81" label="Breast tumor - Subjects with History of/Scheduled for Anti-neoplastic Therapy - Subjects with history of/scheduled for targeted therapy"/><FilterOption id="5879" count="80" label="Colorectal tumor - Subjects with Co-morbid Conditions"/><FilterOption id="6941" count="80" label="HIV infection - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients - Hypersensitivity/Contraindications to study medications or its excipients"/><FilterOption id="6892" count="80" label="HIV infection - Subjects with history of/scheduled to receive therapy for other indication"/><FilterOption id="6757" count="80" label="Lung tumor - Subjects with Protocol Specified Participation Status - Subjects with history of/current participation in other clinical trials"/><FilterOption id="5949" count="79" label="Colorectal tumor - Subjects with history of/scheduled to receive radiation therapy"/><FilterOption id="6660" count="79" label="Leukemia - Subjects with History of Treatment with Non-chemotherapeutic Drugs"/><FilterOption id="20174" count="79" label="Pain - Subjects with History/ Scheduled to Undergo Other Therapy/Procedures - Subjects with history/scheduled to receive other drug therapies"/><FilterOption id="6474" count="78" label="Breast tumor - Protocol Specified Other Exclusion Criteria - Protocol specified exclusion criteria for females"/><FilterOption id="3058" count="78" label="Chronic obstructive pulmonary disease - Subjects co-morbid with Respiratory Diseases/Disorders"/><FilterOption id="5744" count="78" label="Head and neck tumor - Subjects with Co-morbid Conditions"/><FilterOption id="20123" count="78" label="Pain - Subjects with Co-morbid Conditions - Subjects with infectious disorders/disease"/><FilterOption id="4967" count="78" label="Prostate tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="4847" count="76" label="Prostate tumor - Subjects with Advanced/Metastatic Prostate Cancer - Subjects with brain metastasis"/><FilterOption id="10732" count="76" label="Solid tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="10738" count="76" label="Solid tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"/><FilterOption id="9003" count="75" label="Bladder cancer - Subjects with Co-morbid Conditions"/><FilterOption id="5848" count="75" label="Colorectal tumor - Subjects co-morbid with gastrointestinal diseases/disorders"/><FilterOption id="17531" count="75" label="End stage renal disease - Subjects co-morbid with infections"/><FilterOption id="4764" count="74" label="Lymphoma - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of stem cell therapy"/><FilterOption id="20292" count="73" label="Breast tumor - Subjects with History of/Scheduled for Anti-neoplastic Therapy - Subjects with history of/scheduled to receive an investigational drug"/><FilterOption id="17557" count="72" label="Breast tumor - Subjects with Abnormal Laboratory Findings"/><FilterOption id="4762" count="72" label="Lymphoma - Subjects with History of/Scheduled to Receive Therapy - Subject with history of radiotherapy"/><FilterOption id="9809" count="72" label="Ovary tumor - Subjects with History of/Active Malignancy/Cancer"/><FilterOption id="5176" count="70" label="Lung tumor - Subjects with Co-morbid Conditions - Subjects co-morbid with hematological disease/disorders"/><FilterOption id="5470" count="70" label="Melanoma - Subjects co-morbid with inflammatory disorders"/><FilterOption id="10717" count="70" label="Solid tumor - Subjects with Abnormal Organ Function - Subjects with abnormal/unacceptable cardiac function"/><FilterOption id="5934" count="69" label="Colorectal tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"/><FilterOption id="17541" count="69" label="End stage renal disease - Subjects with History of/Scheduled for Disease Specific Pharmacological Therapy"/><FilterOption id="837" count="69" label="Non-insulin dependent diabetes - Subjects co-morbid with renal disease/disorder"/><FilterOption id="5954" count="68" label="Colorectal tumor - Subjects with History of/Scheduled for Intervention/Surgery"/><FilterOption id="5236" count="68" label="Lung tumor - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients"/><FilterOption id="4783" count="68" label="Lymphoma - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"/><FilterOption id="851" count="68" label="Non-insulin dependent diabetes - Subjects with Diabetes Mellitus - Subjects with type 1 diabetes mellitus"/><FilterOption id="925" count="68" label="Non-insulin dependent diabetes - Subjects with History of/Active Malignancy/Cancer"/></Filter><Filter label="Trial Date Enrollment End By Month" name="trialDateEnrollmentEndByMonth" total="100"><FilterOption count="48" label="201905"/><FilterOption count="45" label="201705"/><FilterOption count="43" label="201803"/><FilterOption count="43" label="201904"/><FilterOption count="42" label="201802"/><FilterOption count="40" label="201603"/><FilterOption count="38" label="201509"/><FilterOption count="37" label="201807"/><FilterOption count="37" label="201901"/><FilterOption count="36" label="201906"/><FilterOption count="35" label="201504"/><FilterOption count="35" label="201510"/><FilterOption count="35" label="201708"/><FilterOption count="35" label="201709"/><FilterOption count="34" label="201512"/><FilterOption count="34" label="201801"/><FilterOption count="34" label="201809"/><FilterOption count="33" label="201607"/><FilterOption count="32" label="201601"/><FilterOption count="32" label="201608"/><FilterOption count="32" label="201703"/><FilterOption count="32" label="201710"/><FilterOption count="32" label="201806"/><FilterOption count="31" label="201302"/><FilterOption count="31" label="201609"/><FilterOption count="31" label="201810"/><FilterOption count="31" label="201812"/><FilterOption count="31" label="201903"/><FilterOption count="30" label="201311"/><FilterOption count="30" label="201503"/><FilterOption count="30" label="201506"/><FilterOption count="30" label="201507"/><FilterOption count="30" label="201706"/><FilterOption count="30" label="201711"/><FilterOption count="28" label="201305"/><FilterOption count="28" label="201505"/><FilterOption count="28" label="201605"/><FilterOption count="28" label="201811"/><FilterOption count="28" label="201902"/><FilterOption count="27" label="201511"/><FilterOption count="27" label="201805"/><FilterOption count="26" label="201105"/><FilterOption count="26" label="201210"/><FilterOption count="26" label="201308"/><FilterOption count="26" label="201310"/><FilterOption count="26" label="201312"/><FilterOption count="26" label="201502"/><FilterOption count="26" label="201604"/><FilterOption count="26" label="201701"/><FilterOption count="26" label="201808"/><FilterOption count="25" label="201307"/><FilterOption count="25" label="201402"/><FilterOption count="25" label="201408"/><FilterOption count="25" label="201702"/><FilterOption count="24" label="201106"/><FilterOption count="24" label="201406"/><FilterOption count="24" label="201612"/><FilterOption count="24" label="201712"/><FilterOption count="23" label="201207"/><FilterOption count="23" label="201301"/><FilterOption count="23" label="201501"/><FilterOption count="23" label="201606"/><FilterOption count="23" label="201611"/><FilterOption count="22" label="201110"/><FilterOption count="22" label="201203"/><FilterOption count="22" label="201309"/><FilterOption count="22" label="201403"/><FilterOption count="22" label="201704"/><FilterOption count="22" label="201707"/><FilterOption count="21" label="200810"/><FilterOption count="21" label="201004"/><FilterOption count="21" label="201103"/><FilterOption count="21" label="201112"/><FilterOption count="21" label="201401"/><FilterOption count="21" label="201404"/><FilterOption count="21" label="201405"/><FilterOption count="21" label="201508"/><FilterOption count="20" label="200906"/><FilterOption count="20" label="201001"/><FilterOption count="20" label="201107"/><FilterOption count="20" label="201201"/><FilterOption count="20" label="201410"/><FilterOption count="20" label="201804"/><FilterOption count="19" label="200909"/><FilterOption count="19" label="201005"/><FilterOption count="19" label="201602"/><FilterOption count="19" label="201610"/><FilterOption count="18" label="200910"/><FilterOption count="18" label="201010"/><FilterOption count="18" label="201409"/><FilterOption count="17" label="200904"/><FilterOption count="17" label="201101"/><FilterOption count="17" label="201102"/><FilterOption count="17" label="201109"/><FilterOption count="17" label="201303"/><FilterOption count="17" label="201304"/><FilterOption count="17" label="201306"/><FilterOption count="17" label="201407"/><FilterOption count="17" label="201411"/><FilterOption count="17" label="201412"/></Filter><Filter label="Funder Type" name="trialFunderType" total="5"><FilterOption id="CMP" count="5600" label="Company"/><FilterOption id="ACA" count="1368" label="Academic"/><FilterOption id="OTH" count="45" label="Others"/><FilterOption id="GOV" count="43" label="Government"/><FilterOption id="NGO" count="26" label="Non-Government"/></Filter><Filter label="Trial Region" name="trialRegions" total="11"><FilterOption id="NSWE" count="6365" label="Northern, Southern &amp; Western Europe"/><FilterOption id="USCA" count="3860" label="US &amp; Canada"/><FilterOption id="EEUR" count="3500" label="Eastern Europe"/><FilterOption id="EAPO" count="2188" label="East Asia &amp; Pacific Ocean"/><FilterOption id="AUNZ" count="2132" label="Australia &amp; New Zealand"/><FilterOption id="MENA" count="1889" label="Middle East &amp; North Africa"/><FilterOption id="SOAM" count="1793" label="South America"/><FilterOption id="CAAC" count="1407" label="Central America &amp; Caribbean"/><FilterOption id="CSAF" count="912" label="Central &amp; Southern Africa"/><FilterOption id="SOCA" count="599" label="Southern &amp; Central Asia"/><FilterOption id="INDO" count="4" label="Indian Ocean"/></Filter><Filter label="Patient Segment Index" name="trialPatientSegmentIndex" total="100"><FilterOption id="3634" count="307" label="Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with metastatic/stage IV lung cancer"/><FilterOption id="3954" count="295" label="Breast tumor - Subjects with Advanced/Metastatic Breast Cancer/Stage IV Breast Cancer"/><FilterOption id="3617" count="283" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)"/><FilterOption id="10295" count="218" label="Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with locally advanced/stage III lung cancer"/><FilterOption id="7126" count="193" label="HIV infection - Subjects with HIV Infection - Subjects with HIV-1 Infection"/><FilterOption id="7961" count="185" label="Solid tumor - Subjects with Advanced/Metastatic Solid Tumors"/><FilterOption id="3623" count="161" label="Lung tumor - Subjects with Advanced Stage Lung Cancer"/><FilterOption id="3824" count="156" label="Colorectal tumor - Subjects with TNM stage IV/Metastatic/Advanced Colorectal Cancer"/><FilterOption id="3952" count="151" label="Breast tumor - Subjects with Locally Advanced Breast Cancer"/><FilterOption id="7967" count="145" label="Solid tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3965" count="144" label="Breast tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3937" count="142" label="Breast tumor - Subjects with HER-2 Negative Breast Cancer"/><FilterOption id="3530" count="131" label="Lymphoma - Subjects with Treatment Resistant Disease"/><FilterOption id="461" count="122" label="Hepatitis C virus infection - Subjects with Chronic Hepatitis C Infection"/><FilterOption id="3647" count="120" label="Lung tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3936" count="118" label="Breast tumor - Subjects with HER-2 Positive Breast Cancer"/><FilterOption id="3525" count="118" label="Lymphoma - Subjects with Relapse/Recurrent Lymphoma"/><FilterOption id="502" count="115" label="Rheumatoid arthritis - Active Rheumatoid Arthritis"/><FilterOption id="145" count="110" label="Non-insulin dependent diabetes - Subjects with Moderate Glycemic Control"/><FilterOption id="103" count="108" label="Non-insulin dependent diabetes - Subjects with Poor/Inadequate Glycemic Control"/><FilterOption id="3966" count="106" label="Breast tumor - Subjects with Relapsed/Recurrent Breast cancer"/><FilterOption id="3931" count="103" label="Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Estrogen receptor positive (ER+) breast cancer"/><FilterOption id="3564" count="102" label="Prostate tumor - Subjects with Advanced/Metastatic Prostate Cancer"/><FilterOption id="12053" count="100" label="Lung tumor - Treatment Naive Subjects"/><FilterOption id="8073" count="90" label="Pancreas tumor - Subjects with Advanced/Metastatic Pancreatic Cancer"/><FilterOption id="3650" count="89" label="Lung tumor - Subjects with Recurrent/Relapsed Lung Cancer"/><FilterOption id="3814" count="84" label="Colorectal tumor - Subjects with Colon Cancer"/><FilterOption id="513" count="84" label="Rheumatoid arthritis - Subjects with Treatment Resistant Disease"/><FilterOption id="7877" count="83" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC) - Subjects with non-squamous cell lung cancer"/><FilterOption id="3938" count="81" label="Breast tumor - Subjects with Triple Negative Breast Cancer"/><FilterOption id="3667" count="81" label="Melanoma - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="3945" count="77" label="Breast tumor - Subjects with Stage III Breast Cancer"/><FilterOption id="3956" count="75" label="Breast tumor - Subjects with Un-resectable/Non-operable Breast Cancer"/><FilterOption id="7487" count="75" label="Hepatitis C virus infection - Subjects Infected with HCV Genotype 1"/><FilterOption id="3500" count="72" label="Lymphoma - Subjects with Specific Grade of Lymphoma - Subjects with Indolent (slow-growing, low grade) Lymphoma"/><FilterOption id="3583" count="72" label="Prostate tumor - Subjects with Castrate Resistant Prostate Cancer"/><FilterOption id="3813" count="71" label="Colorectal tumor - Subjects with Rectal Cancer"/><FilterOption id="3977" count="71" label="Leukemia - Subjects with Acute Myeloid Leukemia (AML)"/><FilterOption id="3473" count="71" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma - Subjects with follicular lymphoma"/><FilterOption id="3926" count="70" label="Multiple myeloma - Subjects with Relapsed/Recurrent Multiple Myeloma"/><FilterOption id="3586" count="70" label="Prostate tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="8010" count="69" label="Stomach tumor - Subjects with Advanced/Metastatic Gastric Cancer"/><FilterOption id="3778" count="68" label="Head and neck tumor - Subjects with Specific Histological Sub-type of HNC - Subjects with squamous cell carcinoma"/><FilterOption id="3472" count="68" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma - Subjects with diffuse large B cell lymphoma"/><FilterOption id="3680" count="67" label="Melanoma - Subjects with Stage IV Melanoma"/><FilterOption id="100" count="67" label="Non-insulin dependent diabetes - Subjects on Treatment/Requiring &gt;1 Antidiabetic Agent"/><FilterOption id="3565" count="67" label="Prostate tumor - Subjects with Stage IV Prostate Cancer"/><FilterOption id="3774" count="66" label="Head and neck tumor - Subjects with Advanced/Metastatic Head and Neck Cancer"/><FilterOption id="3489" count="66" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma"/><FilterOption id="3923" count="66" label="Multiple myeloma - Subjects with Treatment Resistant Disease"/><FilterOption id="128" count="66" label="Multiple sclerosis - Subjects with Relapsing Remitting Multiple Sclerosis (RRMS)"/><FilterOption id="7415" count="65" label="Renal cell carcinoma - Subjects with Metastatic Renal Cell Carcinoma"/><FilterOption id="7810" count="63" label="Bladder cancer - Subjects with Metastatic Bladder Cancer"/><FilterOption id="3637" count="63" label="Lung tumor - Subjects with Unresectable/In-operable Lung Cancer"/><FilterOption id="538" count="63" label="Rheumatoid arthritis - Subjects on Rheumatoid Arthritis Therapy - Methotrexate"/><FilterOption id="12845" count="62" label="Breast tumor - Subjects with gene variants - ERBB2_HUMAN_Amplification"/><FilterOption id="10129" count="62" label="Lung tumor - Subjects with EGFR Positive Lung Cancer"/><FilterOption id="3502" count="62" label="Lymphoma - Subjects with Specific Grade of Lymphoma - Subjects with Aggressive (high grade) Lymphoma"/><FilterOption id="7960" count="62" label="Solid tumor - Subjects with Locally Advanced Solid Tumors"/><FilterOption id="7107" count="60" label="HIV infection - Treatment Naive Subjects"/><FilterOption id="4003" count="60" label="Leukemia - Subjects with Relapsed/Recurrent Leukemia"/><FilterOption id="7879" count="60" label="Ovary tumor - Subjects with Ovarian Epithelial Tumor"/><FilterOption id="12018" count="59" label="Prostate tumor - Subjects with adenocarcinoma of prostate"/><FilterOption id="3932" count="58" label="Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Progesterone receptor positive (PR+) breast cancer"/><FilterOption id="3980" count="58" label="Leukemia - Subjects with Chronic Lymphocytic Leukemia (CLL)"/><FilterOption id="3999" count="58" label="Leukemia - Subjects with Treatment Resistant Disease"/><FilterOption id="102" count="58" label="Non-insulin dependent diabetes - Subjects with Good Glycemic Control"/><FilterOption id="3860" count="57" label="Colorectal tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="3736" count="56" label="Chronic obstructive pulmonary disease - Subjects at risk of developing disease - Smokers"/><FilterOption id="562" count="56" label="Chronic obstructive pulmonary disease - Subjects with GOLD Stage 3/Severe COPD"/><FilterOption id="11954" count="55" label="Bladder cancer - Subjects with Urothelial cell/Transitional Cell Bladder Cancer"/><FilterOption id="8414" count="55" label="Pain - Subjects with Somatic Pain - Subjects with arthritic pain"/><FilterOption id="500" count="55" label="Rheumatoid arthritis - Severe Rheumatoid Arthritis"/><FilterOption id="561" count="54" label="Chronic obstructive pulmonary disease - Subjects with GOLD Stage 2/Moderate COPD"/><FilterOption id="489" count="54" label="Hepatitis C virus infection - Treatment Naive Subjects"/><FilterOption id="499" count="54" label="Rheumatoid arthritis - Moderate Rheumatoid Arthritis"/><FilterOption id="161" count="53" label="Alzheimers disease - Subjects with Mild Alzheimer's Disease"/><FilterOption id="7700" count="53" label="End stage renal disease - Subjects with Non-Dialysis Dependant Chronic Kidney Disease(NDD-CKD) - Subjects with stage 3 chronic kidney disease"/><FilterOption id="7108" count="53" label="HIV infection - Subjects on Prior/Concurrent Antiretroviral Therapy"/><FilterOption id="11612" count="52" label="Menopause - Subjects with Protocol Specified Menstrual Status - Postmenopausal Subjects"/><FilterOption id="3434" count="52" label="Psoriasis - Subjects with Plaque Psoriasis/Psoriasis Vulgaris"/><FilterOption id="7966" count="52" label="Solid tumor - Subjects with Relapsed/Recurrent Solid Tumors"/><FilterOption id="3950" count="51" label="Breast tumor - Subjects with Early Stage Breast Cancer"/><FilterOption id="3944" count="51" label="Breast tumor - Subjects with Stage II Breast Cancer"/><FilterOption id="7486" count="51" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC) - Subjects with squamous cell lung cancer"/><FilterOption id="108" count="51" label="Non-insulin dependent diabetes - Subjects with comorbid conditions - Subjects with obesity"/><FilterOption id="201" count="49" label="Coronary artery disease - Subjects Undergoing/Underwent Percutaneous Coronary Intervention (PCI)"/><FilterOption id="3681" count="49" label="Melanoma - Subjects with Evidence of Metastasis"/><FilterOption id="3698" count="49" label="Melanoma - Subjects with Surgically Non-resectable Melanoma"/><FilterOption id="7918" count="49" label="Ovary tumor - Advanced Ovarian Cancer Subjects - Stage IV or metastatic ovarian cancer subjects"/><FilterOption id="7402" count="49" label="Renal cell carcinoma - Subjects with Clear Cell Renal Cell Carcinoma"/><FilterOption id="11424" count="48" label="Pancreas tumor - Subjects with Adenocarcinoma of Pancreas"/><FilterOption id="9884" count="47" label="Hemophilia - Subjects with Severe Hemophilia"/><FilterOption id="3501" count="47" label="Lymphoma - Subjects with Specific Grade of Lymphoma - Subjects with Moderately Aggressive (intermediate grade) Lymphoma"/><FilterOption id="7414" count="47" label="Renal cell carcinoma - Advanced Stage Renal Cell Carcinoma"/><FilterOption id="8387" count="46" label="Pain - Subjects with Chronic Pain"/><FilterOption id="3452" count="45" label="Psoriasis - Subjects with Severe Psoriasis"/><FilterOption id="8025" count="45" label="Stomach tumor - Subjects with adenocarcinoma of the gastroesophageal junction"/><FilterOption id="9876" count="44" label="Hemophilia - Subjects with Hemophilia A"/><FilterOption id="7962" count="44" label="Solid tumor - Subjects with Unresectable Solid Tumors"/></Filter><Filter label="Primary Completion Filter by Month" name="trialPrimaryCompletionDateByMonth" total="100"><FilterOption count="125" label="201912"/><FilterOption count="66" label="202012"/><FilterOption count="65" label="201812"/><FilterOption count="64" label="201906"/><FilterOption count="64" label="202006"/><FilterOption count="63" label="201909"/><FilterOption count="61" label="201905"/><FilterOption count="61" label="202003"/><FilterOption count="57" label="201803"/><FilterOption count="56" label="201907"/><FilterOption count="55" label="201712"/><FilterOption count="55" label="201910"/><FilterOption count="50" label="201512"/><FilterOption count="49" label="201612"/><FilterOption count="47" label="201606"/><FilterOption count="47" label="201704"/><FilterOption count="47" label="201707"/><FilterOption count="47" label="201808"/><FilterOption count="47" label="201911"/><FilterOption count="46" label="201904"/><FilterOption count="46" label="202001"/><FilterOption count="45" label="201809"/><FilterOption count="45" label="201810"/><FilterOption count="44" label="201908"/><FilterOption count="44" label="202005"/><FilterOption count="44" label="202007"/><FilterOption count="43" label="201807"/><FilterOption count="42" label="201603"/><FilterOption count="42" label="201604"/><FilterOption count="42" label="201609"/><FilterOption count="42" label="201701"/><FilterOption count="42" label="201805"/><FilterOption count="42" label="201806"/><FilterOption count="41" label="201703"/><FilterOption count="41" label="201705"/><FilterOption count="41" label="201706"/><FilterOption count="41" label="201709"/><FilterOption count="41" label="202002"/><FilterOption count="40" label="201801"/><FilterOption count="40" label="201901"/><FilterOption count="39" label="201710"/><FilterOption count="39" label="202009"/><FilterOption count="38" label="201507"/><FilterOption count="38" label="201903"/><FilterOption count="38" label="202106"/><FilterOption count="37" label="201610"/><FilterOption count="37" label="201811"/><FilterOption count="37" label="202010"/><FilterOption count="36" label="201505"/><FilterOption count="36" label="201506"/><FilterOption count="36" label="201605"/><FilterOption count="36" label="201607"/><FilterOption count="36" label="201611"/><FilterOption count="36" label="202004"/><FilterOption count="36" label="202112"/><FilterOption count="35" label="201303"/><FilterOption count="35" label="201804"/><FilterOption count="35" label="202104"/><FilterOption count="35" label="202109"/><FilterOption count="34" label="201402"/><FilterOption count="34" label="201404"/><FilterOption count="33" label="201103"/><FilterOption count="33" label="201310"/><FilterOption count="33" label="201409"/><FilterOption count="33" label="201502"/><FilterOption count="33" label="201510"/><FilterOption count="33" label="201511"/><FilterOption count="33" label="201602"/><FilterOption count="33" label="202011"/><FilterOption count="32" label="201410"/><FilterOption count="32" label="201711"/><FilterOption count="31" label="201309"/><FilterOption count="31" label="201407"/><FilterOption count="30" label="201206"/><FilterOption count="30" label="201305"/><FilterOption count="30" label="201403"/><FilterOption count="30" label="201702"/><FilterOption count="30" label="202103"/><FilterOption count="29" label="201105"/><FilterOption count="29" label="201708"/><FilterOption count="28" label="201112"/><FilterOption count="28" label="201205"/><FilterOption count="28" label="201209"/><FilterOption count="28" label="201302"/><FilterOption count="28" label="201412"/><FilterOption count="28" label="202008"/><FilterOption count="28" label="202101"/><FilterOption count="27" label="201503"/><FilterOption count="26" label="200807"/><FilterOption count="26" label="201011"/><FilterOption count="26" label="201212"/><FilterOption count="26" label="201304"/><FilterOption count="26" label="201401"/><FilterOption count="26" label="201504"/><FilterOption count="26" label="201601"/><FilterOption count="26" label="202108"/><FilterOption count="25" label="200906"/><FilterOption count="25" label="200912"/><FilterOption count="25" label="201007"/><FilterOption count="25" label="201203"/></Filter><Filter label="Trial Country" name="trialCountries" total="100"><FilterOption id="ES" count="6306" label="Spain"/><FilterOption id="DE" count="3719" label="Germany"/><FilterOption id="US" count="3593" label="US"/><FilterOption id="FR" count="3479" label="France"/><FilterOption id="IT" count="3414" label="Italy"/><FilterOption id="GB" count="3210" label="UK"/><FilterOption id="CA" count="2652" label="Canada"/><FilterOption id="BE" count="2572" label="Belgium"/><FilterOption id="PL" count="2415" label="Poland"/><FilterOption id="AU" count="2095" label="Australia"/><FilterOption id="NL" count="2066" label="Netherlands"/><FilterOption id="RU" count="1803" label="Russian Federation"/><FilterOption id="HU" count="1736" label="Hungary"/><FilterOption id="CZ" count="1707" label="Czech Republic"/><FilterOption id="AT" count="1589" label="Austria"/><FilterOption id="SE" count="1474" label="Sweden"/><FilterOption id="KR" count="1440" label="South Korea"/><FilterOption id="IL" count="1391" label="Israel"/><FilterOption id="DK" count="1296" label="Denmark"/><FilterOption id="BR" count="1245" label="Brazil"/><FilterOption id="AR" count="1180" label="Argentina"/><FilterOption id="CH" count="1148" label="Switzerland"/><FilterOption id="MX" count="1136" label="Mexico"/><FilterOption id="TW" count="1098" label="Taiwan"/><FilterOption id="GR" count="1063" label="Greece"/><FilterOption id="RO" count="1025" label="Romania"/><FilterOption id="PT" count="1020" label="Portugal"/><FilterOption id="JP" count="980" label="Japan"/><FilterOption id="TR" count="906" label="Turkey"/><FilterOption id="ZA" count="897" label="South Africa"/><FilterOption id="FI" count="857" label="Finland"/><FilterOption id="BG" count="828" label="Bulgaria"/><FilterOption id="SK" count="751" label="Slovakia"/><FilterOption id="UA" count="734" label="Ukraine"/><FilterOption id="NO" count="710" label="Norway"/><FilterOption id="IE" count="661" label="Ireland"/><FilterOption id="NZ" count="577" label="New Zealand"/><FilterOption id="IN" count="574" label="India"/><FilterOption id="CL" count="573" label="Chile"/><FilterOption id="CN" count="555" label="China"/><FilterOption id="SG" count="537" label="Singapore"/><FilterOption id="HK" count="528" label="Hong Kong"/><FilterOption id="TH" count="477" label="Thailand"/><FilterOption id="CO" count="465" label="Colombia"/><FilterOption id="RS" count="440" label="Serbia"/><FilterOption id="LT" count="437" label="Lithuania"/><FilterOption id="PR" count="434" label="Puerto Rico"/><FilterOption id="HR" count="409" label="Croatia"/><FilterOption id="PE" count="405" label="Peru"/><FilterOption id="EE" count="395" label="Estonia"/><FilterOption id="LV" count="378" label="Latvia"/><FilterOption id="MY" count="373" label="Malaysia"/><FilterOption id="PH" count="287" label="Philippines"/><FilterOption id="X5" count="238" label="Europe"/><FilterOption id="SI" count="199" label="Slovenia"/><FilterOption id="GE" count="107" label="Georgia"/><FilterOption id="EG" count="105" label="Egypt"/><FilterOption id="BY" count="103" label="Belarus"/><FilterOption id="SA" count="101" label="Saudi Arabia"/><FilterOption id="BA" count="99" label="Bosnia and Herzegovina"/><FilterOption id="GT" count="99" label="Guatemala"/><FilterOption id="PA" count="95" label="Panama"/><FilterOption id="LB" count="94" label="Lebanon"/><FilterOption id="XD" count="89" label="North America"/><FilterOption id="VN" count="78" label="Vietnam"/><FilterOption id="X2" count="72" label="Asia"/><FilterOption id="CR" count="65" label="Costa Rica"/><FilterOption id="KP" count="57" label="North Korea"/><FilterOption id="IS" count="50" label="Iceland"/><FilterOption id="VE" count="50" label="Venezuela"/><FilterOption id="MK" count="45" label="Macedonia, The Former Yugoslav Republic of"/><FilterOption id="TN" count="44" label="Tunisia"/><FilterOption id="LU" count="42" label="Luxembourg"/><FilterOption id="XE" count="42" label="South America"/><FilterOption id="EU" count="41" label="EU"/><FilterOption id="AE" count="40" label="United Arab Emirates"/><FilterOption id="ID" count="36" label="Indonesia"/><FilterOption id="DO" count="33" label="Dominican Republic"/><FilterOption id="EC" count="33" label="Ecuador"/><FilterOption id="MD" count="33" label="Moldova, Republic of"/><FilterOption id="PK" count="33" label="Pakistan"/><FilterOption id="JO" count="28" label="Jordan"/><FilterOption id="DZ" count="23" label="Algeria"/><FilterOption id="MA" count="22" label="Morocco"/><FilterOption id="CY" count="19" label="Cyprus"/><FilterOption id="KZ" count="15" label="Kazakhstan"/><FilterOption id="UY" count="15" label="Uruguay"/><FilterOption id="SV" count="14" label="El Salvador"/><FilterOption id="ME" count="14" label="Montenegro"/><FilterOption id="MT" count="13" label="Malta"/><FilterOption id="KW" count="12" label="Kuwait"/><FilterOption id="LK" count="12" label="Sri Lanka"/><FilterOption id="XW" count="11" label="Western Europe"/><FilterOption id="BS" count="10" label="Bahamas"/><FilterOption id="MC" count="10" label="Monaco"/><FilterOption id="AS" count="9" label="American Samoa"/><FilterOption id="QA" count="9" label="Qatar"/><FilterOption id="X0" count="8" label="Africa"/><FilterOption id="AL" count="8" label="Albania"/><FilterOption id="OM" count="8" label="Oman"/></Filter><Filter label="Trial Patient Selection" name="trialTermsPatientSelection" total="17"><FilterOption id="EAMAA" count="5754" label="Middle-aged Adults (45-64 yrs)"/><FilterOption id="EAYAD" count="5705" label="Young Adults (18-44 yrs)"/><FilterOption id="EAAAD" count="5521" label="Aged Adults (65-79 yrs)"/><FilterOption id="EAELD" count="4723" label="Elderly Adults (80 and over)"/><FilterOption id="EAADL" count="635" label="Adolescents (13-17 yrs)"/><FilterOption id="EACHI" count="568" label="Children (6-12 yrs)"/><FilterOption id="EGFEM" count="557" label="Female"/><FilterOption id="EAPRE" count="343" label="Preschool Children (2-5 yrs)"/><FilterOption id="EGMAL" count="266" label="Male"/><FilterOption id="EVHVA" count="257" label="Healthy volunteers accepted"/><FilterOption id="EAINF" count="245" label="Infants (6-23 months)"/><FilterOption id="EANEW" count="195" label="Newborn Infants (up to 5 months)"/><FilterOption id="ECASI" count="68" label="Asian Ancestry"/><FilterOption id="ECJAP" count="66" label="Japanese Ancestry"/><FilterOption id="ECEUR" count="41" label="European Ancestry"/><FilterOption id="EVHVO" count="26" label="Healthy volunteers only"/><FilterOption id="ECAFR" count="13" label="African Ancestry"/></Filter><Filter label="Trial Terms Design" name="trialTermsDesign" total="27"><FilterOption id="SSTINV" count="5997" label="Interventional"/><FilterOption id="SIPTRE" count="5593" label="Treatment"/><FilterOption id="SIARND" count="4358" label="Randomized"/><FilterOption id="SISPRL" count="4357" label="Parallel Assignment"/><FilterOption id="SIMOPN" count="3063" label="Open Label"/><FilterOption id="SIMMBD" count="2673" label="Multiple Blind"/><FilterOption id="SICPLC" count="2308" label="Placebo Control"/><FilterOption id="SICACT" count="1458" label="Active Control"/><FilterOption id="SISSNG" count="1253" label="Single Group Assignment"/><FilterOption id="SIANON" count="1199" label="Non-Randomized"/><FilterOption id="SICNOC" count="896" label="No Control"/><FilterOption id="SSTOBS" count="518" label="Observational"/><FilterOption id="SIPPRE" count="377" label="Prevention"/><FilterOption id="SOTPRO" count="371" label="Prospective"/><FilterOption id="SOSCOH" count="326" label="Cohort"/><FilterOption id="SIMSBD" count="185" label="Single Blind"/><FilterOption id="SISXOV" count="130" label="Crossover Assignment"/><FilterOption id="SOTRET" count="114" label="Retrospective"/><FilterOption id="SODXSC" count="45" label="Cross-sectional"/><FilterOption id="SOSCSC" count="42" label="Case Control"/><FilterOption id="SICDSC" count="25" label="Dose Comparison"/><FilterOption id="SIPDIA" count="24" label="Diagnosis"/><FilterOption id="SODLNG" count="23" label="Longitudinal"/><FilterOption id="SICHST" count="21" label="Historical Control"/><FilterOption id="SISFCT" count="18" label="Factorial Assignment"/><FilterOption id="SISEAA" count="3" label="Expanded Access Assignment"/><FilterOption id="SOSDEF" count="2" label="Defined Population"/></Filter><Filter label="Trial Source" name="trialSources" total="3"><FilterOption id="CTGOVOTHERS" count="4021" label="ClinicalTrials.gov and others"/><FilterOption id="CTGOV" count="2265" label="ClinicalTrials.gov only"/><FilterOption id="OTHERS" count="180" label="Others only"/></Filter><Filter label="Trial Actions Secondary Interventions Primary" name="trialActionsSecondaryInterventionsPrimary" total="100"><FilterOption id="1545" count="2280" label="Anticancer"/><FilterOption id="2953" count="1514" label="Anti-inflammatory"/><FilterOption id="55685" count="1163" label="Anticancer monoclonal antibody"/><FilterOption id="62255" count="1101" label="Anticancer protein kinase inhibitor"/><FilterOption id="991" count="815" label="Antiviral"/><FilterOption id="1589" count="671" label="Apoptosis stimulator"/><FilterOption id="767" count="637" label="Cell cycle inhibitor"/><FilterOption id="61" count="591" label="Angiogenesis inhibitor"/><FilterOption id="7293" count="524" label="Synergist"/><FilterOption id="393" count="492" label="Immunostimulant"/><FilterOption id="7761" count="469" label="T-lymphocyte stimulator"/><FilterOption id="140" count="371" label="DNA synthesis inhibitor"/><FilterOption id="50" count="342" label="Anticancer alkylating agent"/><FilterOption id="1569" count="318" label="Anticancer antimetabolite"/><FilterOption id="1596" count="297" label="Immunomodulator"/><FilterOption id="15184" count="281" label="Systemic antipsoriatic product"/><FilterOption id="2946" count="279" label="Analgesic"/><FilterOption id="399" count="255" label="Hypoglycemic agent"/><FilterOption id="396" count="244" label="Immunosuppressant"/><FilterOption id="2657" count="239" label="Antihypertensive"/><FilterOption id="2576" count="234" label="Microtubule stabilizer"/><FilterOption id="2575" count="217" label="Microtubule inhibitor"/><FilterOption id="1615" count="202" label="Neuroprotectant"/><FilterOption id="2660" count="201" label="Vasoprotectant"/><FilterOption id="70" count="155" label="Anticonvulsant agent"/><FilterOption id="1594" count="128" label="Antibacterial"/><FilterOption id="2659" count="124" label="Cardioprotectant"/><FilterOption id="646" count="117" label="Bronchodilator"/><FilterOption id="12378" count="110" label="Prophylactic vaccine"/><FilterOption id="2947" count="109" label="Antiparkinsonian"/><FilterOption id="2941" count="107" label="Antidepressant"/><FilterOption id="284" count="95" label="Nootropic agent"/><FilterOption id="2667" count="93" label="Antiarteriosclerotic"/><FilterOption id="659" count="91" label="Coagulation inhibitor"/><FilterOption id="695" count="89" label="Metastasis inhibitor"/><FilterOption id="449" count="84" label="Antiarrhythmic agent"/><FilterOption id="439" count="84" label="RNA synthesis inhibitor"/><FilterOption id="750" count="82" label="DNA intercalator"/><FilterOption id="610" count="79" label="Hematopoietic stimulator"/><FilterOption id="382" count="79" label="TNF alpha synthesis inhibitor"/><FilterOption id="388" count="79" label="Vasodilator"/><FilterOption id="59620" count="77" label="Unspecified drug target"/><FilterOption id="2943" count="74" label="Antipsychotic"/><FilterOption id="805" count="73" label="Folate modulator"/><FilterOption id="71" count="70" label="Antihypercholesterolemic agent"/><FilterOption id="747" count="70" label="HIV replication inhibitor"/><FilterOption id="62254" count="69" label="Anticancer hormone antagonist"/><FilterOption id="12379" count="67" label="Therapeutic vaccine"/><FilterOption id="664" count="66" label="Fibrosuppressant"/><FilterOption id="539" count="61" label="Immunotoxin"/><FilterOption id="2942" count="60" label="Anxiolytic"/><FilterOption id="12372" count="59" label="Protein subunit vaccine"/><FilterOption id="968" count="58" label="Coagulation stimulator"/><FilterOption id="1470" count="56" label="Respiratory system agent"/><FilterOption id="72" count="55" label="Antihyperlipidemic agent"/><FilterOption id="38206" count="54" label="Biguanide antidiabetic product"/><FilterOption id="312" count="54" label="Platelet aggregation inhibitor"/><FilterOption id="55684" count="52" label="Anticancer antibody"/><FilterOption id="1332" count="51" label="Gastrointestinal system agent"/><FilterOption id="15319" count="48" label="Hepatitis C virus replication inhibitor"/><FilterOption id="15187" count="48" label="Systemic dermatological antibacterial product"/><FilterOption id="89" count="46" label="Bone resorption inhibitor"/><FilterOption id="15128" count="45" label="Ophthalmological agent"/><FilterOption id="2954" count="44" label="Steroidal anti-inflammatory"/><FilterOption id="7292" count="44" label="Vulnerary agent"/><FilterOption id="1538" count="42" label="Bacterial protein synthesis inhibitor"/><FilterOption id="285" count="42" label="Norepinephrine uptake inhibitor"/><FilterOption id="12371" count="42" label="Subunit vaccine"/><FilterOption id="7760" count="42" label="T-lymphocyte inhibitor"/><FilterOption id="3189" count="41" label="Corticosteroid agonist"/><FilterOption id="1532" count="38" label="Viral replication inhibitor"/><FilterOption id="2970" count="35" label="Anti-emetic"/><FilterOption id="104" count="34" label="Bacterial cell wall synthesis inhibitor"/><FilterOption id="1748" count="32" label="Fungicide"/><FilterOption id="12367" count="30" label="Inactivated viral vaccine"/><FilterOption id="463" count="30" label="Ribosome binding agent"/><FilterOption id="3" count="29" label="5-HT uptake inhibitor"/><FilterOption id="5580" count="29" label="Chemotaxis inhibitor"/><FilterOption id="12596" count="29" label="Osteoclast inhibitor"/><FilterOption id="937" count="28" label="Androgen synthesis inhibitor"/><FilterOption id="5704" count="28" label="B-lymphocyte adhesion inhibitor"/><FilterOption id="5710" count="28" label="B-lymphocyte migration inhibitor"/><FilterOption id="38439" count="28" label="DPP IV inhibitor antidiabetic product"/><FilterOption id="12364" count="26" label="Live attenuated viral vaccine"/><FilterOption id="74" count="25" label="Antioxidant agent"/><FilterOption id="7294" count="25" label="Antisense oligonucleotide inhibitor"/><FilterOption id="2939" count="25" label="CNS modulator"/><FilterOption id="137" count="25" label="Diuretic agent"/><FilterOption id="7220" count="25" label="Neoplasm diagnostic agent"/><FilterOption id="15148" count="25" label="Ocular antineovascularisation agent"/><FilterOption id="3272" count="24" label="Growth hormone release inhibitor"/><FilterOption id="15180" count="24" label="Topical antipruritic product"/><FilterOption id="1570" count="23" label="Allergen"/><FilterOption id="7018" count="23" label="Antihypertriglyceridemic agent"/><FilterOption id="11593" count="23" label="DNA repair inhibitor"/><FilterOption id="38212" count="23" label="Human insulin intermediate acting product"/><FilterOption id="1590" count="22" label="Apoptosis inhibitor"/><FilterOption id="1540" count="22" label="Macrolide antibiotic"/><FilterOption id="12370" count="22" label="Recombinant viral vector vaccine"/><FilterOption id="966" count="21" label="Cardiac agent"/></Filter><Filter label="Trial Endpoint Achieved" name="trialEndpointsAchieved" total="3"><FilterOption id="UNSPECIFIED" count="1748" label="Unspecified"/><FilterOption id="YES" count="1227" label="Yes"/><FilterOption id="NO" count="456" label="No"/></Filter><Filter label="Endpoint Index Secondary" name="trialEndpointIndexSecondary" total="100"><FilterOption id="8712" count="217" label="Breast tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8489" count="206" label="Lung tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8481" count="195" label="Lung tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8719" count="188" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="8663" count="184" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8998" count="161" label="Breast tumor - Assessment of adverse events"/><FilterOption id="8738" count="154" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of duration of tumor response"/><FilterOption id="8522" count="153" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of duration of response"/><FilterOption id="15312" count="149" label="Solid tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8505" count="142" label="Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"/><FilterOption id="8713" count="136" label="Breast tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8514" count="125" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="8639" count="120" label="Lung tumor - Assessment of Safety and Tolerability"/><FilterOption id="8513" count="114" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="9153" count="114" label="Lung tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="7538" count="114" label="Lymphoma - Assessment of Overall Survival (OS)"/><FilterOption id="9122" count="104" label="Breast tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="9215" count="101" label="HIV infection - Assessment of CD4 Cell Responses - Assessment of CD4 cell count/percentage"/><FilterOption id="7547" count="101" label="Lymphoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8721" count="99" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="7611" count="99" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of tumor response rate (Duration of response)"/><FilterOption id="15207" count="98" label="Solid tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8187" count="95" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of Objective/Overall Response Rate (ORR)"/><FilterOption id="15212" count="95" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"/><FilterOption id="8996" count="90" label="Breast tumor - Assessment of Safety and Tolerability"/><FilterOption id="8722" count="89" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Clinical Benefit Rate (CBR)"/><FilterOption id="1503" count="89" label="Non-insulin dependent diabetes - Anthropometric Assessments - Assessment of body weight"/><FilterOption id="8720" count="88" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="7879" count="88" label="Leukemia - Assessment of Overall Survival (OS)"/><FilterOption id="9213" count="86" label="HIV infection - Assessment of Viral Load - Assessment of HIV RNA levels"/><FilterOption id="7680" count="85" label="Lymphoma - Assessment of adverse events"/><FilterOption id="9218" count="84" label="HIV infection - Assessment of Immune Response"/><FilterOption id="8640" count="84" label="Lung tumor - Assessment of Safety and Tolerability - Adverse events as graded by CTCAE/CTC"/><FilterOption id="8430" count="83" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="15218" count="82" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of duration of tumor response"/><FilterOption id="8151" count="81" label="Colorectal tumor - Assessment of Overall Survival (OS)"/><FilterOption id="9247" count="80" label="HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="8523" count="80" label="Lung tumor - Assessment of Disease Progression"/><FilterOption id="7563" count="79" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="8078" count="77" label="Leukemia - Assessment of adverse events"/><FilterOption id="3900" count="77" label="Rheumatoid arthritis - DAS-28 (Disease Activity Score) Response"/><FilterOption id="7569" count="76" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="8516" count="73" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Stable Disease"/><FilterOption id="8519" count="73" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Tumor Growth Control Rate (TGCR)"/><FilterOption id="22595" count="72" label="End stage renal disease - Assessment of adverse events"/><FilterOption id="6863" count="72" label="Hepatitis C virus infection - Assessment of Viral Load/Viral Kinetics"/><FilterOption id="8163" count="70" label="Colorectal tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8189" count="70" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of duration of response"/><FilterOption id="1345" count="70" label="Non-insulin dependent diabetes - Glycemic Control Analysis - Assessment of fasting blood glucose"/><FilterOption id="15287" count="68" label="Solid tumor - Assessment of adverse events"/><FilterOption id="2622" count="66" label="Coronary artery disease - Assessment of Mortality/Death Rates - Cardiovascular mortality"/><FilterOption id="26033" count="66" label="Pain - Assessment of adverse events"/><FilterOption id="6940" count="65" label="Melanoma - Assessment of Response Rates (RR) - Assessment of overall/objective response rate"/><FilterOption id="10828" count="65" label="Ovary tumor - Assessment of Overall Survival (OS)"/><FilterOption id="7354" count="64" label="Multiple myeloma - Assessment of Overall Survival (OS)"/><FilterOption id="8555" count="62" label="Lung tumor - Assessment of Mortality/Death Rates"/><FilterOption id="6924" count="61" label="Melanoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="7908" count="59" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="8651" count="59" label="Lung tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="6919" count="59" label="Melanoma - Assessment of Overall Survival (OS)"/><FilterOption id="10830" count="58" label="Ovary tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="37159" count="56" label="Breast tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="7564" count="56" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="4000" count="56" label="Rheumatoid arthritis - Assessment of Inflammatory &amp; Oxidative Stress Markers - Assessment of C-reactive protein (CRP)/high sensitivity C-reactive protein (hs-CRP)"/><FilterOption id="8759" count="55" label="Breast tumor - Patient Reported Outcomes/Quality of Life Assessments"/><FilterOption id="10939" count="55" label="Ovary tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="13357" count="55" label="Pancreas tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"/><FilterOption id="8725" count="54" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Stable Disease"/><FilterOption id="8451" count="54" label="Colorectal tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="15215" count="54" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="7393" count="53" label="Multiple myeloma - Assessment of Response Rates (RR) - Assessment of tumor response rate (Duration of response)"/><FilterOption id="25959" count="53" label="Pain - Assessment of Functional Disability/Physical Function"/><FilterOption id="8999" count="52" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of safety as measured by NCI CTCAE/NCI-CTC criteria"/><FilterOption id="7367" count="52" label="Multiple myeloma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="1626" count="52" label="Non-insulin dependent diabetes - Assessment of Adverse Events"/><FilterOption id="13352" count="52" label="Pancreas tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="11717" count="51" label="Bladder cancer - Assessment of Overall Survival (OS)"/><FilterOption id="7679" count="51" label="Lymphoma - Assessment of Safety and Tolerability"/><FilterOption id="7045" count="51" label="Prostate tumor - Assessment of Overall Survival (OS)"/><FilterOption id="10540" count="51" label="Renal cell carcinoma - Assessment of Overall Survival (OS)"/><FilterOption id="3884" count="51" label="Rheumatoid arthritis - American College of Rheumatology (ACR) 50 Response"/><FilterOption id="8744" count="50" label="Breast tumor - Assessment of Disease Progression"/><FilterOption id="1624" count="50" label="Non-insulin dependent diabetes - Assessment of Safety and Tolerability"/><FilterOption id="8997" count="49" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of serious adverse events"/><FilterOption id="3736" count="49" label="Hepatitis C virus infection - Assessment of Sustained Virologic Response (SVR)"/><FilterOption id="7909" count="49" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="8641" count="49" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of frequency and severity of adverse events"/><FilterOption id="7049" count="49" label="Prostate tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="12156" count="49" label="Stomach tumor - Assessment of Response Rates (RR) - Assessment of objective/overall response rate (ORR)"/><FilterOption id="8508" count="48" label="Lung tumor - Assessment of Overall Response"/><FilterOption id="3885" count="48" label="Rheumatoid arthritis - American College of Rheumatology (ACR) 70 Response"/><FilterOption id="28074" count="47" label="Lung tumor - Patient Reported Outcomes/Quality of Life Assessments - Assessment by EORTC QLQ-C30"/><FilterOption id="7360" count="47" label="Multiple myeloma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="11722" count="46" label="Bladder cancer - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8563" count="46" label="Lung tumor - Patient Reported Outcomes/Quality of Life Assessments"/><FilterOption id="25874" count="46" label="Pain - Assessment of Intensity of Pain - Based on Visual analog scale[VAS]"/><FilterOption id="25986" count="46" label="Pain - Patient Reported Outcomes/Quality of Life Assessments - Assessment by Patient Global Impression Scale (PGI)"/><FilterOption id="11728" count="45" label="Bladder cancer - Assessment of Response Rates (RR) - Assessment of objective/overall response rate (ORR)"/><FilterOption id="8745" count="45" label="Breast tumor - Assessment of Disease Progression - Assessment of Time to Tumor Progression (TTP)"/><FilterOption id="7027" count="45" label="Melanoma - Assessment of adverse events"/></Filter><Filter label="Biomarker" name="trialBiomarkerNames" total="100"><FilterOption id="1211" count="637" label="Alanine transaminase"/><FilterOption id="12058" count="569" label="Total body mass"/><FilterOption id="2527" count="547" label="Aspartate aminotransferase"/><FilterOption id="1236" count="453" label="Hemoglobin"/><FilterOption id="213" count="441" label="Creatinine"/><FilterOption id="2054" count="438" label="Blood platelets"/><FilterOption id="1904" count="416" label="Heart rate"/><FilterOption id="46" count="404" label="C-reactive protein"/><FilterOption id="1735" count="376" label="Glucose"/><FilterOption id="1925" count="362" label="Neutrophils"/><FilterOption id="2586" count="343" label="Blood pressure"/><FilterOption id="2387" count="340" label="Bilirubin"/><FilterOption id="3" count="330" label="HER2"/><FilterOption id="330" count="308" label="Systolic blood pressure"/><FilterOption id="125" count="306" label="Leukocyte count"/><FilterOption id="217" count="272" label="Triglycerides"/><FilterOption id="332" count="270" label="Diastolic blood pressure"/><FilterOption id="133" count="268" label="Total cholesterol"/><FilterOption id="152" count="262" label="Low-density lipoprotein cholesterol"/><FilterOption id="4806" count="254" label="Lymphocytes"/><FilterOption id="28899" count="253" label="Alkaline phosphatase"/><FilterOption id="289" count="249" label="Hemoglobin A, glycosylated"/><FilterOption id="153" count="234" label="High-density lipoprotein cholesterol"/><FilterOption id="118" count="223" label="Albumin"/><FilterOption id="1857" count="216" label="T-cell surface glycoprotein CD4"/><FilterOption id="8" count="210" label="Epidermal growth factor receptor"/><FilterOption id="824" count="201" label="Programmed cell death 1 ligand 1"/><FilterOption id="7895" count="194" label="Estimated glomerular filtration rate"/><FilterOption id="44216" count="187" label="Body temperature"/><FilterOption id="113" count="182" label="Body Mass Index"/><FilterOption id="5" count="179" label="Estrogen receptor"/><FilterOption id="1880" count="168" label="T-Helper Lymphocytes"/><FilterOption id="2098" count="161" label="Potassium"/><FilterOption id="2713" count="155" label="Forced expiratory volume"/><FilterOption id="2417" count="152" label="Calcium"/><FilterOption id="176" count="151" label="Interleukin-6"/><FilterOption id="148" count="151" label="QT interval"/><FilterOption id="2662" count="150" label="Sodium"/><FilterOption id="8458" count="149" label="gamma-Glutamyltransferase"/><FilterOption id="14767" count="141" label="Lipids"/><FilterOption id="3447" count="141" label="T-cell surface glycoprotein CD8 alpha chain"/><FilterOption id="8024" count="139" label="Creatine kinase"/><FilterOption id="4522" count="138" label="Erythrocytes"/><FilterOption id="6" count="130" label="Progesterone receptor"/><FilterOption id="1289" count="126" label="Tumor mass"/><FilterOption id="1221" count="125" label="Hematocrit"/><FilterOption id="248" count="123" label="Eosinophils"/><FilterOption id="52" count="123" label="GTPase KRas"/><FilterOption id="30214" count="122" label="Joint swelling"/><FilterOption id="46506" count="121" label="T-Lymphocytes"/><FilterOption id="17697" count="120" label="Body height"/><FilterOption id="6663" count="118" label="B-lymphocytes"/><FilterOption id="46505" count="116" label="Cytotoxic T-Lymphocytes"/><FilterOption id="30217" count="116" label="Joint tenderness"/><FilterOption id="7033" count="113" label="Lipase"/><FilterOption id="2358" count="113" label="Urea nitrogen"/><FilterOption id="36136" count="112" label="Cytokines"/><FilterOption id="44218" count="112" label="Human immunodeficiency virus RNA"/><FilterOption id="1945" count="111" label="Left ventricular ejection fraction"/><FilterOption id="82" count="110" label="B-Raf proto-oncogene serine/threonine-protein kinase"/><FilterOption id="147" count="106" label="Six-minute walk distance"/><FilterOption id="38" count="105" label="Prostate-specific antigen"/><FilterOption id="106" count="101" label="N-terminal Pro Brain Natriuretic Peptide"/><FilterOption id="274" count="101" label="Tumor necrosis factor"/><FilterOption id="154" count="98" label="Lactate dehydrogenase"/><FilterOption id="10260" count="98" label="Respiratory frequency"/><FilterOption id="808" count="97" label="Insulin"/><FilterOption id="44186" count="94" label="Hepatitis C virus RNA"/><FilterOption id="288" count="93" label="Uric acid"/><FilterOption id="1912" count="92" label="Forced Vital Capacity"/><FilterOption id="8097" count="90" label="Monocytes"/><FilterOption id="5700" count="87" label="ALK receptor"/><FilterOption id="781" count="87" label="Erythrocyte sedimentation rate"/><FilterOption id="18315" count="84" label="Visual acuity"/><FilterOption id="3374" count="83" label="Bone mineral density"/><FilterOption id="9807" count="81" label="Basophils"/><FilterOption id="1183" count="78" label="Urinary albumin to creatinine ratio"/><FilterOption id="252" count="77" label="Interferon gamma"/><FilterOption id="11857" count="77" label="Transaminases"/><FilterOption id="11114" count="75" label="Brain"/><FilterOption id="6993" count="74" label="Alpha-amylase 1"/><FilterOption id="418" count="74" label="Waist circumference"/><FilterOption id="7" count="73" label="Antigen KI-67"/><FilterOption id="3247" count="73" label="Chlorides"/><FilterOption id="1731" count="72" label="B-lymphocyte antigen CD20"/><FilterOption id="3451" count="72" label="Immunoglobulin G"/><FilterOption id="12516" count="71" label="Urinary protein"/><FilterOption id="2626" count="69" label="Total protein"/><FilterOption id="19714" count="68" label="Muscle strength"/><FilterOption id="3083" count="68" label="Phosphate"/><FilterOption id="2382" count="68" label="Phosphorus"/><FilterOption id="215" count="65" label="Apolipoprotein B-100"/><FilterOption id="22" count="65" label="Breast cancer type 1 susceptibility protein"/><FilterOption id="41" count="64" label="Breast cancer type 2 susceptibility protein"/><FilterOption id="64" count="61" label="Circulating Tumor Cells"/><FilterOption id="10684" count="60" label="Blood cells"/><FilterOption id="71" count="60" label="CA-125 antigen"/><FilterOption id="92" count="60" label="Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform"/><FilterOption id="214" count="57" label="Apolipoprotein A-I"/><FilterOption id="2515" count="57" label="Magnesium"/></Filter><Filter label="Trial Terms Endpoint" name="trialTermsEndpoint" total="6"><FilterOption id="SIEEFC" count="5866" label="Efficacy"/><FilterOption id="SIESFT" count="5676" label="Safety"/><FilterOption id="SIEPCK" count="2717" label="Pharmacokinetics"/><FilterOption id="SIEPCD" count="1574" label="Pharmacodynamics"/><FilterOption id="SIEBAV" count="26" label="Bioavailability"/><FilterOption id="SIEBEQ" count="24" label="Bioequivalence"/></Filter><Filter label="Trial Interventions Primary In Regimen Name Display" name="trialInterventionsPrimaryInRegimenNameDisplay" total="100"><FilterOption id="3803" count="171" label="paclitaxel"/><FilterOption id="44383" count="152" label="carboplatin"/><FilterOption id="3199" count="126" label="gemcitabine"/><FilterOption id="8047" count="103" label="bevacizumab"/><FilterOption id="2953" count="99" label="docetaxel"/><FilterOption id="54804" count="93" label="nivolumab"/><FilterOption id="6736" count="87" label="rituximab"/><FilterOption id="3792" count="83" label="oxaliplatin"/><FilterOption id="12205" count="75" label="capecitabine"/><FilterOption id="5369" count="71" label="ribavirin"/><FilterOption id="72699" count="70" label="atezolizumab"/><FilterOption id="70667" count="66" label="pembrolizumab"/><FilterOption id="3536" count="65" label="pemetrexed disodium"/><FilterOption id="6386" count="65" label="trastuzumab"/><FilterOption id="2871" count="60" label="irinotecan"/><FilterOption id="7310" count="59" label="ritonavir"/><FilterOption id="23625" count="56" label="peginterferon alfa-2a"/><FilterOption id="36630" count="52" label="ipilimumab"/><FilterOption id="29016" count="47" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"/><FilterOption id="15954" count="44" label="bortezomib"/><FilterOption id="6050" count="44" label="metformin hydrochloride"/><FilterOption id="10388" count="43" label="cetuximab"/><FilterOption id="3072" count="41" label="etoposide phosphate"/><FilterOption id="27572" count="36" label="lenalidomide"/><FilterOption id="81193" count="34" label="durvalumab"/><FilterOption id="13340" count="33" label="everolimus"/><FilterOption id="47000" count="32" label="bendamustine"/><FilterOption id="11961" count="32" label="erlotinib"/><FilterOption id="3313" count="31" label="fulvestrant"/><FilterOption id="2784" count="31" label="letrozole"/><FilterOption id="6156" count="25" label="fludarabine"/><FilterOption id="28532" count="25" label="pertuzumab"/><FilterOption id="10309" count="24" label="abiraterone"/><FilterOption id="3669" count="24" label="mycophenolate mofetil"/><FilterOption id="53227" count="24" label="obinutuzumab"/><FilterOption id="32981" count="23" label="darunavir"/><FilterOption id="7934" count="22" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="13022" count="22" label="epirubicin"/><FilterOption id="55237" count="22" label="ibrutinib"/><FilterOption id="3081" count="21" label="exemestane"/><FilterOption id="33591" count="21" label="lapatinib"/><FilterOption id="4529" count="21" label="temozolomide"/><FilterOption id="53200" count="20" label="daratumumab"/><FilterOption id="4510" count="20" label="tacrolimus"/><FilterOption id="6408" count="20" label="vinorelbine"/><FilterOption id="56544" count="19" label="cobimetinib"/><FilterOption id="12646" count="19" label="panitumumab"/><FilterOption id="37370" count="18" label="azacitidine"/><FilterOption id="71886" count="18" label="ribavirin (oral tablet, HCV), Roche"/><FilterOption id="14681" count="17" label="lopinavir + ritonavir"/><FilterOption id="27696" count="16" label="pomalidomide"/><FilterOption id="96193" count="16" label="spartalizumab"/><FilterOption id="12973" count="16" label="sunitinib"/><FilterOption id="70895" count="16" label="venetoclax"/><FilterOption id="15254" count="15" label="atazanavir"/><FilterOption id="2836" count="15" label="clopidogrel"/><FilterOption id="58741" count="15" label="daclatasvir"/><FilterOption id="45902" count="15" label="ramucirumab"/><FilterOption id="55288" count="15" label="trametinib"/><FilterOption id="72538" count="14" label="abemaciclib"/><FilterOption id="48181" count="14" label="lamivudine + abacavir, GlaxoSmithKline"/><FilterOption id="45841" count="14" label="lenvatinib mesylate"/><FilterOption id="16063" count="14" label="olaparib"/><FilterOption id="10271" count="14" label="palbociclib"/><FilterOption id="65360" count="14" label="ribociclib"/><FilterOption id="49219" count="14" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="45562" count="14" label="tremelimumab"/><FilterOption id="61901" count="13" label="buparlisib"/><FilterOption id="54601" count="13" label="carfilzomib"/><FilterOption id="53133" count="13" label="dabrafenib"/><FilterOption id="3474" count="13" label="lamivudine"/><FilterOption id="39069" count="13" label="simeprevir"/><FilterOption id="29831" count="13" label="sorafenib"/><FilterOption id="14163" count="12" label="adalimumab"/><FilterOption id="3321" count="12" label="anastrozole"/><FilterOption id="5999" count="12" label="ciclosporin, Novartis"/><FilterOption id="10172" count="12" label="efavirenz"/><FilterOption id="54488" count="12" label="raltegravir"/><FilterOption id="10096" count="12" label="telaprevir"/><FilterOption id="12731" count="12" label="tipranavir"/><FilterOption id="2807" count="11" label="atorvastatin"/><FilterOption id="83065" count="11" label="avelumab"/><FilterOption id="61668" count="11" label="faldaprevir"/><FilterOption id="83873" count="11" label="osimertinib"/><FilterOption id="65416" count="11" label="sofosbuvir"/><FilterOption id="14493" count="11" label="tenofovir disoproxil fumarate"/><FilterOption id="65353" count="10" label="alpelisib"/><FilterOption id="51160" count="10" label="nintedanib"/><FilterOption id="44314" count="10" label="tamoxifen"/><FilterOption id="54469" count="10" label="vemurafenib"/><FilterOption id="39209" count="9" label="axitinib"/><FilterOption id="55305" count="9" label="binimetinib"/><FilterOption id="59062" count="9" label="dolutegravir"/><FilterOption id="53981" count="9" label="enzalutamide"/><FilterOption id="3130" count="9" label="filgrastim"/><FilterOption id="11603" count="9" label="gefitinib"/><FilterOption id="59460" count="9" label="isatuximab"/><FilterOption id="11519" count="9" label="mitoxantrone"/><FilterOption id="50341" count="9" label="neratinib"/><FilterOption id="4126" count="9" label="pioglitazone"/></Filter><Filter label="Trial Document Source" name="trialDocumentSource" total="5"><FilterOption id="OTHER" count="2542" label="Other Publications"/><FilterOption id="PR" count="2427" label="Press Releases"/><FilterOption id="SERIAL" count="2315" label="Serial Publications"/><FilterOption id="CORPORATE" count="598" label="Corporate Publications"/><FilterOption id="CONFERENCE" count="556" label="Conference Reports"/></Filter><Filter label="Trial Interventions Primary Alone Name Display" name="trialInterventionsPrimaryAloneNameDisplay" total="100"><FilterOption id="54804" count="46" label="nivolumab"/><FilterOption id="14163" count="36" label="adalimumab"/><FilterOption id="55275" count="29" label="secukinumab"/><FilterOption id="72699" count="26" label="atezolizumab"/><FilterOption id="4567" count="24" label="etanercept"/><FilterOption id="81193" count="23" label="durvalumab"/><FilterOption id="70667" count="22" label="pembrolizumab"/><FilterOption id="32677" count="22" label="rivaroxaban"/><FilterOption id="16063" count="21" label="olaparib"/><FilterOption id="45499" count="21" label="tofacitinib citrate (oral, inflammation), Pfizer"/><FilterOption id="74726" count="21" label="upadacitinib"/><FilterOption id="24343" count="20" label="dabigatran etexilate"/><FilterOption id="6259" count="20" label="tocilizumab (intravenous), Roche/Chugai"/><FilterOption id="13340" count="18" label="everolimus"/><FilterOption id="12973" count="18" label="sunitinib"/><FilterOption id="52967" count="17" label="apixaban"/><FilterOption id="11961" count="17" label="erlotinib"/><FilterOption id="27572" count="17" label="lenalidomide"/><FilterOption id="83873" count="17" label="osimertinib"/><FilterOption id="43738" count="17" label="pazopanib"/><FilterOption id="8047" count="16" label="bevacizumab"/><FilterOption id="53981" count="16" label="enzalutamide"/><FilterOption id="10154" count="16" label="fingolimod"/><FilterOption id="35644" count="16" label="methoxy polyethylene glycol-epoetin beta"/><FilterOption id="58782" count="16" label="sacubitril + valsartan trisodium hemipentahydrate"/><FilterOption id="6850" count="15" label="infliximab"/><FilterOption id="17814" count="15" label="pregabalin"/><FilterOption id="6736" count="15" label="rituximab"/><FilterOption id="2953" count="14" label="docetaxel"/><FilterOption id="29831" count="14" label="sorafenib"/><FilterOption id="44897" count="13" label="apremilast"/><FilterOption id="59098" count="13" label="baricitinib"/><FilterOption id="12205" count="13" label="capecitabine"/><FilterOption id="3089" count="13" label="eptacog alfa (activated)"/><FilterOption id="14681" count="13" label="lopinavir + ritonavir"/><FilterOption id="8165" count="13" label="tiotropium bromide"/><FilterOption id="36669" count="13" label="trastuzumab emtansine"/><FilterOption id="48946" count="12" label="dasatinib"/><FilterOption id="10606" count="12" label="eltrombopag"/><FilterOption id="55237" count="12" label="ibrutinib"/><FilterOption id="3803" count="12" label="paclitaxel"/><FilterOption id="77337" count="12" label="risankizumab"/><FilterOption id="42858" count="12" label="ustekinumab"/><FilterOption id="54449" count="11" label="afatinib"/><FilterOption id="47733" count="11" label="canakinumab"/><FilterOption id="65240" count="11" label="evolocumab"/><FilterOption id="42857" count="11" label="golimumab"/><FilterOption id="36630" count="11" label="ipilimumab"/><FilterOption id="51388" count="11" label="nilotinib"/><FilterOption id="36332" count="11" label="ticagrelor"/><FilterOption id="69858" count="10" label="ceritinib"/><FilterOption id="52192" count="10" label="dapagliflozin propanediol"/><FilterOption id="58762" count="10" label="empagliflozin"/><FilterOption id="6050" count="10" label="metformin hydrochloride"/><FilterOption id="54624" count="10" label="regorafenib"/><FilterOption id="72538" count="9" label="abemaciclib"/><FilterOption id="37592" count="9" label="brivaracetam"/><FilterOption id="15593" count="9" label="eculizumab"/><FilterOption id="51255" count="9" label="edoxaban"/><FilterOption id="67629" count="9" label="filgotinib"/><FilterOption id="14336" count="9" label="fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"/><FilterOption id="47941" count="9" label="GSK-1437173A"/><FilterOption id="64060" count="9" label="guselkumab"/><FilterOption id="9313" count="9" label="lanreotide"/><FilterOption id="52854" count="9" label="macitentan"/><FilterOption id="51160" count="9" label="nintedanib"/><FilterOption id="54662" count="9" label="ruxolitinib (oral, myeloproliferative disorders), Incyte/Novartis"/><FilterOption id="29717" count="8" label="aliskiren"/><FilterOption id="5871" count="8" label="bosentan"/><FilterOption id="50935" count="8" label="cabozantinib S-malate"/><FilterOption id="55798" count="8" label="crizotinib"/><FilterOption id="49721" count="8" label="denosumab"/><FilterOption id="28773" count="8" label="eribulin mesylate"/><FilterOption id="32355" count="8" label="indacaterol"/><FilterOption id="62451" count="8" label="ixekizumab"/><FilterOption id="25049" count="8" label="laquinimod"/><FilterOption id="3669" count="8" label="mycophenolate mofetil"/><FilterOption id="4151" count="8" label="pramipexole"/><FilterOption id="8713" count="8" label="sildenafil citrate"/><FilterOption id="6386" count="8" label="trastuzumab"/><FilterOption id="2765" count="8" label="zoledronic acid"/><FilterOption id="69066" count="7" label="alectinib"/><FilterOption id="18425" count="7" label="ambrisentan"/><FilterOption id="7781" count="7" label="aripiprazole"/><FilterOption id="100097" count="7" label="bictegravir + emtricitabine + tenofovir alafenamide (HIV-1 infection), Gilead"/><FilterOption id="28035" count="7" label="cabazitaxel"/><FilterOption id="21138" count="7" label="certolizumab pegol"/><FilterOption id="53133" count="7" label="dabrafenib"/><FilterOption id="61317" count="7" label="daprodustat (oral, anemia), GlaxoSmithKline"/><FilterOption id="54082" count="7" label="fremanezumab"/><FilterOption id="3199" count="7" label="gemcitabine"/><FilterOption id="37613" count="7" label="maraviroc"/><FilterOption id="48638" count="7" label="ocrelizumab"/><FilterOption id="56776" count="7" label="SHP-647"/><FilterOption id="2716" count="6" label="alemtuzumab"/><FilterOption id="31831" count="6" label="belimumab"/><FilterOption id="98856" count="6" label="BMS-986165"/><FilterOption id="30379" count="6" label="bosutinib"/><FilterOption id="57592" count="6" label="canagliflozin"/><FilterOption id="59953" count="6" label="capmatinib"/></Filter><Filter label="Trial Interventions Control In Regimen Name Display" name="trialInterventionsControlInRegimenNameDisplay" total="100"><FilterOption id="44383" count="107" label="carboplatin"/><FilterOption id="3803" count="81" label="paclitaxel"/><FilterOption id="3199" count="63" label="gemcitabine"/><FilterOption id="2953" count="43" label="docetaxel"/><FilterOption id="8047" count="42" label="bevacizumab"/><FilterOption id="3792" count="42" label="oxaliplatin"/><FilterOption id="6736" count="39" label="rituximab"/><FilterOption id="3536" count="37" label="pemetrexed disodium"/><FilterOption id="6386" count="34" label="trastuzumab"/><FilterOption id="12205" count="33" label="capecitabine"/><FilterOption id="6050" count="24" label="metformin hydrochloride"/><FilterOption id="7310" count="24" label="ritonavir"/><FilterOption id="3072" count="21" label="etoposide phosphate"/><FilterOption id="2871" count="20" label="irinotecan"/><FilterOption id="49219" count="20" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="29016" count="19" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"/><FilterOption id="15954" count="15" label="bortezomib"/><FilterOption id="47000" count="14" label="bendamustine"/><FilterOption id="6408" count="14" label="vinorelbine"/><FilterOption id="15254" count="13" label="atazanavir"/><FilterOption id="32981" count="12" label="darunavir"/><FilterOption id="10252" count="12" label="insulin glargine"/><FilterOption id="10309" count="11" label="abiraterone"/><FilterOption id="10388" count="11" label="cetuximab"/><FilterOption id="2836" count="11" label="clopidogrel"/><FilterOption id="13022" count="11" label="epirubicin"/><FilterOption id="23625" count="11" label="peginterferon alfa-2a"/><FilterOption id="14163" count="10" label="adalimumab"/><FilterOption id="10172" count="10" label="efavirenz"/><FilterOption id="6156" count="10" label="fludarabine"/><FilterOption id="27572" count="10" label="lenalidomide"/><FilterOption id="8832" count="9" label="glimepiride"/><FilterOption id="48181" count="9" label="lamivudine + abacavir, GlaxoSmithKline"/><FilterOption id="3669" count="9" label="mycophenolate mofetil"/><FilterOption id="44375" count="9" label="warfarin"/><FilterOption id="10411" count="8" label="insulin aspart"/><FilterOption id="11519" count="8" label="mitoxantrone"/><FilterOption id="3081" count="7" label="exemestane"/><FilterOption id="33591" count="7" label="lapatinib"/><FilterOption id="27696" count="7" label="pomalidomide"/><FilterOption id="44384" count="6" label="ceftriaxone"/><FilterOption id="59062" count="6" label="dolutegravir"/><FilterOption id="7934" count="6" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="11961" count="6" label="erlotinib"/><FilterOption id="13340" count="6" label="everolimus"/><FilterOption id="2784" count="6" label="letrozole"/><FilterOption id="5369" count="6" label="ribavirin"/><FilterOption id="4510" count="6" label="tacrolimus"/><FilterOption id="3321" count="5" label="anastrozole"/><FilterOption id="13928" count="5" label="enoxaparin sodium"/><FilterOption id="3474" count="5" label="lamivudine"/><FilterOption id="14681" count="5" label="lopinavir + ritonavir"/><FilterOption id="53227" count="5" label="obinutuzumab"/><FilterOption id="28532" count="5" label="pertuzumab"/><FilterOption id="14493" count="5" label="tenofovir disoproxil fumarate"/><FilterOption id="36332" count="5" label="ticagrelor"/><FilterOption id="12150" count="5" label="vincristine sulfate (liposomal injection), Spectrum Pharmaceuticals"/><FilterOption id="37370" count="4" label="azacitidine"/><FilterOption id="54601" count="4" label="carfilzomib"/><FilterOption id="62275" count="4" label="cobicistat"/><FilterOption id="5907" count="4" label="duloxetine"/><FilterOption id="17518" count="4" label="escitalopram"/><FilterOption id="3353" count="4" label="insulin lispro"/><FilterOption id="21374" count="4" label="pegfilgrastim"/><FilterOption id="71886" count="4" label="ribavirin (oral tablet, HCV), Roche"/><FilterOption id="44401" count="4" label="vancomycin"/><FilterOption id="72699" count="3" label="atezolizumab"/><FilterOption id="5999" count="3" label="ciclosporin, Novartis"/><FilterOption id="44370" count="3" label="clindamycin"/><FilterOption id="72148" count="3" label="darunavir + cobicistat (fixed dose, HIV infection), Janssen R&amp;D/ Gilead"/><FilterOption id="13239" count="3" label="decitabine"/><FilterOption id="4728" count="3" label="emtricitabine"/><FilterOption id="30682" count="3" label="etravirine"/><FilterOption id="11367" count="3" label="ezetimibe"/><FilterOption id="7286" count="3" label="goserelin acetate"/><FilterOption id="3616" count="3" label="meropenem"/><FilterOption id="3700" count="3" label="nevirapine"/><FilterOption id="54804" count="3" label="nivolumab"/><FilterOption id="3750" count="3" label="ondansetron"/><FilterOption id="70667" count="3" label="pembrolizumab"/><FilterOption id="4126" count="3" label="pioglitazone"/><FilterOption id="54488" count="3" label="raltegravir"/><FilterOption id="52857" count="3" label="rilpivirine hydrochloride"/><FilterOption id="4259" count="3" label="saquinavir"/><FilterOption id="15183" count="3" label="sertraline"/><FilterOption id="44314" count="3" label="tamoxifen"/><FilterOption id="44316" count="3" label="zidovudine"/><FilterOption id="6242" count="2" label="abacavir"/><FilterOption id="2500" count="2" label="amlodipine"/><FilterOption id="7867" count="2" label="amprenavir"/><FilterOption id="7781" count="2" label="aripiprazole"/><FilterOption id="2807" count="2" label="atorvastatin"/><FilterOption id="11141" count="2" label="basiliximab"/><FilterOption id="16915" count="2" label="calcium levofolinate"/><FilterOption id="69973" count="2" label="dolutegravir + lamivudine + abacavir (HIV), ViiV"/><FilterOption id="59624" count="2" label="dulaglutide"/><FilterOption id="51371" count="2" label="elvitegravir"/><FilterOption id="25880" count="2" label="enteric-coated mycophenolate sodium, Novartis"/><FilterOption id="28773" count="2" label="eribulin mesylate"/><FilterOption id="4567" count="2" label="etanercept"/></Filter><Filter label="Trial Category" name="trialCategory" total="18"><FilterOption id="4" count="4318" label="Small molecule"/><FilterOption id="3" count="2411" label="Biological"/><FilterOption id="8" count="356" label="Medical device"/><FilterOption id="9" count="236" label="Medical procedure"/><FilterOption id="16" count="200" label="Behavioral intervention"/><FilterOption id="5" count="192" label="Vaccine"/><FilterOption id="11" count="132" label="Dietary supplement"/><FilterOption id="15" count="119" label="Radiation therapy"/><FilterOption id="6" count="88" label="Cell therapy"/><FilterOption id="7" count="78" label="Gene therapy"/><FilterOption id="18" count="55" label="Pathophysiology"/><FilterOption id="14" count="43" label="Diagnostic"/><FilterOption id="17" count="32" label="Biomarker identification"/><FilterOption id="10" count="8" label="Borderline product"/><FilterOption id="2" count="5" label="Drug"/><FilterOption id="19" count="3" label="Surgical procedure"/><FilterOption id="13" count="2" label="Hospital solutions"/><FilterOption id="12" count="1" label="Herbal preparation"/></Filter><Filter label="Trial Outcome Available" name="trialOutcomesAvailable" total="2"><FilterOption id="YES" count="3446" label="Yes"/><FilterOption id="NO" count="3084" label="No"/></Filter><Filter label="Trial Actions Primary Interventions Primary" name="trialActionsPrimaryInterventionsPrimary" total="100"><FilterOption id="67136" count="249" label="Programmed cell death protein 1 inhibitor"/><FilterOption id="740" count="240" label="Epidermal growth factor receptor antagonist"/><FilterOption id="3848" count="224" label="VEGF-2 receptor antagonist"/><FilterOption id="3808" count="205" label="Kit tyrosine kinase inhibitor"/><FilterOption id="3846" count="193" label="VEGF-1 receptor antagonist"/><FilterOption id="3850" count="181" label="VEGF-3 receptor antagonist"/><FilterOption id="14007" count="164" label="Programmed cell death ligand 1 inhibitor"/><FilterOption id="372" count="163" label="Thymidylate synthase inhibitor"/><FilterOption id="5085" count="154" label="B-lymphocyte antigen CD20 inhibitor"/><FilterOption id="3756" count="147" label="Erbb2 tyrosine kinase receptor inhibitor"/><FilterOption id="3806" count="126" label="Flt3 tyrosine kinase inhibitor"/><FilterOption id="48492" count="125" label="PDGF receptor beta antagonist"/><FilterOption id="12521" count="119" label="VEGF ligand inhibitor"/><FilterOption id="948" count="111" label="PDGF receptor antagonist"/><FilterOption id="142" count="110" label="Topoisomerase II inhibitor"/><FilterOption id="3816" count="107" label="RET tyrosine kinase receptor family inhibitor"/><FilterOption id="1722" count="107" label="VEGF receptor antagonist"/><FilterOption id="48489" count="101" label="PDGF receptor alpha antagonist"/><FilterOption id="3754" count="100" label="EGFR family tyrosine kinase receptor inhibitor"/><FilterOption id="3562" count="99" label="Jak1 tyrosine kinase inhibitor"/><FilterOption id="10240" count="97" label="mTOR inhibitor"/><FilterOption id="3688" count="95" label="FGF3 receptor antagonist"/><FilterOption id="721" count="92" label="TNF binding agent"/><FilterOption id="3682" count="91" label="FGF1 receptor antagonist"/><FilterOption id="138" count="90" label="DNA polymerase inhibitor"/><FilterOption id="141" count="90" label="Topoisomerase I inhibitor"/><FilterOption id="5482" count="89" label="Cytotoxic T-lymphocyte protein-4 inhibitor"/><FilterOption id="3154" count="87" label="CSF-1 antagonist"/><FilterOption id="1016" count="87" label="HIV-1 reverse transcriptase inhibitor"/><FilterOption id="1832" count="87" label="Nucleoside reverse transcriptase inhibitor"/><FilterOption id="204" count="86" label="HIV protease inhibitor"/><FilterOption id="385" count="84" label="Protein tyrosine kinase inhibitor"/><FilterOption id="768" count="82" label="HIV-1 protease inhibitor"/><FilterOption id="381" count="82" label="TNF alpha ligand inhibitor"/><FilterOption id="4548" count="81" label="Raf B protein kinase inhibitor"/><FilterOption id="135" count="75" label="DHFR inhibitor"/><FilterOption id="120" count="73" label="Factor Xa antagonist"/><FilterOption id="181" count="71" label="GAR transformylase inhibitor"/><FilterOption id="214" count="71" label="Interferon alpha 2 ligand"/><FilterOption id="38283" count="71" label="Poly ADP ribose polymerase 1 inhibitor"/><FilterOption id="374" count="71" label="Transferase inhibitor"/><FilterOption id="3685" count="68" label="FGF2 receptor antagonist"/><FilterOption id="38286" count="68" label="Poly ADP ribose polymerase 2 inhibitor"/><FilterOption id="7424" count="67" label="Cytochrome P450 3A4 inhibitor"/><FilterOption id="40" count="66" label="Beta 2 adrenoceptor agonist"/><FilterOption id="4917" count="66" label="Proteasome inhibitor"/><FilterOption id="12349" count="64" label="Hepatitis C virus NS3 protease inhibitor"/><FilterOption id="76" count="63" label="Aromatase inhibitor"/><FilterOption id="76090" count="62" label="mTOR complex 1 inhibitor"/><FilterOption id="13571" count="61" label="Bcr protein inhibitor"/><FilterOption id="675" count="61" label="Hepatocyte growth factor receptor antagonist"/><FilterOption id="471" count="61" label="IL-6 receptor antagonist"/><FilterOption id="3584" count="60" label="Lck tyrosine kinase inhibitor"/><FilterOption id="3576" count="59" label="Src tyrosine kinase inhibitor"/><FilterOption id="8805" count="58" label="AMP activated protein kinase stimulator"/><FilterOption id="4314" count="57" label="Cyclin-dependent kinase-4 inhibitor"/><FilterOption id="4318" count="57" label="Cyclin-dependent kinase-6 inhibitor"/><FilterOption id="7588" count="57" label="HIV-1 integrase inhibitor"/><FilterOption id="629" count="54" label="Inosine monophosphate dehydrogenase inhibitor"/><FilterOption id="4762" count="54" label="MEK-1 protein kinase inhibitor"/><FilterOption id="4764" count="54" label="MEK-2 protein kinase inhibitor"/><FilterOption id="2585" count="52" label="Glucagon-like peptide 1 receptor agonist"/><FilterOption id="2507" count="51" label="PARP inhibitor"/><FilterOption id="3524" count="50" label="Abl tyrosine kinase inhibitor"/><FilterOption id="4010" count="50" label="Calcineurin inhibitor"/><FilterOption id="286" count="50" label="Estrogen receptor antagonist"/><FilterOption id="23014" count="50" label="Insulin ligand"/><FilterOption id="400" count="50" label="Insulin receptor agonist"/><FilterOption id="1833" count="47" label="Non-nucleoside reverse transcriptase inhibitor"/><FilterOption id="3834" count="47" label="Tek tyrosine kinase receptor inhibitor"/><FilterOption id="3592" count="46" label="Btk tyrosine kinase inhibitor"/><FilterOption id="76469" count="45" label="26S proteasome complex inhibitor"/><FilterOption id="168" count="45" label="FGF receptor antagonist"/><FilterOption id="1575" count="44" label="Phosphoinositide 3-kinase inhibitor"/><FilterOption id="4550" count="44" label="Raf 1 protein kinase inhibitor"/><FilterOption id="498" count="44" label="Sodium channel inhibitor"/><FilterOption id="205" count="43" label="HMG CoA reductase inhibitor"/><FilterOption id="3252" count="43" label="Insulin-like growth factor 1 receptor antagonist"/><FilterOption id="60" count="42" label="Androgen receptor antagonist"/><FilterOption id="262" count="42" label="Muscarinic M3 receptor antagonist"/><FilterOption id="770" count="41" label="Endothelin ET-A receptor antagonist"/><FilterOption id="38289" count="41" label="Poly ADP ribose polymerase 3 inhibitor"/><FilterOption id="43842" count="40" label="Hepatitis C virus protein NS5A inhibitor"/><FilterOption id="541" count="40" label="Tubulin receptor antagonist"/><FilterOption id="115" count="38" label="Factor VIII agonist"/><FilterOption id="4802" count="38" label="IL-17 antagonist"/><FilterOption id="3564" count="38" label="Jak2 tyrosine kinase inhibitor"/><FilterOption id="3796" count="38" label="MET tyrosine kinase receptor family inhibitor"/><FilterOption id="4020" count="38" label="Sodium glucose transporter-2 inhibitor"/><FilterOption id="511" count="38" label="TNF antagonist"/><FilterOption id="64" count="37" label="Angiotensin II receptor antagonist"/><FilterOption id="3758" count="37" label="Erbb3 tyrosine kinase receptor inhibitor"/><FilterOption id="3818" count="37" label="Ret tyrosine kinase receptor inhibitor"/><FilterOption id="3760" count="36" label="Erbb4 tyrosine kinase receptor inhibitor"/><FilterOption id="12358" count="36" label="Hepatitis C virus NS5B polymerase inhibitor"/><FilterOption id="4913" count="36" label="P2Y12 purinoceptor antagonist"/><FilterOption id="3736" count="35" label="Anaplastic lymphoma kinase receptor inhibitor"/><FilterOption id="9748" count="35" label="IL-23 antagonist"/><FilterOption id="1689" count="35" label="VEGF-A ligand inhibitor"/><FilterOption id="111" count="34" label="Factor IIa antagonist"/></Filter><Filter label="Trial Company Collaborator" name="trialCompaniesCollaborator" total="100"><FilterOption id="18767" count="55" label="Pfizer Inc"/><FilterOption id="1013295" count="54" label="Astellas Pharma Inc"/><FilterOption id="28355" count="54" label="GlaxoSmithKline plc"/><FilterOption id="1059823" count="50" label="Merck Sharp &amp; Dohme Corp"/><FilterOption id="1009547" count="47" label="Sanofi SA"/><FilterOption id="19446" count="46" label="Roche Holding AG"/><FilterOption id="20300" count="43" label="Takeda Pharmaceutical Co Ltd"/><FilterOption id="15065" count="42" label="Bristol-Myers Squibb Co"/><FilterOption id="14190" count="40" label="AstraZeneca plc"/><FilterOption id="1017818" count="38" label="Instituto de Salud Carlos III"/><FilterOption id="23137" count="34" label="Novartis AG"/><FilterOption id="19453" count="32" label="Genentech Inc"/><FilterOption id="18681" count="29" label="Ono Pharmaceutical Co Ltd"/><FilterOption id="17810" count="28" label="Eli Lilly &amp; Co"/><FilterOption id="19214" count="27" label="Regeneron Pharmaceuticals Inc"/><FilterOption id="15331" count="25" label="Celgene Corp"/><FilterOption id="20519" count="24" label="National Cancer Institute"/><FilterOption id="14109" count="22" label="Amgen Inc"/><FilterOption id="14455" count="22" label="Bayer AG"/><FilterOption id="1101929" count="21" label="IQVIA Holdings Inc"/><FilterOption id="1067538" count="21" label="Janssen Research &amp; Development LLC"/><FilterOption id="1033116" count="21" label="PAREXEL International"/><FilterOption id="1057369" count="20" label="La Paz University Hospital (Madrid)"/><FilterOption id="18077" count="18" label="Merck &amp; Co Inc"/><FilterOption id="20452" count="18" label="UCB SA"/><FilterOption id="1065900" count="17" label="Apices Soluciones, S.L."/><FilterOption id="26178" count="17" label="F Hoffmann-La Roche AG"/><FilterOption id="1055006" count="17" label="Ministry of Health, Spain"/><FilterOption id="1072507" count="16" label="AbbVie Inc"/><FilterOption id="19620" count="16" label="Eisai Inc"/><FilterOption id="1059977" count="14" label="European Commission"/><FilterOption id="18440" count="14" label="Myriad Genetics Inc"/><FilterOption id="1042255" count="13" label="Breast International Group"/><FilterOption id="1045910" count="13" label="Hospital Clinico San Carlos"/><FilterOption id="18101" count="13" label="Merck KGaA"/><FilterOption id="1116693" count="13" label="Productos Roche, S.A. de C.V."/><FilterOption id="1003065" count="12" label="Hospital Vall D'Hebron"/><FilterOption id="17332" count="12" label="Johnson &amp; Johnson"/><FilterOption id="24652" count="12" label="Shire plc"/><FilterOption id="1084506" count="11" label="European Network of Gynaecological Oncological Trial Groups"/><FilterOption id="23119" count="11" label="European Organisation for Research and Treatment of Cancer (EORTC)"/><FilterOption id="1006639" count="11" label="Hospital Universitario Ramon y Cajal"/><FilterOption id="1033989" count="11" label="Pharmaceutical Product Development LLC"/><FilterOption id="1067340" count="11" label="Pivotal SL"/><FilterOption id="25554" count="11" label="Seattle Genetics Inc"/><FilterOption id="1063946" count="11" label="Syneos Health Inc"/><FilterOption id="13601" count="10" label="Abbott Laboratories"/><FilterOption id="1056444" count="10" label="Foundation Medicine Inc"/><FilterOption id="1041702" count="10" label="Gynecologic Oncology Group"/><FilterOption id="17216" count="10" label="Incyte Corp"/><FilterOption id="1005244" count="9" label="Biogen Inc"/><FilterOption id="14881" count="9" label="Boehringer Ingelheim International GmbH"/><FilterOption id="15414" count="9" label="Chugai Pharmaceutical Co Ltd"/><FilterOption id="22676" count="9" label="Exelixis Inc"/><FilterOption id="1070222" count="9" label="Fundación Mutua Madrileña"/><FilterOption id="1040862" count="9" label="Hospital General Universitario Gregorio Marañon"/><FilterOption id="1033112" count="9" label="Hospital Universitario 12 de Octubre"/><FilterOption id="1056709" count="9" label="ICON Clinical Research"/><FilterOption id="1100315" count="9" label="PRA Health Sciences"/><FilterOption id="20348" count="9" label="Teva Pharmaceutical Industries Ltd"/><FilterOption id="21082" count="9" label="Walter and Eliza Hall Institute of Medical Research"/><FilterOption id="25902" count="8" label="Array BioPharma Inc"/><FilterOption id="1079783" count="8" label="FUNDACIÓ INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU"/><FilterOption id="27741" count="8" label="Galapagos NV"/><FilterOption id="16450" count="8" label="Gilead Sciences Inc"/><FilterOption id="29481" count="8" label="Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC"/><FilterOption id="1014884" count="8" label="Medivation Inc"/><FilterOption id="19063" count="8" label="Pharmacyclics Inc"/><FilterOption id="1026270" count="8" label="Servicio Regional De Salud De La Consejeria De Salud De La Comunidad De Madrid"/><FilterOption id="19864" count="7" label="Adir &amp; Co"/><FilterOption id="1017506" count="7" label="Daiichi Sankyo Co Ltd"/><FilterOption id="1039423" count="7" label="Hospital Clinic of Barcelona"/><FilterOption id="1040940" count="7" label="Hospital Universitari de Bellvitge"/><FilterOption id="1072601" count="7" label="Hospital Universitario Virgen de la Arrixa"/><FilterOption id="1144568" count="7" label="Novartis Pharma Services AG"/><FilterOption id="1097931" count="6" label="Andalusian Initiative for Advanced Therapies"/><FilterOption id="21283" count="6" label="Astellas Pharma Europe BV"/><FilterOption id="1018807" count="6" label="Covance Inc"/><FilterOption id="1048337" count="6" label="Duke Clinical Research Institute"/><FilterOption id="1039086" count="6" label="Germans Trias i Pujol Hospital"/><FilterOption id="1104124" count="6" label="GlaxoSmithKline LLC"/><FilterOption id="17416" count="6" label="Janssen LP"/><FilterOption id="21404" count="6" label="MorphoSys AG"/><FilterOption id="1045801" count="6" label="The European Union"/><FilterOption id="1061163" count="5" label="Abbott Vascular"/><FilterOption id="23948" count="5" label="Assistance Publique Hopitaux de Paris"/><FilterOption id="22123" count="5" label="Cleveland Clinic Foundation"/><FilterOption id="1091345" count="5" label="Complejo Hospitalario de Navarra"/><FilterOption id="1069026" count="5" label="Effice Servicios Para la Investigacion"/><FilterOption id="1039403" count="5" label="German Federal Ministry of Education and Research"/><FilterOption id="19461" count="5" label="Hoffmann-La Roche Inc"/><FilterOption id="25599" count="5" label="Novartis Pharma AG"/><FilterOption id="20556" count="5" label="Universidad Complutense de Madrid"/><FilterOption id="23505" count="5" label="University College London"/><FilterOption id="1125317" count="4" label="ADIR Association"/><FilterOption id="14438" count="4" label="Baxter Healthcare Corp"/><FilterOption id="27847" count="4" label="Boston Scientific Corp"/><FilterOption id="29469" count="4" label="Cancer Research UK"/><FilterOption id="1045739" count="4" label="Chiltern International Inc."/><FilterOption id="1013107" count="4" label="CNIC - Fundacion Centro National de Investigaciones Cardiovasculares Carlos III"/></Filter><Filter label="Trial Actions Secondary Interventions Control" name="trialActionsSecondaryInterventionsControl" total="100"><FilterOption id="1545" count="765" label="Anticancer"/><FilterOption id="767" count="286" label="Cell cycle inhibitor"/><FilterOption id="2953" count="273" label="Anti-inflammatory"/><FilterOption id="140" count="218" label="DNA synthesis inhibitor"/><FilterOption id="55685" count="216" label="Anticancer monoclonal antibody"/><FilterOption id="991" count="208" label="Antiviral"/><FilterOption id="1569" count="194" label="Anticancer antimetabolite"/><FilterOption id="50" count="184" label="Anticancer alkylating agent"/><FilterOption id="62255" count="178" label="Anticancer protein kinase inhibitor"/><FilterOption id="2576" count="134" label="Microtubule stabilizer"/><FilterOption id="61" count="131" label="Angiogenesis inhibitor"/><FilterOption id="1589" count="121" label="Apoptosis stimulator"/><FilterOption id="2575" count="119" label="Microtubule inhibitor"/><FilterOption id="2660" count="116" label="Vasoprotectant"/><FilterOption id="7293" count="76" label="Synergist"/><FilterOption id="399" count="75" label="Hypoglycemic agent"/><FilterOption id="2946" count="72" label="Analgesic"/><FilterOption id="15184" count="58" label="Systemic antipsoriatic product"/><FilterOption id="1594" count="57" label="Antibacterial"/><FilterOption id="1596" count="52" label="Immunomodulator"/><FilterOption id="396" count="52" label="Immunosuppressant"/><FilterOption id="805" count="46" label="Folate modulator"/><FilterOption id="646" count="43" label="Bronchodilator"/><FilterOption id="659" count="41" label="Coagulation inhibitor"/><FilterOption id="104" count="40" label="Bacterial cell wall synthesis inhibitor"/><FilterOption id="2657" count="39" label="Antihypertensive"/><FilterOption id="747" count="38" label="HIV replication inhibitor"/><FilterOption id="393" count="36" label="Immunostimulant"/><FilterOption id="7761" count="36" label="T-lymphocyte stimulator"/><FilterOption id="750" count="35" label="DNA intercalator"/><FilterOption id="15187" count="35" label="Systemic dermatological antibacterial product"/><FilterOption id="38206" count="33" label="Biguanide antidiabetic product"/><FilterOption id="2659" count="32" label="Cardioprotectant"/><FilterOption id="38215" count="27" label="Human insulin long acting product"/><FilterOption id="610" count="26" label="Hematopoietic stimulator"/><FilterOption id="12378" count="26" label="Prophylactic vaccine"/><FilterOption id="2954" count="25" label="Steroidal anti-inflammatory"/><FilterOption id="70" count="24" label="Anticonvulsant agent"/><FilterOption id="3189" count="24" label="Corticosteroid agonist"/><FilterOption id="62254" count="23" label="Anticancer hormone antagonist"/><FilterOption id="1615" count="22" label="Neuroprotectant"/><FilterOption id="382" count="22" label="TNF alpha synthesis inhibitor"/><FilterOption id="2667" count="20" label="Antiarteriosclerotic"/><FilterOption id="312" count="20" label="Platelet aggregation inhibitor"/><FilterOption id="2941" count="18" label="Antidepressant"/><FilterOption id="2947" count="18" label="Antiparkinsonian"/><FilterOption id="38211" count="17" label="Human insulin fast acting product"/><FilterOption id="71" count="16" label="Antihypercholesterolemic agent"/><FilterOption id="1538" count="16" label="Bacterial protein synthesis inhibitor"/><FilterOption id="1479" count="16" label="RNA synthesis modulator"/><FilterOption id="2970" count="15" label="Anti-emetic"/><FilterOption id="1535" count="15" label="Beta lactam antibiotic"/><FilterOption id="89" count="15" label="Bone resorption inhibitor"/><FilterOption id="73547" count="15" label="Carbapenem"/><FilterOption id="664" count="15" label="Fibrosuppressant"/><FilterOption id="38205" count="14" label="Sulphonylurea antidiabetic product"/><FilterOption id="1532" count="14" label="Viral replication inhibitor"/><FilterOption id="3" count="13" label="5-HT uptake inhibitor"/><FilterOption id="2942" count="13" label="Anxiolytic"/><FilterOption id="3246" count="13" label="Insulin release stimulator"/><FilterOption id="463" count="13" label="Ribosome binding agent"/><FilterOption id="72" count="12" label="Antihyperlipidemic agent"/><FilterOption id="2943" count="12" label="Antipsychotic"/><FilterOption id="32411" count="12" label="Hepatitis B virus replication inhibitor"/><FilterOption id="1129" count="12" label="Non-steroid hormone receptor antagonist"/><FilterOption id="285" count="12" label="Norepinephrine uptake inhibitor"/><FilterOption id="15148" count="12" label="Ocular antineovascularisation agent"/><FilterOption id="7760" count="12" label="T-lymphocyte inhibitor"/><FilterOption id="937" count="11" label="Androgen synthesis inhibitor"/><FilterOption id="12596" count="11" label="Osteoclast inhibitor"/><FilterOption id="388" count="11" label="Vasodilator"/><FilterOption id="968" count="10" label="Coagulation stimulator"/><FilterOption id="284" count="10" label="Nootropic agent"/><FilterOption id="439" count="10" label="RNA synthesis inhibitor"/><FilterOption id="1748" count="9" label="Fungicide"/><FilterOption id="12367" count="9" label="Inactivated viral vaccine"/><FilterOption id="12375" count="9" label="Toxoid vaccine"/><FilterOption id="1537" count="8" label="Cephalosporin"/><FilterOption id="12373" count="8" label="Polysaccharide subunit vaccine"/><FilterOption id="62253" count="7" label="Anticancer hormone"/><FilterOption id="3984" count="7" label="Bacterial nucleic acid synthesis inhibitor"/><FilterOption id="15128" count="7" label="Ophthalmological agent"/><FilterOption id="12372" count="7" label="Protein subunit vaccine"/><FilterOption id="12371" count="7" label="Subunit vaccine"/><FilterOption id="1540" count="6" label="Macrolide antibiotic"/><FilterOption id="563" count="6" label="Microtubule modulator"/><FilterOption id="882" count="5" label="5-HETE modulator"/><FilterOption id="1541" count="5" label="Aminoglycoside antibiotic"/><FilterOption id="449" count="5" label="Antiarrhythmic agent"/><FilterOption id="7018" count="5" label="Antihypertriglyceridemic agent"/><FilterOption id="5704" count="5" label="B-lymphocyte adhesion inhibitor"/><FilterOption id="5710" count="5" label="B-lymphocyte migration inhibitor"/><FilterOption id="5580" count="5" label="Chemotaxis inhibitor"/><FilterOption id="871" count="5" label="GABA modulator"/><FilterOption id="614" count="5" label="Lipid uptake inhibitor"/><FilterOption id="12364" count="5" label="Live attenuated viral vaccine"/><FilterOption id="695" count="5" label="Metastasis inhibitor"/><FilterOption id="2955" count="5" label="Non-steroidal anti-inflammatory"/><FilterOption id="15180" count="5" label="Topical antipruritic product"/><FilterOption id="59620" count="5" label="Unspecified drug target"/></Filter><Filter label="Biomarker Type" name="trialBiomarkerTypes" total="7"><FilterOption id="37" count="3276" label="Proteomic"/><FilterOption id="38" count="3151" label="Genomic"/><FilterOption id="31" count="1773" label="Physiological"/><FilterOption id="32" count="1488" label="Biochemical"/><FilterOption id="75" count="1159" label="Cellular"/><FilterOption id="39" count="722" label="Anthropomorphic"/><FilterOption id="40" count="669" label="Structural (imaging)"/></Filter><Filter label="Biomarker Role" name="trialBiomarkerRoles" total="4"><FilterOption id="695863716" count="3548" label="Therapeutic effect marker"/><FilterOption id="1571666123" count="1493" label="Disease marker"/><FilterOption id="730490367" count="1257" label="Toxic effect marker"/><FilterOption id="3242045531" count="22" label="Not determined"/></Filter><Filter label="Interventions" name="trialInterventions" total="100"><FilterOption id="3803" count="177" label="paclitaxel"/><FilterOption id="44383" count="154" label="carboplatin"/><FilterOption id="3199" count="127" label="gemcitabine"/><FilterOption id="54804" count="118" label="nivolumab"/><FilterOption id="8047" count="113" label="bevacizumab"/><FilterOption id="2953" count="109" label="docetaxel"/><FilterOption id="6736" count="96" label="rituximab"/><FilterOption id="72699" count="90" label="atezolizumab"/><FilterOption id="12205" count="86" label="capecitabine"/><FilterOption id="3792" count="85" label="oxaliplatin"/><FilterOption id="70667" count="85" label="pembrolizumab"/><FilterOption id="5369" count="73" label="ribavirin"/><FilterOption id="3536" count="71" label="pemetrexed disodium"/><FilterOption id="6386" count="71" label="trastuzumab"/><FilterOption id="36630" count="62" label="ipilimumab"/><FilterOption id="7310" count="62" label="ritonavir"/><FilterOption id="2871" count="61" label="irinotecan"/><FilterOption id="23625" count="59" label="peginterferon alfa-2a"/><FilterOption id="29016" count="54" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"/><FilterOption id="6050" count="53" label="metformin hydrochloride"/><FilterOption id="27572" count="51" label="lenalidomide"/><FilterOption id="13340" count="48" label="everolimus"/><FilterOption id="81193" count="47" label="durvalumab"/><FilterOption id="11961" count="47" label="erlotinib"/><FilterOption id="10388" count="46" label="cetuximab"/><FilterOption id="15954" count="45" label="bortezomib"/><FilterOption id="14163" count="44" label="adalimumab"/><FilterOption id="3072" count="43" label="etoposide phosphate"/><FilterOption id="3313" count="35" label="fulvestrant"/><FilterOption id="2784" count="35" label="letrozole"/><FilterOption id="16063" count="34" label="olaparib"/><FilterOption id="12973" count="34" label="sunitinib"/><FilterOption id="47000" count="32" label="bendamustine"/><FilterOption id="3669" count="31" label="mycophenolate mofetil"/><FilterOption id="55275" count="29" label="secukinumab"/><FilterOption id="55237" count="28" label="ibrutinib"/><FilterOption id="14681" count="28" label="lopinavir + ritonavir"/><FilterOption id="29831" count="28" label="sorafenib"/><FilterOption id="10309" count="26" label="abiraterone"/><FilterOption id="4567" count="26" label="etanercept"/><FilterOption id="53227" count="26" label="obinutuzumab"/><FilterOption id="28532" count="26" label="pertuzumab"/><FilterOption id="6259" count="26" label="tocilizumab (intravenous), Roche/Chugai"/><FilterOption id="32981" count="25" label="darunavir"/><FilterOption id="6156" count="25" label="fludarabine"/><FilterOption id="33591" count="25" label="lapatinib"/><FilterOption id="32677" count="25" label="rivaroxaban"/><FilterOption id="74726" count="25" label="upadacitinib"/><FilterOption id="7934" count="24" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="3081" count="24" label="exemestane"/><FilterOption id="83873" count="24" label="osimertinib"/><FilterOption id="4510" count="24" label="tacrolimus"/><FilterOption id="4529" count="24" label="temozolomide"/><FilterOption id="53981" count="23" label="enzalutamide"/><FilterOption id="43738" count="23" label="pazopanib"/><FilterOption id="24343" count="22" label="dabigatran etexilate"/><FilterOption id="53200" count="22" label="daratumumab"/><FilterOption id="13022" count="22" label="epirubicin"/><FilterOption id="12646" count="22" label="panitumumab"/><FilterOption id="45499" count="22" label="tofacitinib citrate (oral, inflammation), Pfizer"/><FilterOption id="37370" count="21" label="azacitidine"/><FilterOption id="6408" count="21" label="vinorelbine"/><FilterOption id="72538" count="20" label="abemaciclib"/><FilterOption id="56544" count="20" label="cobimetinib"/><FilterOption id="27696" count="20" label="pomalidomide"/><FilterOption id="54488" count="20" label="raltegravir"/><FilterOption id="49219" count="20" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="36332" count="20" label="ticagrelor"/><FilterOption id="52967" count="19" label="apixaban"/><FilterOption id="15254" count="19" label="atazanavir"/><FilterOption id="2836" count="19" label="clopidogrel"/><FilterOption id="45841" count="19" label="lenvatinib mesylate"/><FilterOption id="51160" count="19" label="nintedanib"/><FilterOption id="10271" count="19" label="palbociclib"/><FilterOption id="71886" count="19" label="ribavirin (oral tablet, HCV), Roche"/><FilterOption id="45562" count="19" label="tremelimumab"/><FilterOption id="48946" count="18" label="dasatinib"/><FilterOption id="45902" count="18" label="ramucirumab"/><FilterOption id="96193" count="18" label="spartalizumab"/><FilterOption id="36669" count="18" label="trastuzumab emtansine"/><FilterOption id="83065" count="17" label="avelumab"/><FilterOption id="10606" count="17" label="eltrombopag"/><FilterOption id="6850" count="17" label="infliximab"/><FilterOption id="17814" count="17" label="pregabalin"/><FilterOption id="58782" count="17" label="sacubitril + valsartan trisodium hemipentahydrate"/><FilterOption id="14493" count="17" label="tenofovir disoproxil fumarate"/><FilterOption id="8165" count="17" label="tiotropium bromide"/><FilterOption id="70895" count="17" label="venetoclax"/><FilterOption id="54449" count="16" label="afatinib"/><FilterOption id="39209" count="16" label="axitinib"/><FilterOption id="61901" count="16" label="buparlisib"/><FilterOption id="50935" count="16" label="cabozantinib S-malate"/><FilterOption id="53133" count="16" label="dabrafenib"/><FilterOption id="59062" count="16" label="dolutegravir"/><FilterOption id="10154" count="16" label="fingolimod"/><FilterOption id="35644" count="16" label="methoxy polyethylene glycol-epoetin beta"/><FilterOption id="65360" count="16" label="ribociclib"/><FilterOption id="55288" count="16" label="trametinib"/><FilterOption id="2807" count="15" label="atorvastatin"/><FilterOption id="47733" count="15" label="canakinumab"/></Filter><Filter label="Endpoint Index Primary" name="trialEndpointIndexPrimary" total="100"><FilterOption id="8489" count="118" label="Lung tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8713" count="112" label="Breast tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="15287" count="103" label="Solid tumor - Assessment of adverse events"/><FilterOption id="15293" count="100" label="Solid tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="9153" count="99" label="Lung tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="3736" count="90" label="Hepatitis C virus infection - Assessment of Sustained Virologic Response (SVR)"/><FilterOption id="9213" count="87" label="HIV infection - Assessment of Viral Load - Assessment of HIV RNA levels"/><FilterOption id="8481" count="80" label="Lung tumor - Assessment of Overall Survival (OS)"/><FilterOption id="6863" count="79" label="Hepatitis C virus infection - Assessment of Viral Load/Viral Kinetics"/><FilterOption id="9155" count="73" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="8505" count="71" label="Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"/><FilterOption id="1359" count="69" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels - Change in HbA1c"/><FilterOption id="8719" count="60" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="2622" count="60" label="Coronary artery disease - Assessment of Mortality/Death Rates - Cardiovascular mortality"/><FilterOption id="7547" count="56" label="Lymphoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="9008" count="55" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="8998" count="55" label="Breast tumor - Assessment of adverse events"/><FilterOption id="8523" count="55" label="Lung tumor - Assessment of Disease Progression"/><FilterOption id="8721" count="54" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="8163" count="54" label="Colorectal tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8513" count="52" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="7569" count="52" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="9247" count="51" label="HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="10830" count="51" label="Ovary tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="15312" count="51" label="Solid tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="8514" count="50" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="7563" count="50" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="15212" count="49" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"/><FilterOption id="15285" count="49" label="Solid tumor - Assessment of Safety and Tolerability"/><FilterOption id="7908" count="41" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="3883" count="41" label="Rheumatoid arthritis - American College of Rheumatology (ACR) 20 Response"/><FilterOption id="7704" count="40" label="Lymphoma - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="15286" count="40" label="Solid tumor - Assessment of Safety and Tolerability - Assessment of serious adverse events"/><FilterOption id="8436" count="39" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="8670" count="39" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"/><FilterOption id="7360" count="39" label="Multiple myeloma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8720" count="38" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="15309" count="37" label="Solid tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="8187" count="36" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of Objective/Overall Response Rate (ORR)"/><FilterOption id="2" count="35" label="Hypertension - Assessment of Blood Pressure (BP) - BP control rate"/><FilterOption id="8639" count="35" label="Lung tumor - Assessment of Safety and Tolerability"/><FilterOption id="10545" count="35" label="Renal cell carcinoma - Assessment of Progression Free Survival (PFS)"/><FilterOption id="3900" count="35" label="Rheumatoid arthritis - DAS-28 (Disease Activity Score) Response"/><FilterOption id="8744" count="34" label="Breast tumor - Assessment of Disease Progression"/><FilterOption id="7680" count="33" label="Lymphoma - Assessment of adverse events"/><FilterOption id="10243" count="33" label="Thrombosis - Assessment of Thrombotic/Thromboembolic Events - Assessment of venous thrombosis/thromboembolism"/><FilterOption id="8714" count="32" label="Breast tumor - Assessment of Disease Free Survival (DFS)"/><FilterOption id="22595" count="32" label="End stage renal disease - Assessment of adverse events"/><FilterOption id="8555" count="32" label="Lung tumor - Assessment of Mortality/Death Rates"/><FilterOption id="8640" count="32" label="Lung tumor - Assessment of Safety and Tolerability - Adverse events as graded by CTCAE/CTC"/><FilterOption id="1358" count="32" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels"/><FilterOption id="25874" count="32" label="Pain - Assessment of Intensity of Pain - Based on Visual analog scale[VAS]"/><FilterOption id="8430" count="31" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="7879" count="31" label="Leukemia - Assessment of Overall Survival (OS)"/><FilterOption id="7564" count="31" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"/><FilterOption id="22545" count="30" label="End stage renal disease - Hematological Assessments - Assessment of hemoglobin levels"/><FilterOption id="7891" count="30" label="Leukemia - Assessment of Progression Free Survival (PFS)"/><FilterOption id="8140" count="30" label="Leukemia - Protocol Specified Other Endpoints - Assessment of Clinical Efficacy"/><FilterOption id="1561" count="30" label="Non-insulin dependent diabetes - Assessment of Mortality/Death Rates - Cardiovascular mortality"/><FilterOption id="7045" count="30" label="Prostate tumor - Assessment of Overall Survival (OS)"/><FilterOption id="7049" count="30" label="Prostate tumor - Assessment of Progression Free Survival (PFS)"/><FilterOption id="2492" count="29" label="Coronary artery disease - Assessment of Cardiovascular Events - Acute/New Myocardial infarction (MI)/MI (Q-wave and non-Q wave)"/><FilterOption id="2619" count="29" label="Coronary artery disease - Assessment of Cardiovascular Events - Assessment of major adverse cardiac events (MACEs)"/><FilterOption id="8078" count="29" label="Leukemia - Assessment of adverse events"/><FilterOption id="25875" count="29" label="Pain - Assessment of Intensity of Pain - Based on Numerical Rating Scale [NRS]"/><FilterOption id="13344" count="29" label="Pancreas tumor - Assessment of Overall Survival (OS)"/><FilterOption id="4144" count="29" label="Rheumatoid arthritis - Assessment of adverse events"/><FilterOption id="26827" count="29" label="Solid tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="17220" count="28" label="Anemia - Hematological Assessments - Assessment of hemoglobin status"/><FilterOption id="8996" count="28" label="Breast tumor - Assessment of Safety and Tolerability"/><FilterOption id="23916" count="28" label="Hypercholesterolemia - Assessment of Low-Density Lipoprotein (LDL)"/><FilterOption id="23051" count="28" label="Lipid metabolism disorder - Assessment of Low-Density Lipoprotein (LDL)"/><FilterOption id="6940" count="28" label="Melanoma - Assessment of Response Rates (RR) - Assessment of overall/objective response rate"/><FilterOption id="7367" count="28" label="Multiple myeloma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"/><FilterOption id="4139" count="28" label="Rheumatoid arthritis - Assessment of Safety and Tolerability"/><FilterOption id="2292" count="27" label="Alzheimers disease - Cognitive, Global and Functional Assessments - Alzheimer's disease assessment scale - cognition (ADAS-cog)"/><FilterOption id="3809" count="27" label="Hepatitis C virus infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="26033" count="27" label="Pain - Assessment of adverse events"/><FilterOption id="2981" count="26" label="Acute coronary syndrome - Assessment of Mortality/Death Rates - Cardiovascular mortality"/><FilterOption id="8641" count="26" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of frequency and severity of adverse events"/><FilterOption id="1548" count="26" label="Non-insulin dependent diabetes - Assessment of Cardiovascular Events - Assessment of myocardial infarction"/><FilterOption id="1540" count="26" label="Non-insulin dependent diabetes - Assessment of Stroke"/><FilterOption id="11728" count="25" label="Bladder cancer - Assessment of Response Rates (RR) - Assessment of objective/overall response rate (ORR)"/><FilterOption id="8754" count="25" label="Breast tumor - Assessment of Mortality/Death Rates"/><FilterOption id="8556" count="25" label="Lung tumor - Assessment of Mortality/Death Rates - Assessment of all cause mortality"/><FilterOption id="15215" count="25" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"/><FilterOption id="37159" count="24" label="Breast tumor - Assessment of Laboratory/Diagnostic Measures"/><FilterOption id="9122" count="24" label="Breast tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="2515" count="24" label="Coronary artery disease - Assessment of Thrombotic/Thromboembolic Events - Fatal /Non-fatal stroke"/><FilterOption id="8077" count="24" label="Leukemia - Assessment of Safety and Tolerability"/><FilterOption id="10914" count="24" label="Ovary tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"/><FilterOption id="10895" count="24" label="Ovary tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"/><FilterOption id="17461" count="24" label="Stem cell transplantation - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"/><FilterOption id="10247" count="24" label="Thrombosis - Assessment of Thrombotic/Thromboembolic Events - Assessment of pulmonary embolism(PE)"/><FilterOption id="9310" count="23" label="Breast tumor - Imaging/Radiological Assessments"/><FilterOption id="4283" count="23" label="Chronic obstructive pulmonary disease - Assessment of Forced Expiratory Volume in One Second (FEV1) - FEV1 trough response"/><FilterOption id="12048" count="23" label="Hepatobiliary system tumor - Assessment of Overall Survival (OS)"/><FilterOption id="8663" count="23" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"/><FilterOption id="7489" count="23" label="Multiple myeloma - Assessment of Safety and Tolerability - Assessment of other adverse events"/><FilterOption id="25959" count="23" label="Pain - Assessment of Functional Disability/Physical Function"/></Filter><Filter label="Sponsors/Collaborators" name="trialCompanies" total="100"><FilterOption id="23137" count="419" label="Novartis AG"/><FilterOption id="19446" count="404" label="Roche Holding AG"/><FilterOption id="18767" count="356" label="Pfizer Inc"/><FilterOption id="28355" count="327" label="GlaxoSmithKline plc"/><FilterOption id="15065" count="241" label="Bristol-Myers Squibb Co"/><FilterOption id="14190" count="238" label="AstraZeneca plc"/><FilterOption id="17810" count="219" label="Eli Lilly &amp; Co"/><FilterOption id="26178" count="189" label="F Hoffmann-La Roche AG"/><FilterOption id="14455" count="155" label="Bayer AG"/><FilterOption id="1059823" count="153" label="Merck Sharp &amp; Dohme Corp"/><FilterOption id="1009547" count="147" label="Sanofi SA"/><FilterOption id="1067538" count="144" label="Janssen Research &amp; Development LLC"/><FilterOption id="1144568" count="134" label="Novartis Pharma Services AG"/><FilterOption id="14881" count="132" label="Boehringer Ingelheim International GmbH"/><FilterOption id="1072507" count="127" label="AbbVie Inc"/><FilterOption id="15331" count="126" label="Celgene Corp"/><FilterOption id="14109" count="116" label="Amgen Inc"/><FilterOption id="1091809" count="108" label="Janssen-Cilag International NV (BE)"/><FilterOption id="25599" count="107" label="Novartis Pharma AG"/><FilterOption id="16450" count="101" label="Gilead Sciences Inc"/><FilterOption id="1013295" count="98" label="Astellas Pharma Inc"/><FilterOption id="19453" count="93" label="Genentech Inc"/><FilterOption id="18614" count="87" label="Novo Nordisk A/S"/><FilterOption id="30062" count="82" label="AstraZeneca AB"/><FilterOption id="29218" count="78" label="AbbVie Deutschland GmbH &amp; Co KG"/><FilterOption id="15133" count="76" label="Bristol-Myers Squibb International Corp"/><FilterOption id="1121088" count="72" label="Novartis Farmaceutica SA"/><FilterOption id="1038736" count="64" label="PETHEMA Foundation"/><FilterOption id="1057369" count="63" label="La Paz University Hospital (Madrid)"/><FilterOption id="20300" count="60" label="Takeda Pharmaceutical Co Ltd"/><FilterOption id="22546" count="55" label="Boehringer Ingelheim GmbH"/><FilterOption id="13601" count="53" label="Abbott Laboratories"/><FilterOption id="1003983" count="51" label="Bayer HealthCare AG"/><FilterOption id="23119" count="50" label="European Organisation for Research and Treatment of Cancer (EORTC)"/><FilterOption id="20452" count="48" label="UCB SA"/><FilterOption id="24652" count="47" label="Shire plc"/><FilterOption id="15414" count="46" label="Chugai Pharmaceutical Co Ltd"/><FilterOption id="1017818" count="46" label="Instituto de Salud Carlos III"/><FilterOption id="1005244" count="45" label="Biogen Inc"/><FilterOption id="19620" count="45" label="Eisai Inc"/><FilterOption id="18101" count="45" label="Merck KGaA"/><FilterOption id="1045910" count="43" label="Hospital Clinico San Carlos"/><FilterOption id="1119200" count="43" label="Sanofi-Aventis Research and Development"/><FilterOption id="1050515" count="43" label="ViiV Healthcare Ltd"/><FilterOption id="1110770" count="41" label="Novartis Farma SpA"/><FilterOption id="19214" count="41" label="Regeneron Pharmaceuticals Inc"/><FilterOption id="20348" count="41" label="Teva Pharmaceutical Industries Ltd"/><FilterOption id="1040862" count="40" label="Hospital General Universitario Gregorio Marañon"/><FilterOption id="1042061" count="40" label="Spanish Breast Cancer Research Group"/><FilterOption id="22586" count="39" label="Boehringer Ingelheim Corp"/><FilterOption id="17839" count="39" label="Eli Lilly SA"/><FilterOption id="17216" count="38" label="Incyte Corp"/><FilterOption id="1087775" count="36" label="Novartis Oncology"/><FilterOption id="1145220" count="35" label="GlaxoSmithKline Research &amp; Development Ltd"/><FilterOption id="17332" count="34" label="Johnson &amp; Johnson"/><FilterOption id="18077" count="34" label="Merck &amp; Co Inc"/><FilterOption id="27053" count="33" label="Glaxo Group Research Ltd"/><FilterOption id="18681" count="33" label="Ono Pharmaceutical Co Ltd"/><FilterOption id="17259" count="32" label="Ipsen"/><FilterOption id="19461" count="31" label="Hoffmann-La Roche Inc"/><FilterOption id="20556" count="31" label="Universidad Complutense de Madrid"/><FilterOption id="23780" count="30" label="Actelion Ltd"/><FilterOption id="15121" count="30" label="Bristol-Myers Squibb Belgium SA"/><FilterOption id="1122528" count="30" label="SCS Boehringer Ingelheim Comm.V"/><FilterOption id="1020322" count="29" label="Daiichi Sankyo Inc"/><FilterOption id="24166" count="29" label="GlaxoSmithKline Biologicals"/><FilterOption id="1039423" count="29" label="Hospital Clinic of Barcelona"/><FilterOption id="1079538" count="29" label="Instituto de Investigación Hospital Universitario La Paz"/><FilterOption id="1103352" count="28" label="Boehringer Ingelheim Espana Sa"/><FilterOption id="1044292" count="28" label="Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal"/><FilterOption id="21991" count="28" label="Takeda Oncology"/><FilterOption id="20519" count="27" label="National Cancer Institute"/><FilterOption id="1110884" count="26" label="Biogen Idec Research Ltd"/><FilterOption id="22563" count="26" label="Boehringer Ingelheim Ltd"/><FilterOption id="1035512" count="26" label="EMD Serono Inc"/><FilterOption id="1003570" count="26" label="Janssen R&amp;D (Ireland)"/><FilterOption id="18008" count="26" label="MedImmune LLC"/><FilterOption id="16299" count="26" label="Sanofi Genzyme"/><FilterOption id="14112" count="26" label="Wyeth"/><FilterOption id="1006639" count="25" label="Hospital Universitario Ramon y Cajal"/><FilterOption id="22554" count="24" label="Boehringer Ingelheim BV"/><FilterOption id="1092773" count="24" label="Hospital Puerta de Hierro Majadahonda"/><FilterOption id="1003065" count="24" label="Hospital Vall D'Hebron"/><FilterOption id="14913" count="23" label="Eisai Ltd"/><FilterOption id="29481" count="23" label="Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC"/><FilterOption id="21283" count="22" label="Astellas Pharma Europe BV"/><FilterOption id="27847" count="22" label="Boston Scientific Corp"/><FilterOption id="1033112" count="22" label="Hospital Universitario 12 de Octubre"/><FilterOption id="1095980" count="22" label="NOVARTIS FARMACEUTICA, S.A. DE C.V."/><FilterOption id="22598" count="22" label="Unilfarma Lda"/><FilterOption id="DOL1000131" count="22" label="Universidad Autonoma de Madrid"/><FilterOption id="1007052" count="22" label="Universidad Europea De Madrid"/><FilterOption id="25902" count="21" label="Array BioPharma Inc"/><FilterOption id="1101929" count="21" label="IQVIA Holdings Inc"/><FilterOption id="1055006" count="21" label="Ministry of Health, Spain"/><FilterOption id="1033116" count="21" label="PAREXEL International"/><FilterOption id="22555" count="20" label="Boehringer Ingelheim Ellas AE"/><FilterOption id="27108" count="20" label="Glaxo SA"/><FilterOption id="25554" count="20" label="Seattle Genetics Inc"/><FilterOption id="1065900" count="19" label="Apices Soluciones, S.L."/></Filter><Filter label="Last Changed Date By Day" name="trialDateChangeLastByDay" total="100"><FilterOption count="214" label="2019-01-24"/><FilterOption count="128" label="2019-01-25"/><FilterOption count="105" label="2019-01-26"/><FilterOption count="102" label="2019-07-03"/><FilterOption count="99" label="2018-10-14"/><FilterOption count="99" label="2019-03-07"/><FilterOption count="98" label="2019-06-27"/><FilterOption count="97" label="2018-10-15"/><FilterOption count="91" label="2019-06-28"/><FilterOption count="90" label="2019-06-26"/><FilterOption count="86" label="2019-06-07"/><FilterOption count="84" label="2019-06-20"/><FilterOption count="83" label="2019-06-25"/><FilterOption count="82" label="2019-07-01"/><FilterOption count="80" label="2019-07-02"/><FilterOption count="77" label="2018-10-12"/><FilterOption count="75" label="2019-06-17"/><FilterOption count="73" label="2019-06-21"/><FilterOption count="70" label="2019-06-06"/><FilterOption count="68" label="2019-06-12"/><FilterOption count="68" label="2019-06-14"/><FilterOption count="67" label="2018-10-13"/><FilterOption count="58" label="2019-06-19"/><FilterOption count="56" label="2019-06-18"/><FilterOption count="53" label="2013-12-02"/><FilterOption count="49" label="2019-06-10"/><FilterOption count="46" label="2019-06-13"/><FilterOption count="45" label="2019-05-31"/><FilterOption count="43" label="2018-10-16"/><FilterOption count="40" label="2019-06-11"/><FilterOption count="40" label="2019-06-24"/><FilterOption count="38" label="2019-05-15"/><FilterOption count="38" label="2019-05-17"/><FilterOption count="38" label="2019-05-22"/><FilterOption count="38" label="2019-05-23"/><FilterOption count="35" label="2018-07-07"/><FilterOption count="32" label="2019-02-07"/><FilterOption count="32" label="2019-05-24"/><FilterOption count="31" label="2018-06-09"/><FilterOption count="31" label="2019-05-27"/><FilterOption count="31" label="2019-06-22"/><FilterOption count="28" label="2019-04-05"/><FilterOption count="28" label="2019-06-04"/><FilterOption count="27" label="2019-04-11"/><FilterOption count="26" label="2018-11-27"/><FilterOption count="26" label="2018-12-12"/><FilterOption count="26" label="2019-05-30"/><FilterOption count="26" label="2019-06-03"/><FilterOption count="25" label="2019-06-08"/><FilterOption count="24" label="2018-12-14"/><FilterOption count="23" label="2018-12-05"/><FilterOption count="23" label="2019-05-07"/><FilterOption count="23" label="2019-06-05"/><FilterOption count="22" label="2019-03-21"/><FilterOption count="22" label="2019-04-25"/><FilterOption count="21" label="2018-06-23"/><FilterOption count="21" label="2018-11-13"/><FilterOption count="21" label="2019-03-20"/><FilterOption count="21" label="2019-04-09"/><FilterOption count="21" label="2019-04-23"/><FilterOption count="21" label="2019-05-09"/><FilterOption count="21" label="2019-05-10"/><FilterOption count="21" label="2019-05-21"/><FilterOption count="20" label="2018-11-16"/><FilterOption count="20" label="2018-12-13"/><FilterOption count="19" label="2018-06-02"/><FilterOption count="19" label="2018-11-30"/><FilterOption count="19" label="2019-03-01"/><FilterOption count="19" label="2019-05-13"/><FilterOption count="18" label="2018-01-23"/><FilterOption count="18" label="2018-04-28"/><FilterOption count="18" label="2018-11-29"/><FilterOption count="18" label="2019-02-06"/><FilterOption count="18" label="2019-02-21"/><FilterOption count="18" label="2019-03-29"/><FilterOption count="18" label="2019-04-15"/><FilterOption count="18" label="2019-04-17"/><FilterOption count="18" label="2019-05-02"/><FilterOption count="18" label="2019-05-14"/><FilterOption count="18" label="2019-06-15"/><FilterOption count="18" label="2019-06-29"/><FilterOption count="17" label="2018-06-30"/><FilterOption count="17" label="2018-11-17"/><FilterOption count="17" label="2018-11-20"/><FilterOption count="17" label="2018-11-22"/><FilterOption count="17" label="2018-12-10"/><FilterOption count="17" label="2018-12-20"/><FilterOption count="17" label="2019-05-16"/><FilterOption count="16" label="2018-05-23"/><FilterOption count="16" label="2018-05-26"/><FilterOption count="16" label="2018-05-29"/><FilterOption count="16" label="2018-11-23"/><FilterOption count="16" label="2019-02-22"/><FilterOption count="16" label="2019-03-22"/><FilterOption count="16" label="2019-05-03"/><FilterOption count="16" label="2019-05-29"/><FilterOption count="15" label="2018-01-24"/><FilterOption count="15" label="2018-05-19"/><FilterOption count="15" label="2018-12-18"/><FilterOption count="15" label="2019-02-04"/></Filter><Filter label="Trial Date End By Month" name="trialDateEndByMonth" total="100"><FilterOption count="151" label="201912"/><FilterOption count="89" label="202012"/><FilterOption count="70" label="202112"/><FilterOption count="66" label="201812"/><FilterOption count="63" label="201906"/><FilterOption count="62" label="202006"/><FilterOption count="61" label="202003"/><FilterOption count="59" label="201512"/><FilterOption count="55" label="201909"/><FilterOption count="54" label="201910"/><FilterOption count="52" label="201712"/><FilterOption count="52" label="202007"/><FilterOption count="49" label="201905"/><FilterOption count="48" label="201907"/><FilterOption count="47" label="202005"/><FilterOption count="46" label="201612"/><FilterOption count="46" label="201710"/><FilterOption count="46" label="201803"/><FilterOption count="46" label="201805"/><FilterOption count="46" label="202001"/><FilterOption count="44" label="201801"/><FilterOption count="44" label="201904"/><FilterOption count="43" label="201811"/><FilterOption count="43" label="202106"/><FilterOption count="42" label="201604"/><FilterOption count="42" label="201706"/><FilterOption count="42" label="201806"/><FilterOption count="42" label="201911"/><FilterOption count="42" label="202002"/><FilterOption count="41" label="201808"/><FilterOption count="40" label="201701"/><FilterOption count="40" label="202009"/><FilterOption count="39" label="201312"/><FilterOption count="39" label="201412"/><FilterOption count="39" label="201901"/><FilterOption count="38" label="201704"/><FilterOption count="38" label="201903"/><FilterOption count="38" label="201908"/><FilterOption count="37" label="201112"/><FilterOption count="37" label="202010"/><FilterOption count="37" label="202101"/><FilterOption count="36" label="201310"/><FilterOption count="36" label="201709"/><FilterOption count="36" label="201809"/><FilterOption count="36" label="201810"/><FilterOption count="36" label="202004"/><FilterOption count="36" label="202109"/><FilterOption count="35" label="201506"/><FilterOption count="35" label="201611"/><FilterOption count="35" label="201705"/><FilterOption count="35" label="202011"/><FilterOption count="34" label="201212"/><FilterOption count="34" label="201606"/><FilterOption count="34" label="201807"/><FilterOption count="34" label="202102"/><FilterOption count="34" label="202107"/><FilterOption count="33" label="201504"/><FilterOption count="33" label="201605"/><FilterOption count="33" label="201711"/><FilterOption count="32" label="201103"/><FilterOption count="32" label="201508"/><FilterOption count="32" label="202008"/><FilterOption count="32" label="202212"/><FilterOption count="31" label="201203"/><FilterOption count="31" label="201303"/><FilterOption count="31" label="201401"/><FilterOption count="31" label="201409"/><FilterOption count="31" label="201503"/><FilterOption count="31" label="201601"/><FilterOption count="31" label="201707"/><FilterOption count="31" label="201708"/><FilterOption count="31" label="201902"/><FilterOption count="31" label="202108"/><FilterOption count="30" label="201304"/><FilterOption count="30" label="201305"/><FilterOption count="30" label="201501"/><FilterOption count="30" label="201502"/><FilterOption count="30" label="201507"/><FilterOption count="30" label="201603"/><FilterOption count="30" label="201610"/><FilterOption count="30" label="201804"/><FilterOption count="29" label="201209"/><FilterOption count="29" label="201407"/><FilterOption count="29" label="201505"/><FilterOption count="29" label="201510"/><FilterOption count="29" label="201607"/><FilterOption count="29" label="201609"/><FilterOption count="29" label="202104"/><FilterOption count="29" label="202105"/><FilterOption count="29" label="202203"/><FilterOption count="28" label="201007"/><FilterOption count="28" label="201105"/><FilterOption count="28" label="201210"/><FilterOption count="28" label="201301"/><FilterOption count="28" label="201309"/><FilterOption count="28" label="201402"/><FilterOption count="28" label="201406"/><FilterOption count="28" label="201703"/><FilterOption count="27" label="201405"/><FilterOption count="27" label="202103"/></Filter><Filter label="Trial Date Start By Month" name="trialDateStartByMonth" total="100"><FilterOption count="67" label="201703"/><FilterOption count="65" label="201810"/><FilterOption count="63" label="201806"/><FilterOption count="59" label="201606"/><FilterOption count="59" label="201701"/><FilterOption count="58" label="201712"/><FilterOption count="57" label="201511"/><FilterOption count="56" label="201210"/><FilterOption count="54" label="201506"/><FilterOption count="53" label="201507"/><FilterOption count="53" label="201610"/><FilterOption count="52" label="201403"/><FilterOption count="52" label="201410"/><FilterOption count="52" label="201512"/><FilterOption count="52" label="201804"/><FilterOption count="51" label="201412"/><FilterOption count="51" label="201611"/><FilterOption count="50" label="201309"/><FilterOption count="50" label="201704"/><FilterOption count="49" label="201605"/><FilterOption count="48" label="201211"/><FilterOption count="48" label="201707"/><FilterOption count="47" label="201310"/><FilterOption count="47" label="201609"/><FilterOption count="46" label="201401"/><FilterOption count="46" label="201706"/><FilterOption count="45" label="201411"/><FilterOption count="45" label="201501"/><FilterOption count="45" label="201509"/><FilterOption count="45" label="201612"/><FilterOption count="45" label="201802"/><FilterOption count="44" label="201103"/><FilterOption count="44" label="201106"/><FilterOption count="44" label="201311"/><FilterOption count="44" label="201603"/><FilterOption count="44" label="201604"/><FilterOption count="44" label="201702"/><FilterOption count="43" label="200812"/><FilterOption count="43" label="201711"/><FilterOption count="43" label="201801"/><FilterOption count="43" label="201805"/><FilterOption count="43" label="201904"/><FilterOption count="42" label="201301"/><FilterOption count="42" label="201504"/><FilterOption count="42" label="201803"/><FilterOption count="42" label="201811"/><FilterOption count="41" label="200909"/><FilterOption count="41" label="201010"/><FilterOption count="41" label="201112"/><FilterOption count="41" label="201212"/><FilterOption count="41" label="201607"/><FilterOption count="41" label="201812"/><FilterOption count="40" label="201110"/><FilterOption count="40" label="201306"/><FilterOption count="40" label="201510"/><FilterOption count="40" label="201602"/><FilterOption count="39" label="200904"/><FilterOption count="39" label="201206"/><FilterOption count="39" label="201312"/><FilterOption count="39" label="201405"/><FilterOption count="39" label="201601"/><FilterOption count="39" label="201807"/><FilterOption count="39" label="201903"/><FilterOption count="38" label="200804"/><FilterOption count="38" label="201304"/><FilterOption count="38" label="201705"/><FilterOption count="37" label="201109"/><FilterOption count="37" label="201204"/><FilterOption count="37" label="201205"/><FilterOption count="36" label="201009"/><FilterOption count="36" label="201111"/><FilterOption count="36" label="201201"/><FilterOption count="36" label="201308"/><FilterOption count="36" label="201402"/><FilterOption count="36" label="201406"/><FilterOption count="36" label="201407"/><FilterOption count="36" label="201709"/><FilterOption count="35" label="200901"/><FilterOption count="35" label="201012"/><FilterOption count="35" label="201101"/><FilterOption count="35" label="201102"/><FilterOption count="35" label="201105"/><FilterOption count="35" label="201203"/><FilterOption count="35" label="201503"/><FilterOption count="35" label="201505"/><FilterOption count="34" label="201107"/><FilterOption count="34" label="201209"/><FilterOption count="33" label="200912"/><FilterOption count="33" label="201001"/><FilterOption count="33" label="201011"/><FilterOption count="33" label="201404"/><FilterOption count="33" label="201710"/><FilterOption count="33" label="201901"/><FilterOption count="33" label="201902"/><FilterOption count="32" label="200810"/><FilterOption count="32" label="201104"/><FilterOption count="32" label="201303"/><FilterOption count="32" label="201906"/><FilterOption count="31" label="200611"/><FilterOption count="31" label="200801"/></Filter><Filter label="Trial Phase" name="trialPhase" total="15"><FilterOption id="C3" count="2482" label="Phase 3 Clinical"/><FilterOption id="C2" count="1337" label="Phase 2 Clinical"/><FilterOption id="C4" count="671" label="Phase 4 Clinical"/><FilterOption id="PNA" count="491" label="Phase Not Applicable"/><FilterOption id="C12" count="312" label="Phase 1/Phase 2 Clinical"/><FilterOption id="C1" count="268" label="Phase 1 Clinical"/><FilterOption id="NS" count="219" label="Phase not specified"/><FilterOption id="C3B" count="208" label="Phase 3b Clinical"/><FilterOption id="C2B" count="175" label="Phase 2b Clinical"/><FilterOption id="C23" count="138" label="Phase 2/Phase 3 Clinical"/><FilterOption id="C1B" count="109" label="Phase 1b Clinical"/><FilterOption id="C2A" count="87" label="Phase 2a Clinical"/><FilterOption id="C3A" count="18" label="Phase 3a Clinical"/><FilterOption id="C0" count="9" label="Phase 0 Clinical"/><FilterOption id="C1A" count="6" label="Phase 1a Clinical"/></Filter><Filter label="Inclusion Criteria Index" name="trialInclusionCriteriaIndex" total="100"><FilterOption id="3976" count="326" label="Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="3977" count="326" label="Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="3900" count="303" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)"/><FilterOption id="3957" count="288" label="Lung tumor - Subjects Confirmed of Lung Cancer by Specific Modes - Subjects with cytologically/histologically confirmed diagnosis of lung cancer"/><FilterOption id="4840" count="287" label="Breast tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="4880" count="267" label="Breast tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="4879" count="265" label="Breast tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="3936" count="256" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage IV lung cancer"/><FilterOption id="3940" count="225" label="Lung tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="3938" count="220" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with advanced stage lung cancer"/><FilterOption id="584" count="197" label="Non-insulin dependent diabetes - Subjects with Diabetes Mellitus - Subjects with type 2 diabetes mellitus"/><FilterOption id="3914" count="184" label="Lung tumor - Subjects with Measurable Disease - Subjects with measurable disease as per RECIST criteria"/><FilterOption id="13096" count="177" label="Solid tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="3537" count="165" label="Lymphoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="3538" count="165" label="Lymphoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="4483" count="157" label="Colorectal tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="4032" count="154" label="Lung tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"/><FilterOption id="4024" count="153" label="Lung tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"/><FilterOption id="22417" count="151" label="Breast tumor - Subjects with Locally Advanced Cancer/Tumor"/><FilterOption id="13110" count="148" label="Solid tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="13111" count="148" label="Solid tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="5418" count="147" label="HIV infection - Subjects with HIV Infection - Subjects with HIV-1 infection"/><FilterOption id="13129" count="147" label="Solid tumor - Subjects with Treatment Refractory Disease"/><FilterOption id="22381" count="146" label="Lung tumor - Protocol Specified Other Inclusion Criteria - Protocol specified inclusion criteria for females"/><FilterOption id="4814" count="143" label="Breast tumor - Subjects with HER-2 Negative Breast Cancer"/><FilterOption id="4074" count="140" label="Lung tumor - Subjects with Protocol Specified Compliance Status - Subjects able to comply with the study protocol procedures/ requirements"/><FilterOption id="4528" count="139" label="Colorectal tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="4527" count="138" label="Colorectal tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="3935" count="135" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage IIIB lung cancer"/><FilterOption id="5317" count="124" label="HIV infection - Subjects with Protocol Specified HIV Viral Load"/><FilterOption id="4894" count="122" label="Breast tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer chemotherapy"/><FilterOption id="4922" count="122" label="Breast tumor - Subjects with Progressive/Treatment Refractory Disease"/><FilterOption id="1751" count="122" label="Hepatitis C virus infection - Subjects with Chronic Hepatitis C Infection"/><FilterOption id="4857" count="121" label="Breast tumor - Subjects with Measurable Disease - Subjects with measurable disease as per RECIST criteria"/><FilterOption id="3539" count="120" label="Lymphoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"/><FilterOption id="3933" count="119" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage III lung cancer"/><FilterOption id="4813" count="118" label="Breast tumor - Subjects with HER-2 Positive Breast Cancer"/><FilterOption id="901" count="116" label="Non-insulin dependent diabetes - Subjects with specific level of glycemic control - Subjects with Moderate Glycemic Control"/><FilterOption id="4073" count="115" label="Lung tumor - Protocol Specified Other Inclusion Criteria"/><FilterOption id="3989" count="113" label="Lung tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer chemotherapy"/><FilterOption id="3971" count="113" label="Lung tumor - Subjects with Protocol Specified Life Expectancy - Subjects with life expectancy of three months or more"/><FilterOption id="5086" count="110" label="Leukemia - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="4106" count="110" label="Lung tumor - Subjects with Protocol Specified Reproductive Status - Men with adequate contraception"/><FilterOption id="4923" count="109" label="Breast tumor - Subjects with Relapsed/Recurrent Disease"/><FilterOption id="607" count="109" label="Non-insulin dependent diabetes - Subjects with specific level of glycemic control - Subjects with Poor/Inadequate Glycemic Control"/><FilterOption id="5087" count="108" label="Leukemia - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="3548" count="108" label="Lymphoma - Subjects Diagnosed Based on Histo-Pathological Examination"/><FilterOption id="4808" count="105" label="Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Estrogen receptor positive (ER+) breast cancer"/><FilterOption id="22262" count="103" label="Pain - Protocol Specified Other Inclusion Criteria"/><FilterOption id="7091" count="102" label="Prostate tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="4509" count="101" label="Colorectal tumor - Subjects with Histologically Confirmed Colorectal Cancer"/><FilterOption id="3987" count="100" label="Lung tumor - Treatment Naive Subjects"/><FilterOption id="4877" count="99" label="Breast tumor - Subjects with Protocol Specified Life Expectancy"/><FilterOption id="4817" count="97" label="Breast tumor - Postmenopausal Breast Cancer Women"/><FilterOption id="4569" count="96" label="Colorectal tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematopoetic/marrow function"/><FilterOption id="4041" count="96" label="Lung tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"/><FilterOption id="3614" count="95" label="Lymphoma - Subjects with Progressive/Treatment Refractory Disease"/><FilterOption id="3997" count="93" label="Lung tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="4856" count="91" label="Breast tumor - Subjects with Measurable Disease"/><FilterOption id="3978" count="90" label="Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"/><FilterOption id="4565" count="89" label="Colorectal tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"/><FilterOption id="4564" count="88" label="Colorectal tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"/><FilterOption id="5088" count="88" label="Leukemia - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"/><FilterOption id="8817" count="88" label="Pancreas tumor - Subjects with Advanced/Metastatic Cancer"/><FilterOption id="4468" count="87" label="Colorectal tumor - Subjects with Colon Cancer"/><FilterOption id="4467" count="86" label="Colorectal tumor - Subjects with Rectal Cancer"/><FilterOption id="3642" count="86" label="Lymphoma - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"/><FilterOption id="32043" count="85" label="Lung tumor - Subjects with Protocol Specified Participation Status - Subjects able/willing to provide written informed consent"/><FilterOption id="4169" count="85" label="Melanoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="4170" count="85" label="Melanoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="13131" count="85" label="Solid tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"/><FilterOption id="4955" count="83" label="Breast tumor - Subjects with Protocol Specified Participation Status - Subjects willing/able to provide informed consent/assent"/><FilterOption id="3609" count="83" label="Lymphoma - Subjects with Relapsed/Recurrent Disease"/><FilterOption id="4864" count="81" label="Breast tumor - Subjects with Normal/Acceptable Organ Function - Subjects with acceptable hematological test values"/><FilterOption id="4815" count="81" label="Breast tumor - Subjects with Triple Negative Breast Cancer"/><FilterOption id="4895" count="80" label="Breast tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer hormonal therapy"/><FilterOption id="4471" count="80" label="Colorectal tumor - Subjects with Measurable Disease - Subjects with measurable disease as per modified RECIST Criteria"/><FilterOption id="4558" count="80" label="Colorectal tumor - Subjects with Treatment Resistant Disease"/><FilterOption id="5074" count="80" label="Leukemia - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"/><FilterOption id="4827" count="78" label="Breast tumor - TNM Stage III Breast Cancer"/><FilterOption id="5073" count="78" label="Leukemia - Subjects with Normal/Acceptable Organ Function - Subjects with normal/adequate liver function"/><FilterOption id="4691" count="78" label="Multiple myeloma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="4692" count="78" label="Multiple myeloma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="13132" count="78" label="Solid tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"/><FilterOption id="8263" count="77" label="Ovary tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="4397" count="76" label="Head and neck tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"/><FilterOption id="4162" count="76" label="Melanoma - Subjects with Diagnosis of Melanoma - Subjects with histological diagnosis of melanoma"/><FilterOption id="22416" count="75" label="Breast tumor - Subjects with Unresectable Breast Cancer"/><FilterOption id="4398" count="75" label="Head and neck tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/><FilterOption id="6663" count="75" label="Hepatitis C virus infection - Subjects Infected with HCV Genotype 1"/><FilterOption id="4098" count="75" label="Lung tumor - Protocol Specified Other Inclusion Criteria - Subjects recovered from all prior therapies and/or their toxic/adverse effects"/><FilterOption id="13133" count="75" label="Solid tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"/><FilterOption id="4893" count="73" label="Breast tumor - Subjects with History of Anti Cancer Therapy"/><FilterOption id="4981" count="72" label="Leukemia - Subjects with Acute Myeloid Leukemia (AML)"/><FilterOption id="3755" count="72" label="Prostate tumor - Subjects with Castrate Resistant Prostate Cancer"/><FilterOption id="3448" count="71" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma - Subjects with follicular lymphoma"/><FilterOption id="3622" count="71" label="Lymphoma - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"/><FilterOption id="3628" count="71" label="Lymphoma - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"/><FilterOption id="4139" count="71" label="Melanoma - Subjects with Stage IV Melanoma"/><FilterOption id="8264" count="71" label="Ovary tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"/></Filter><Filter label="Trial Interventions Control Alone Name Display" name="trialInterventionsControlAloneNameDisplay" total="100"><FilterOption id="2953" count="50" label="docetaxel"/><FilterOption id="3803" count="34" label="paclitaxel"/><FilterOption id="3199" count="25" label="gemcitabine"/><FilterOption id="12205" count="22" label="capecitabine"/><FilterOption id="13928" count="19" label="enoxaparin sodium"/><FilterOption id="7413" count="18" label="darbepoetin alfa"/><FilterOption id="3313" count="17" label="fulvestrant"/><FilterOption id="44375" count="16" label="warfarin"/><FilterOption id="11961" count="15" label="erlotinib"/><FilterOption id="37370" count="14" label="azacitidine"/><FilterOption id="6736" count="14" label="rituximab"/><FilterOption id="14163" count="13" label="adalimumab"/><FilterOption id="70667" count="13" label="pembrolizumab"/><FilterOption id="29831" count="13" label="sorafenib"/><FilterOption id="12973" count="13" label="sunitinib"/><FilterOption id="8165" count="13" label="tiotropium bromide"/><FilterOption id="10252" count="12" label="insulin glargine"/><FilterOption id="4577" count="12" label="topotecan"/><FilterOption id="11460" count="11" label="imatinib"/><FilterOption id="2784" count="11" label="letrozole"/><FilterOption id="4529" count="11" label="temozolomide"/><FilterOption id="44401" count="11" label="vancomycin"/><FilterOption id="6408" count="11" label="vinorelbine"/><FilterOption id="2807" count="10" label="atorvastatin"/><FilterOption id="7934" count="9" label="doxorubicin (liposomal, STEALTH), Alza"/><FilterOption id="6050" count="9" label="metformin hydrochloride"/><FilterOption id="3536" count="9" label="pemetrexed disodium"/><FilterOption id="4567" count="8" label="etanercept"/><FilterOption id="3081" count="8" label="exemestane"/><FilterOption id="14336" count="8" label="fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"/><FilterOption id="3360" count="8" label="interferon beta-1a, Biogen"/><FilterOption id="14493" count="8" label="tenofovir disoproxil fumarate"/><FilterOption id="3321" count="7" label="anastrozole"/><FilterOption id="6850" count="7" label="infliximab"/><FilterOption id="54804" count="7" label="nivolumab"/><FilterOption id="22395" count="7" label="ranibizumab"/><FilterOption id="42858" count="7" label="ustekinumab"/><FilterOption id="28773" count="6" label="eribulin mesylate"/><FilterOption id="13340" count="6" label="everolimus"/><FilterOption id="2871" count="6" label="irinotecan"/><FilterOption id="3616" count="6" label="meropenem"/><FilterOption id="13460" count="6" label="oseltamivir"/><FilterOption id="10488" count="6" label="tolterodine"/><FilterOption id="2836" count="5" label="clopidogrel"/><FilterOption id="13239" count="5" label="decitabine"/><FilterOption id="53981" count="5" label="enzalutamide"/><FilterOption id="3159" count="5" label="fluticasone propionate"/><FilterOption id="5267" count="5" label="leuprorelin acetate"/><FilterOption id="5148" count="5" label="liraglutide"/><FilterOption id="12978" count="5" label="moxifloxacin"/><FilterOption id="42299" count="5" label="ofatumumab"/><FilterOption id="43738" count="5" label="pazopanib"/><FilterOption id="9702" count="5" label="recombinant interferon beta-1a, Merck Serono"/><FilterOption id="44312" count="5" label="salmeterol"/><FilterOption id="8713" count="5" label="sildenafil citrate"/><FilterOption id="4513" count="5" label="tamsulosin hydrochloride"/><FilterOption id="53547" count="4" label="aflibercept (intravitreal, wet AMD, macular edema, diabetic retinopathy), Regeneron/Bayer"/><FilterOption id="72699" count="4" label="atezolizumab"/><FilterOption id="8047" count="4" label="bevacizumab"/><FilterOption id="44697" count="4" label="carbamazepine (extended-release), Novartis"/><FilterOption id="44388" count="4" label="carbidopa + levodopa"/><FilterOption id="10388" count="4" label="cetuximab"/><FilterOption id="5999" count="4" label="ciclosporin, Novartis"/><FilterOption id="55798" count="4" label="crizotinib"/><FilterOption id="2992" count="4" label="donepezil hydrochloride"/><FilterOption id="67892" count="4" label="epoetin alfa (Procrit/Eprex), Johnson &amp; Johnson"/><FilterOption id="3350" count="4" label="Fluarix"/><FilterOption id="11603" count="4" label="gefitinib"/><FilterOption id="55237" count="4" label="ibrutinib"/><FilterOption id="36630" count="4" label="ipilimumab"/><FilterOption id="31620" count="4" label="octocog alfa, Baxalta"/><FilterOption id="23625" count="4" label="peginterferon alfa-2a"/><FilterOption id="12420" count="4" label="rosuvastatin"/><FilterOption id="44313" count="4" label="simvastatin"/><FilterOption id="50038" count="4" label="tenofovir disoproxil fumarate + emtricitabine + efavirenz, Gilead/BMS/Merck &amp; Co"/><FilterOption id="11232" count="4" label="tobramycin (nebulized), Novartis"/><FilterOption id="2773" count="4" label="valsartan"/><FilterOption id="6747" count="3" label="adefovir dipivoxil"/><FilterOption id="2500" count="3" label="amlodipine"/><FilterOption id="2509" count="3" label="anagrelide"/><FilterOption id="15954" count="3" label="bortezomib"/><FilterOption id="44383" count="3" label="carboplatin"/><FilterOption id="4728" count="3" label="emtricitabine"/><FilterOption id="44289" count="3" label="enalapril"/><FilterOption id="7607" count="3" label="follitropin alfa"/><FilterOption id="6140" count="3" label="formoterol"/><FilterOption id="8710" count="3" label="glatiramer acetate"/><FilterOption id="6621" count="3" label="Havrix"/><FilterOption id="11036" count="3" label="linezolid"/><FilterOption id="14681" count="3" label="lopinavir + ritonavir"/><FilterOption id="3669" count="3" label="mycophenolate mofetil"/><FilterOption id="29016" count="3" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"/><FilterOption id="8747" count="3" label="palivizumab"/><FilterOption id="17814" count="3" label="pregabalin"/><FilterOption id="4234" count="3" label="risedronate sodium"/><FilterOption id="55275" count="3" label="secukinumab"/><FilterOption id="15478" count="3" label="solifenacin"/><FilterOption id="49219" count="3" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"/><FilterOption id="6386" count="3" label="trastuzumab"/><FilterOption id="15130" count="3" label="vinflunine"/></Filter><Filter label="Trial Actions Primary Interventions Control" name="trialActionsPrimaryInterventionsControl" total="100"><FilterOption id="372" count="99" label="Thymidylate synthase inhibitor"/><FilterOption id="5085" count="63" label="B-lymphocyte antigen CD20 inhibitor"/><FilterOption id="740" count="52" label="Epidermal growth factor receptor antagonist"/><FilterOption id="3808" count="51" label="Kit tyrosine kinase inhibitor"/><FilterOption id="1016" count="49" label="HIV-1 reverse transcriptase inhibitor"/><FilterOption id="374" count="49" label="Transferase inhibitor"/><FilterOption id="142" count="48" label="Topoisomerase II inhibitor"/><FilterOption id="135" count="47" label="DHFR inhibitor"/><FilterOption id="1832" count="47" label="Nucleoside reverse transcriptase inhibitor"/><FilterOption id="181" count="46" label="GAR transformylase inhibitor"/><FilterOption id="3848" count="46" label="VEGF-2 receptor antagonist"/><FilterOption id="12521" count="45" label="VEGF ligand inhibitor"/><FilterOption id="3846" count="45" label="VEGF-1 receptor antagonist"/><FilterOption id="3756" count="44" label="Erbb2 tyrosine kinase receptor inhibitor"/><FilterOption id="138" count="43" label="DNA polymerase inhibitor"/><FilterOption id="721" count="41" label="TNF binding agent"/><FilterOption id="141" count="38" label="Topoisomerase I inhibitor"/><FilterOption id="3850" count="38" label="VEGF-3 receptor antagonist"/><FilterOption id="76" count="35" label="Aromatase inhibitor"/><FilterOption id="23014" count="35" label="Insulin ligand"/><FilterOption id="400" count="35" label="Insulin receptor agonist"/><FilterOption id="48492" count="34" label="PDGF receptor beta antagonist"/><FilterOption id="381" count="34" label="TNF alpha ligand inhibitor"/><FilterOption id="8805" count="33" label="AMP activated protein kinase stimulator"/><FilterOption id="3816" count="31" label="RET tyrosine kinase receptor family inhibitor"/><FilterOption id="40" count="29" label="Beta 2 adrenoceptor agonist"/><FilterOption id="3806" count="29" label="Flt3 tyrosine kinase inhibitor"/><FilterOption id="204" count="29" label="HIV protease inhibitor"/><FilterOption id="768" count="29" label="HIV-1 protease inhibitor"/><FilterOption id="948" count="29" label="PDGF receptor antagonist"/><FilterOption id="262" count="28" label="Muscarinic M3 receptor antagonist"/><FilterOption id="67136" count="26" label="Programmed cell death protein 1 inhibitor"/><FilterOption id="7424" count="24" label="Cytochrome P450 3A4 inhibitor"/><FilterOption id="3754" count="24" label="EGFR family tyrosine kinase receptor inhibitor"/><FilterOption id="1741" count="24" label="Low molecular weight heparin"/><FilterOption id="286" count="22" label="Estrogen receptor antagonist"/><FilterOption id="111" count="22" label="Factor IIa antagonist"/><FilterOption id="113" count="22" label="Factor IX antagonist"/><FilterOption id="114" count="22" label="Factor VII antagonist"/><FilterOption id="119" count="22" label="Factor X antagonist"/><FilterOption id="4917" count="22" label="Proteasome inhibitor"/><FilterOption id="1722" count="22" label="VEGF receptor antagonist"/><FilterOption id="10583" count="22" label="Vitamin K epoxide reductase inhibitor"/><FilterOption id="12162" count="21" label="Erythropoietin ligand"/><FilterOption id="48489" count="21" label="PDGF receptor alpha antagonist"/><FilterOption id="4548" count="21" label="Raf B protein kinase inhibitor"/><FilterOption id="214" count="19" label="Interferon alpha 2 ligand"/><FilterOption id="1833" count="19" label="Non-nucleoside reverse transcriptase inhibitor"/><FilterOption id="76469" count="18" label="26S proteasome complex inhibitor"/><FilterOption id="629" count="18" label="Inosine monophosphate dehydrogenase inhibitor"/><FilterOption id="259" count="18" label="Muscarinic receptor antagonist"/><FilterOption id="6512" count="17" label="DNA methyltransferase inhibitor"/><FilterOption id="261" count="17" label="Muscarinic M1 receptor antagonist"/><FilterOption id="4010" count="16" label="Calcineurin inhibitor"/><FilterOption id="3154" count="16" label="CSF-1 antagonist"/><FilterOption id="10240" count="16" label="mTOR inhibitor"/><FilterOption id="4913" count="16" label="P2Y12 purinoceptor antagonist"/><FilterOption id="2506" count="16" label="PARP modulator"/><FilterOption id="57003" count="16" label="Peptidoglycan recognition protein inhibitor"/><FilterOption id="4550" count="16" label="Raf 1 protein kinase inhibitor"/><FilterOption id="3524" count="15" label="Abl tyrosine kinase inhibitor"/><FilterOption id="7588" count="15" label="HIV-1 integrase inhibitor"/><FilterOption id="205" count="15" label="HMG CoA reductase inhibitor"/><FilterOption id="13571" count="14" label="Bcr protein inhibitor"/><FilterOption id="71851" count="14" label="HIV GAG POL polyprotein inhibitor"/><FilterOption id="12395" count="14" label="HIV GAG protein inhibitor"/><FilterOption id="481" count="14" label="Interferon beta ligand"/><FilterOption id="11778" count="13" label="PurH purine biosynthesis protein inhibitor"/><FilterOption id="4542" count="13" label="Raf protein kinase inhibitor"/><FilterOption id="814" count="13" label="Tubulin modulator"/><FilterOption id="76090" count="12" label="mTOR complex 1 inhibitor"/><FilterOption id="66340" count="12" label="Penicillin binding protein inhibitor"/><FilterOption id="7025" count="12" label="Signal transduction inhibitor"/><FilterOption id="15" count="11" label="5-HT 3 receptor antagonist"/><FilterOption id="7472" count="11" label="Cytochrome P450 17 inhibitor"/><FilterOption id="82444" count="11" label="DNA helicase inhibitor"/><FilterOption id="51708" count="11" label="DNA polymerase alpha inhibitor"/><FilterOption id="6830" count="11" label="DNA primase inhibitor"/><FilterOption id="346" count="11" label="Ribonucleotide reductase inhibitor"/><FilterOption id="18" count="10" label="ACE inhibitor"/><FilterOption id="431" count="10" label="DNA gyrase inhibitor"/><FilterOption id="2585" count="10" label="Glucagon-like peptide 1 receptor agonist"/><FilterOption id="385" count="10" label="Protein tyrosine kinase inhibitor"/><FilterOption id="60" count="9" label="Androgen receptor antagonist"/><FilterOption id="64" count="9" label="Angiotensin II receptor antagonist"/><FilterOption id="7418" count="9" label="Cytochrome P450 3 inhibitor"/><FilterOption id="3688" count="9" label="FGF3 receptor antagonist"/><FilterOption id="1092" count="9" label="GNRH receptor agonist"/><FilterOption id="3584" count="9" label="Lck tyrosine kinase inhibitor"/><FilterOption id="14007" count="9" label="Programmed cell death ligand 1 inhibitor"/><FilterOption id="13" count="8" label="5-HT 2 receptor antagonist"/><FilterOption id="150" count="8" label="Dopamine D2 receptor antagonist"/><FilterOption id="3682" count="8" label="FGF1 receptor antagonist"/><FilterOption id="511" count="8" label="TNF antagonist"/><FilterOption id="8222" count="8" label="Type II TNF receptor modulator"/><FilterOption id="6515" count="7" label="Cytosine DNA methyltransferase inhibitor"/><FilterOption id="1671" count="7" label="HIV integrase inhibitor"/><FilterOption id="1584" count="7" label="IL-12 receptor antagonist"/><FilterOption id="9748" count="7" label="IL-23 antagonist"/><FilterOption id="516" count="7" label="Muscarinic M2 receptor antagonist"/></Filter><Filter label="Trial Indications Adverse" name="trialIndicationsAdverse" total="100"><FilterOption id="102" count="1030" label="Diarrhea"/><FilterOption id="226" count="941" label="Nausea"/><FilterOption id="829" count="825" label="Fatigue"/><FilterOption id="148" count="646" label="Headache"/><FilterOption id="1991" count="622" label="Neutropenia"/><FilterOption id="110" count="588" label="Emesis"/><FilterOption id="17" count="566" label="Anemia"/><FilterOption id="3020" count="408" label="Skin rash"/><FilterOption id="3038" count="395" label="Appetite loss"/><FilterOption id="324" count="388" label="Thrombocytopenia"/><FilterOption id="1833" count="377" label="Fever"/><FilterOption id="404" count="364" label="Constipation"/><FilterOption id="2274" count="347" label="Rhinopharyngitis"/><FilterOption id="178" count="296" label="Hypertension"/><FilterOption id="516" count="277" label="Upper respiratory tract infection"/><FilterOption id="3062" count="273" label="Death"/><FilterOption id="360" count="256" label="Pneumonia"/><FilterOption id="2439" count="252" label="Arthralgia"/><FilterOption id="82" count="250" label="Cough"/><FilterOption id="746" count="244" label="Infectious disease"/><FilterOption id="3472" count="237" label="Abdominal pain"/><FilterOption id="2400" count="222" label="Dyspnea"/><FilterOption id="680" count="200" label="Leukopenia"/><FilterOption id="3454" count="193" label="Dizziness"/><FilterOption id="3221" count="192" label="Back pain"/><FilterOption id="3795" count="189" label="Febrile neutropenia"/><FilterOption id="402" count="182" label="Edema"/><FilterOption id="279" count="177" label="Pruritus"/><FilterOption id="1009" count="165" label="Urinary tract infection"/><FilterOption id="20" count="154" label="Pain"/><FilterOption id="13" count="150" label="Alopecia"/><FilterOption id="1016" count="145" label="Stomatitis"/><FilterOption id="1039" count="129" label="Myalgia"/><FilterOption id="552" count="125" label="Bleeding"/><FilterOption id="750" count="125" label="Insomnia"/><FilterOption id="129" count="104" label="Gastrointestinal disease"/><FilterOption id="259" count="104" label="Peripheral neuropathy"/><FilterOption id="1821" count="103" label="Hyperglycemia"/><FilterOption id="181" count="95" label="Hypokalemia"/><FilterOption id="50" count="91" label="Bronchitis"/><FilterOption id="1992" count="90" label="Lymphocytopenia"/><FilterOption id="191" count="80" label="Influenza virus infection"/><FilterOption id="1078" count="77" label="Lung embolism"/><FilterOption id="1063" count="77" label="Xerostomia"/><FilterOption id="3073" count="74" label="Drowsiness"/><FilterOption id="2576" count="74" label="Dysgeusia"/><FilterOption id="224" count="74" label="Myocardial infarction"/><FilterOption id="2955" count="74" label="Weight loss"/><FilterOption id="114" count="66" label="Sepsis"/><FilterOption id="445" count="65" label="Hypoglycemia"/><FilterOption id="408" count="65" label="Hypotension"/><FilterOption id="182" count="64" label="Hypothyroidism"/><FilterOption id="432" count="61" label="Dyspepsia"/><FilterOption id="2024" count="59" label="Erythema"/><FilterOption id="93" count="57" label="Depression"/><FilterOption id="505" count="56" label="Hypersensitivity"/><FilterOption id="277" count="55" label="Proteinuria"/><FilterOption id="2434" count="55" label="Vertigo"/><FilterOption id="1263" count="54" label="Mucositis"/><FilterOption id="3050" count="51" label="Chill"/><FilterOption id="1835" count="51" label="Epistaxis"/><FilterOption id="2440" count="51" label="Musculoskeletal pain"/><FilterOption id="1072" count="48" label="Colitis"/><FilterOption id="69" count="48" label="Renal failure"/><FilterOption id="55" count="47" label="Cardiac failure"/><FilterOption id="3868" count="47" label="Xerosis"/><FilterOption id="1280" count="45" label="Hypophosphatemia"/><FilterOption id="25" count="44" label="Anxiety disorder"/><FilterOption id="2954" count="42" label="Weight gain"/><FilterOption id="574" count="41" label="Deep vein thrombosis"/><FilterOption id="94" count="40" label="Dermatitis"/><FilterOption id="1256" count="40" label="Hyponatremia"/><FilterOption id="1542" count="39" label="Atrial fibrillation"/><FilterOption id="2195" count="39" label="Gastroenteritis"/><FilterOption id="172" count="39" label="Hyperbilirubinemia"/><FilterOption id="678" count="38" label="Neuropathy"/><FilterOption id="2529" count="37" label="Hot flashes"/><FilterOption id="65" count="37" label="Stroke"/><FilterOption id="1559" count="36" label="Congestive heart failure"/><FilterOption id="358" count="36" label="Muscle spasm"/><FilterOption id="325" count="36" label="Thromboembolism"/><FilterOption id="626" count="35" label="Heart disease"/><FilterOption id="668" count="35" label="Muscle weakness"/><FilterOption id="453" count="33" label="Pharyngitis"/><FilterOption id="2733" count="32" label="Hypomagnesemia"/><FilterOption id="250" count="32" label="Pancreatitis"/><FilterOption id="95" count="31" label="Dermatological disease"/><FilterOption id="392" count="31" label="Varicella zoster virus infection"/><FilterOption id="154" count="30" label="Hepatitis"/><FilterOption id="188" count="30" label="Inflammatory disease"/><FilterOption id="509" count="29" label="Respiratory tract infection"/><FilterOption id="2184" count="28" label="Gastrointestinal bleeding"/><FilterOption id="444" count="28" label="Hypocalcemia"/><FilterOption id="286" count="27" label="Renal disease"/><FilterOption id="1876" count="27" label="Syncope"/><FilterOption id="2291" count="26" label="Hematuria"/><FilterOption id="201" count="26" label="Liver disease"/><FilterOption id="1091" count="25" label="Bone injury"/><FilterOption id="174" count="25" label="Hypercholesterolemia"/><FilterOption id="2738" count="25" label="Hyperkalemia"/></Filter></Filters><SearchResults><Trial Id="254264"><Indications><Indication>Asthma</Indication></Indications><CompaniesSponsor><Company>Universidad Autonoma de Madrid</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2018-06-02T00:00:00Z</DateChangeLast><DateEnd>2016-09-30T00:00:00Z</DateEnd><DateStart>2015-12-31T00:00:00Z</DateStart><Identifiers><Identifier>NCT02690831</Identifier><Identifier>UNIVERSIDAD AUTONOMA DE MADRID</Identifier></Identifiers><InterventionsControlDisplay><Intervention>Inspiratory muscle training (IMT) alone</Intervention></InterventionsControlDisplay><InterventionsPrimaryDisplay><Intervention>Inspiratory muscle training (IMT) alone</Intervention><Intervention>Manual therapy and motor control exercise alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>40</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The aim of this study was to assess if an intervention of manual therapy and motor control exercises combined with an inspiratory muscle training program was more effective than an inspiratory muscle training program alone in increasing the maximum inspiratory pressure in patients with asthma. In addition, the study pretends to evaluate the changes caused by the intervention regarding possible postural changes and thoracic diameter.</Teaser><TrialCategories><Category>Behavioral intervention</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Single Blind</Term><Term>Active Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Asthma - Assessment of Forced Expiratory Volume in One Second (FEV1)</EndpointIndex><EndpointIndex>Asthma - Assessment of Forced Vital Capacity (FVC)</EndpointIndex><EndpointIndex>Asthma - Assessment of Peak Expiratory Flow/Flow Rate (PEFR)</EndpointIndex><EndpointIndex>Asthma - Assessment of Pulmonary Function</EndpointIndex><EndpointIndex>Asthma - Spirometry Unspecified</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term></TermsPatientSelection><TitleDisplay>Effects of Manual Therapy and Respiratory Muscle Training on the Maximal Inspiratory Pressure in Patients With Asthma</TitleDisplay><BiomarkerNames><BiomarkerName>Forced Vital Capacity </BiomarkerName><BiomarkerName> Forced expiratory volume </BiomarkerName><BiomarkerName> Maximal inspiratory mouth pressure </BiomarkerName><BiomarkerName> Peak expiratory flow rate</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Actual">2016-09-30T00:00:00Z</PrimaryCompletionDate><TrialDuration>9 Months</TrialDuration><NumberOfSites>1</NumberOfSites></Trial><Trial Id="345639"><Indications><Indication>End stage renal disease</Indication><Indication>Kidney dialysis</Indication></Indications><CompaniesCollaborator><Company>Fundacion Renal Inigo Alvarez De Toledo</Company><Company>Universidad Europea De Madrid</Company></CompaniesCollaborator><CompaniesSponsor><Company>Universidad Politecnica de Madrid</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2018-10-13T00:00:00Z</DateChangeLast><DateEnd>2015-10-30T00:00:00Z</DateEnd><DateStart>2014-07-22T00:00:00Z</DateStart><Identifiers><Identifier>MARGARITA PÉREZ RUIZ</Identifier><Identifier>MGGROSS</Identifier><Identifier>NCT03579537</Identifier><Identifier>UNIVERSIDAD POLITÉCNICA MADRID</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>Intradyalisis alone</Intervention><Intervention>exercise programe alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>70</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The aim of the trial was to study the effects of exercise on physical fitness among hemodialysis patients with chronic kidney disease. Regular physical exercise was adapted to the situation of the patient with hemodialysis to help improve the quality of life of the patient.</Teaser><TrialCategories><Category>Behavioral intervention</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Single Group Assignment</Term></TermsDesign><TermsEndpoint><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>End stage renal disease - Anthropometric Assessments</EndpointIndex><EndpointIndex>End stage renal disease - Assessment of Anxiety by Protocol Specified Scales - Assessment by Spielberger State-Trait Anxiety Inventory (STAI)</EndpointIndex><EndpointIndex>End stage renal disease - Assessment of Clinical Symptoms</EndpointIndex><EndpointIndex>End stage renal disease - Assessment of Depression Severity by Specific Criteria - Assessment by Beck Depression Inventory (BDI)</EndpointIndex><EndpointIndex>End stage renal disease - Assessment of Hormone Levels - Assessment of Parathyroid hormone (PTH)</EndpointIndex><EndpointIndex>End stage renal disease - Assessment of Laboratory/Diagnostic Measures</EndpointIndex><EndpointIndex>End stage renal disease - Assessment of Serum Electrolytes - Assessment of calcium</EndpointIndex><EndpointIndex>End stage renal disease - Assessment of Serum Electrolytes - Assessment of plasma potassium</EndpointIndex><EndpointIndex>End stage renal disease - Assessment of Serum Electrolytes - Assessment of sodium</EndpointIndex><EndpointIndex>End stage renal disease - Assessment of iron status</EndpointIndex><EndpointIndex>End stage renal disease - Functional Assessment</EndpointIndex><EndpointIndex>End stage renal disease - Hematological Assessments - Assessment of hematocrit</EndpointIndex><EndpointIndex>End stage renal disease - Hematological Assessments - Assessment of hemoglobin levels</EndpointIndex><EndpointIndex>End stage renal disease - Patient Reported Outcomes/Quality of Life Assessments - Assessment by SF-36/SF-12</EndpointIndex><EndpointIndex>End stage renal disease - Patient Reported Outcomes/Quality of Life Assessments - Assessment by Visual Analog Scale (VAS)</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term></TermsPatientSelection><TitleDisplay>Effects of Exercise on Physical Fitness Among Hemodialysis Patients With Chronic Kidney Disease</TitleDisplay><PatientSegmentTerms><PatientSegment>End stage renal disease - Subjects by disease severity - Subjects with stage 5 chronic kidney disease/end stage renal disease(ESRD)</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Albumin </BiomarkerName><BiomarkerName> Body Mass Index </BiomarkerName><BiomarkerName> Body fat percentage </BiomarkerName><BiomarkerName> Body height </BiomarkerName><BiomarkerName> Calcium </BiomarkerName><BiomarkerName> Chlorides </BiomarkerName><BiomarkerName> Fat mass </BiomarkerName><BiomarkerName> Ferritin </BiomarkerName><BiomarkerName> Hematocrit </BiomarkerName><BiomarkerName> Hemoglobin </BiomarkerName><BiomarkerName> Iron </BiomarkerName><BiomarkerName> Klotho </BiomarkerName><BiomarkerName> Mean corpuscular volume </BiomarkerName><BiomarkerName> Parathyroid hormone </BiomarkerName><BiomarkerName> Phosphorus </BiomarkerName><BiomarkerName> Potassium </BiomarkerName><BiomarkerName> Six-minute walk distance </BiomarkerName><BiomarkerName> Sodium </BiomarkerName><BiomarkerName> Total body mass </BiomarkerName><BiomarkerName> Total iron binding capacity</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Actual">2015-07-15T00:00:00Z</PrimaryCompletionDate><TrialDuration>15 Months</TrialDuration><NumberOfSites>1</NumberOfSites></Trial><Trial Id="380601"><Indications><Indication>Streptococcus pneumoniae infection</Indication></Indications><ActionsSecondaryInterventionsPrimary><Action>Anti-inflammatory</Action><Action>Prophylactic vaccine</Action><Action>Subunit vaccine</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Antibiotic</Technology><Technology>Biological therapeutic</Technology><Technology>Intramuscular formulation</Technology><Technology>Protein conjugated</Technology><Technology>Suspension</Technology></Technologies><CompaniesSponsor><Company>Universidad Complutense de Madrid</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2019-05-15T00:00:00Z</DateChangeLast><DateEnd>2016-04-30T00:00:00Z</DateEnd><DateStart>2007-05-01T00:00:00Z</DateStart><Identifiers><Identifier>HERACLES</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>Prevnar 13 alone</Intervention></InterventionsPrimaryDisplay><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser> The aim of the study was to describe the population impact of the 13-valent pneumococcal conjugate vaccine ( PCV-13 ) on invasive pneumococcal disease (IPD) in children &amp;lt; 15 years of age in the Community of &lt;b&gt;Madrid&lt;/b&gt;, Spain [ 2151809 ].</Teaser><TrialCategories><Category>Biological</Category><Category>Vaccine</Category></TrialCategories><TitleDisplay>HERACLES: An observational, clinical surveillance study to determine the Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years in Madrid, Spain</TitleDisplay><PrimaryCompletionDate/><TrialDuration>108 Months</TrialDuration><NumberOfSites>0</NumberOfSites></Trial><Trial Id="341503"><Indications><Indication>Cognitive disorder</Indication></Indications><CompaniesSponsor><Company>Universidad Autonoma de Madrid</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2019-05-13T00:00:00Z</DateChangeLast><DateEnd>2023-09-30T00:00:00Z</DateEnd><DateStart>2016-01-31T00:00:00Z</DateStart><Identifiers><Identifier>NCT03541135</Identifier><Identifier>SENIORS-ENRICA II</Identifier><Identifier>Sen-ENRICAII</Identifier></Identifiers><PatientCountEnrollment>2800</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Recruiting</RecruitmentStatus><Teaser>Community-living subjects in the region of &lt;b&gt;Madrid&lt;/b&gt;, Spain, aged &amp;gt;/= 65 years will be included and observed in this study.... Non-institutionalized residents in the region of &lt;b&gt;Madrid&lt;/b&gt;, Spain Age &amp;gt;/= 65 years</Teaser><TrialCategories><Category>Behavioral intervention</Category><Category>Dietary supplement</Category></TrialCategories><TermsDesign><Term>Observational</Term><Term>Cohort</Term><Term>Prospective</Term></TermsDesign><EndpointIndex><EndpointIndex>Other musculoskeletal disease - Assessment of Functional Disability/Physical Function</EndpointIndex><EndpointIndex>Other musculoskeletal disease - Assessment of Laboratory/Diagnostic Measures</EndpointIndex><EndpointIndex>Other musculoskeletal disease - Assessment of Mortality/Death Rates</EndpointIndex><EndpointIndex>Other musculoskeletal disease - Assessment of Physical Examination - Muscle strength/activity</EndpointIndex><EndpointIndex>Other musculoskeletal disease - Assessment of Vital Signs</EndpointIndex><EndpointIndex>Other musculoskeletal disease - Neurological Assessments</EndpointIndex><EndpointIndex>Other musculoskeletal disease - Patient Reported Outcomes/Quality of Life Assessments - Assessment by Short Physical Performance Battery Score (SPPB)</EndpointIndex><EndpointIndex>Other neurological disease - Assessment of Functional Disability/Physical Function - Assessment of daily activity/Work disability</EndpointIndex><EndpointIndex>Other neurological disease - Assessment of Laboratory/Diagnostic Measures</EndpointIndex><EndpointIndex>Other neurological disease - Assessment of Mortality/Death Rates - Assessment of mortality</EndpointIndex><EndpointIndex>Other neurological disease - Assessment of Neuropsychological Function - Assessment of memory and learning</EndpointIndex><EndpointIndex>Other neurological disease - Assessment of Vital Signs</EndpointIndex><EndpointIndex>Other neurological disease - Assessment of motor function</EndpointIndex><EndpointIndex>Other neurological disease - Patient Reported Outcomes/Quality of Life Assessments</EndpointIndex><EndpointIndex>Other neurological disease - Protocol Specified Other Endpoints</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term></TermsPatientSelection><TitleDisplay>Sen-ENRICAII: Study on Cardiovascular Health, Nutrition and Physical Functioning in Older Adults in Spain</TitleDisplay><PatientSegmentTerms><PatientSegment>Other musculoskeletal disease - Subjects with specific disease</PatientSegment><PatientSegment>Other neurological disease - Subjects with specific disease - Subjects with Cognitive disorder</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Arterial stiffness </BiomarkerName><BiomarkerName> Augmentation index </BiomarkerName><BiomarkerName> Blood pressure </BiomarkerName><BiomarkerName> Diastolic blood pressure </BiomarkerName><BiomarkerName> Gait </BiomarkerName><BiomarkerName> Muscle strength </BiomarkerName><BiomarkerName> Pulse wave velocity </BiomarkerName><BiomarkerName> Systolic blood pressure</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Actual">2018-09-30T00:00:00Z</PrimaryCompletionDate><TrialDuration>92 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Fernando Rodríguez-Artalejo, MD, PhD</Name><Name>Jose R Banegas, MD, PhD</Name></ContactNames></Trial><Trial Id="313748"><Indications><Indication>Female infertility</Indication></Indications><ActionsPrimaryInterventionsControl><Action>GNRH receptor agonist</Action><Action>GNRH receptor antagonist</Action></ActionsPrimaryInterventionsControl><ActionsPrimaryInterventionsPrimary><Action>GNRH receptor agonist</Action><Action>GNRH receptor antagonist</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsControl><Action>Anticancer</Action><Action>Proceptive</Action></ActionsSecondaryInterventionsControl><ActionsSecondaryInterventionsPrimary><Action>Anticancer</Action><Action>Proceptive</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Injectable controlled release formulation</Technology><Technology>Injectable formulation</Technology><Technology>Intramuscular formulation</Technology><Technology>Parenteral formulation unspecified</Technology><Technology>Peptide</Technology><Technology>Small molecule therapeutic</Technology><Technology>Subcutaneous formulation</Technology><Technology>Sustained release formulation</Technology></Technologies><CompaniesSponsor><Company>Clínica IVI Madrid</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2018-10-12T00:00:00Z</DateChangeLast><DateEnd>2018-12-31T00:00:00Z</DateEnd><DateStart>2017-12-01T00:00:00Z</DateStart><Identifiers><Identifier>1702-MAD-014-MC</Identifier><Identifier>NCT03291821</Identifier></Identifiers><InterventionsControlDisplay><Intervention>conventional ovarian stimulation alone</Intervention><Intervention>embryo freezing alone</Intervention><Intervention>embryo thawing alone</Intervention><Intervention>embryo transfer alone</Intervention><Intervention>intracytoplasmic sperm injection alone</Intervention><Intervention>ovarian puncture alone</Intervention><Intervention>trophectoderm biopsy alone</Intervention><Intervention>Variable regimens including Meriofert , cetrorelix , ganirelix acetate , human menopausal gonadotrophin , triptorelin pamoate</Intervention></InterventionsControlDisplay><InterventionsPrimaryDisplay><Intervention>double ovarian stimulation (DuoStim) alone</Intervention><Intervention>embryo freezing alone</Intervention><Intervention>embryo thawing alone</Intervention><Intervention>embryo transfer alone</Intervention><Intervention>intracytoplasmic sperm injection alone</Intervention><Intervention>ovarian puncture alone</Intervention><Intervention>trophectoderm biopsy alone</Intervention><Intervention>Variable regimens including Meriofert , cetrorelix , ganirelix acetate , human menopausal gonadotrophin , triptorelin pamoate</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>136</PatientCountEnrollment><Phase>Phase 4 Clinical</Phase><RecruitmentStatus>Recruiting</RecruitmentStatus><Teaser> Signed informed consent Age 35 to 42 years Patients from the IVI &lt;b&gt;madrid&lt;/b&gt; undergoing controlled ovarian hyperstimulation cycle including PGT analysis for infertility treatment BMI 18 to 30 kg/m2 Suspicion of suboptimal or poor response: AMH&amp;lt; 1.5 ng/ml AFC&amp;lt; 8 FSH&gt; 10 Poor response in a previous cycle (defined as&amp;lt</Teaser><TrialCategories><Category>Biological</Category><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Open Label</Term><Term>Active Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Infertility - Assessment of Embryo</EndpointIndex><EndpointIndex>Infertility - Assessment of Embryo - Assessment of embryo implantation rate</EndpointIndex><EndpointIndex>Infertility - Assessment of Embryo - Assessment of number of embryos transferred</EndpointIndex><EndpointIndex>Infertility - Assessment of Oocytes - Assessment of number of oocytes fertilised</EndpointIndex><EndpointIndex>Infertility - Assessment of Ovarian Function - Assessment of ovarian stimulation</EndpointIndex><EndpointIndex>Infertility - Assessment of Pregnancy - Assessment of pregnancy loss</EndpointIndex><EndpointIndex>Infertility - Assessment of Safety and Tolerability</EndpointIndex><EndpointIndex>Infertility - Patient Reported Outcomes/Quality of Life Assessments</EndpointIndex><EndpointIndex>Infertility - Protocol Specified Other Endpoints</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Female</Term><Term>Young Adults (18-44 yrs)</Term></TermsPatientSelection><TitleDisplay>DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore</TitleDisplay><PatientSegmentTerms><PatientSegment>Infertility - Subjects with Assisted Reproductive Technique(ART)</PatientSegment><PatientSegment>Infertility - Subjects with Histroy of Infertility - Women with infertility</PatientSegment></PatientSegmentTerms><PrimaryCompletionDate type="Anticipated">2018-10-31T00:00:00Z</PrimaryCompletionDate><TrialDuration>13 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Fernando Bronet</Name><Name>Gustavo N Cecchino, M.D.</Name><Name>Javier MS Romero, M.D.</Name><Name>Juan A Garcia Velasco, M.D., Ph.D.</Name><Name>Maria Cerrillo, M.D., Ph.D.</Name><Name>Maria Cruz</Name><Name>Mónica T Paredes</Name></ContactNames></Trial><Trial Id="348161"><Indications><Indication>HIV infection</Indication><Indication>Hepatitis C virus infection</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>Hepatitis C virus NS3 protease inhibitor</Action><Action>Hepatitis C virus NS5B polymerase inhibitor</Action><Action>Hepatitis C virus protein NS5A inhibitor</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Anti-inflammatory</Action><Action>Antiviral</Action><Action>Hepatitis C virus replication inhibitor</Action><Action>RNA synthesis inhibitor</Action><Action>Synergist</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Capsule formulation</Technology><Technology>Drug combination</Technology><Technology>Film coating</Technology><Technology>Nucleoside synthesis</Technology><Technology>Oral formulation</Technology><Technology>Oral liquid formulation</Technology><Technology>Oral sustained release formulation</Technology><Technology>Prodrug</Technology><Technology>Small molecule therapeutic</Technology><Technology>Solution</Technology><Technology>Stereochemistry</Technology><Technology>Tablet formulation</Technology></Technologies><CompaniesSponsor><Company>Hospital General Universitario Gregorio Marañon</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2018-09-05T00:00:00Z</DateChangeLast><InterventionsPrimaryDisplay><Intervention>paritaprevir + ritonavir + ombitasvir + dasabuvir (oral, HCV infection) AbbVie alone</Intervention><Intervention>sofosbuvir + ledipasvir (fixed-combination/oral, HCV/HBV), Gilead alone</Intervention><Intervention>Variable regimens including Daklinza , ribavirin , simeprevir , sofosbuvir</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>2369</PatientCountEnrollment><Phase>Phase 4 Clinical</Phase><RecruitmentStatus>Status not specified</RecruitmentStatus><Teaser> The aim of this observational study was to evaluate treatment outcomes of interferon-free direct-acting antiviral agent-based therapy in patients with human immunodeficiency virus/hepatitis C virus (HCV)-coinfection enrolled in a prospective &lt;b&gt;Madrid&lt;/b&gt; coinfection registry [ 2058860 ].</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Observational</Term><Term>Prospective</Term></TermsDesign><TitleDisplay>A real-world, Madrid coinfection registry finding study on the effect of all-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in patients with human immunodeficiency virus/HCV-coinfection</TitleDisplay><BiomarkerNames><BiomarkerName>Hepatitis C virus RNA </BiomarkerName><BiomarkerName> T-Helper Lymphocytes </BiomarkerName><BiomarkerName> T-cell surface glycoprotein CD4</BiomarkerName></BiomarkerNames><PrimaryCompletionDate/><NumberOfSites>1</NumberOfSites></Trial><Trial Id="374084"><Indications><Indication>Myalgia</Indication></Indications><CompaniesSponsor><Company>Universidad Europea De Madrid</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2019-03-22T00:00:00Z</DateChangeLast><DateEnd>2019-06-20T00:00:00Z</DateEnd><DateStart>2019-03-12T00:00:00Z</DateStart><Identifiers><Identifier>NCT03872063</Identifier><Identifier>RADO</Identifier></Identifiers><InterventionsControlDisplay><Intervention>eccentric exercises alone</Intervention></InterventionsControlDisplay><InterventionsPrimaryDisplay><Intervention>eccentric exercises alone</Intervention><Intervention>myofascial induction technique alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>40</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Recruiting</RecruitmentStatus><Teaser> Volleyball players Both gender Age range of 18 to 35 years Compete in a federated team in the Community of &lt;b&gt;Madrid&lt;/b&gt;</Teaser><TrialCategories><Category>Behavioral intervention</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Prevention</Term><Term>Randomized</Term><Term>Single Blind</Term><Term>Active Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Other musculoskeletal disease - Assessment by Global Assessment Scales - Visual analogue scales (VAS) for local and general pain/overall disease activity</EndpointIndex><EndpointIndex>Other musculoskeletal disease - Assessment of Laboratory/Diagnostic Measures</EndpointIndex><EndpointIndex>Other musculoskeletal disease - Clinical Assessments</EndpointIndex><EndpointIndex>Pain - Assessment of Functional Disability/Physical Function</EndpointIndex><EndpointIndex>Pain - Assessment of Pain</EndpointIndex><EndpointIndex>Pain - Patient Reported Outcomes/Quality of Life Assessments - Assessment of Pain by Visual Analog Scale (VAS)</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Healthy volunteers accepted</Term><Term>Young Adults (18-44 yrs)</Term></TermsPatientSelection><TitleDisplay>Myofascial Induction and Eccentric Exercises in Volleyball Players</TitleDisplay><PatientSegmentTerms><PatientSegment>Other musculoskeletal disease - Subjects with specific disease</PatientSegment><PatientSegment>Pain - Others - Healthy Subjects</PatientSegment><PatientSegment>Pain - Subjects with Somatic Pain</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Shoulder motion</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Anticipated">2019-04-15T00:00:00Z</PrimaryCompletionDate><TrialDuration>3 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Rubén Cuesta-Barriuso, PhD</Name></ContactNames></Trial><Trial Id="204979"><Indications><Indication>Cystic fibrosis</Indication></Indications><CompaniesCollaborator><Company>Hospital Infantil Universitario Nino Jesus</Company></CompaniesCollaborator><CompaniesSponsor><Company>Universidad Europea De Madrid</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2018-12-15T00:00:00Z</DateChangeLast><DateStart>2011-09-30T00:00:00Z</DateStart><Identifiers><Identifier>CFTRAINING</Identifier><Identifier>KID'STRAININGCF</Identifier><Identifier>NCT01706445</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>Aerobic training alone</Intervention><Intervention>Inspiratory muscle training alone</Intervention><Intervention>Strength training alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>20</PatientCountEnrollment><Phase>Phase not specified</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser> Boy/girl aged 6 to 17 years Living in the &lt;b&gt;Madrid&lt;/b&gt; area</Teaser><TrialCategories><Category>Medical procedure</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Single Blind</Term><Term>Single Group Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Cystic fibrosis - Assessment of Blood Gas Analysis/Alveolar Diffusion Parameters</EndpointIndex><EndpointIndex>Cystic fibrosis - Assessment of Exercise Capacity/Tolerance - Assessment of muscle strength</EndpointIndex><EndpointIndex>Cystic fibrosis - Assessment of Pulmonary Function</EndpointIndex><EndpointIndex>Cystic fibrosis - Patient Reported Outcomes/Quality of Life Assessments - Assessment by CF_questionnaire_revised(CFQ_R)</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Children (6-12 yrs)</Term><Term>Adolescents (13-17 yrs)</Term></TermsPatientSelection><TitleDisplay>Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic Fibrosis</TitleDisplay><PatientSegmentTerms><PatientSegment>Cystic fibrosis - Pediatric Cystic Fibrosis Subjects</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Maximal inspiratory mouth pressure </BiomarkerName><BiomarkerName> Maximal oxygen uptake</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Actual">2012-07-31T00:00:00Z</PrimaryCompletionDate><NumberOfSites>1</NumberOfSites></Trial><Trial Id="377117"><Indications><Indication>Factor VIII deficiency</Indication><Indication>Musculoskeletal disease</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>Factor VIII agonist</Action><Action>Factor VIII modulator</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Blood clotting modulator</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Antibody fragment</Technology><Technology>Biological therapeutic</Technology><Technology>Cell culture technique</Technology><Technology>Formulation powder</Technology><Technology>Freeze drying</Technology><Technology>Immunoglobulin-G</Technology><Technology>Injectable controlled release formulation</Technology><Technology>Protein fusion</Technology><Technology>Protein recombinant</Technology></Technologies><CompaniesSponsor><Company>Universidad Europea De Madrid</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2019-04-19T00:00:00Z</DateChangeLast><DateEnd>2020-12-15T00:00:00Z</DateEnd><DateStart>2019-09-02T00:00:00Z</DateStart><Identifiers><Identifier>LONGHEST</Identifier><Identifier>NCT03914209</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>efmoroctocog alfa alone</Intervention><Intervention>factor VIII therapy alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>40</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Not yet recruiting</RecruitmentStatus><Teaser>This is a multicenter, observational clinical study. A total of 40 patients with hemophilia A will be included in this study. Patients will be recruited from five centers located in various regions of Spain (Community of &lt;b&gt;Madrid&lt;/b&gt;, Galicia, Community of Valenciana, Málaga and Vizcaya). The dependent variables will be: bleeding frequency (self-report of bleeding), changes in the dosage of factor VIII with EHL products ( rFVIIIFc ), pain (measured with the visual analog scale and a pressure Algometer)</Teaser><TrialCategories><Category>Biological</Category><Category>Dietary supplement</Category></TrialCategories><TermsDesign><Term>Observational</Term><Term>Cohort</Term><Term>Prospective</Term></TermsDesign><EndpointIndex><EndpointIndex>Hemophilia - Assessment of Clinical Symptoms - Assessment of bleeding episodes</EndpointIndex><EndpointIndex>Hemophilia - Assessment of Co-morbidity - Assessment of hematologic diseases/disorders</EndpointIndex><EndpointIndex>Hemophilia - Assessment of Exercise Capacity/Tolerance - Assessment of muscle strength</EndpointIndex><EndpointIndex>Hemophilia - Assessment of Functional Disability/Physical Function</EndpointIndex><EndpointIndex>Hemophilia - Assessment of Safety and Tolerability</EndpointIndex><EndpointIndex>Hemophilia - Assessment of blood loss</EndpointIndex><EndpointIndex>Hemophilia - Assessment of compliance/adherence</EndpointIndex><EndpointIndex>Hemophilia - Assessment of pain</EndpointIndex><EndpointIndex>Hemophilia - Clinical Assessments - Assessment of neuropsychiatric function</EndpointIndex><EndpointIndex>Hemophilia - Patient Reported Outcomes/Quality of Life Assessments - Hemophilia Joint Health Score (HJHS)</EndpointIndex><EndpointIndex>Hemophilia - Protocol Specified Other Endpoints</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Healthy volunteers accepted</Term><Term>Male</Term><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term></TermsPatientSelection><TitleDisplay>Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia</TitleDisplay><PatientSegmentTerms><PatientSegment>Hemophilia - Others - Healthy Subjects</PatientSegment><PatientSegment>Hemophilia - Subjects with Hemophilia A</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Muscle strength </BiomarkerName><BiomarkerName> Six-minute walk distance</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Anticipated">2020-11-10T00:00:00Z</PrimaryCompletionDate><TrialDuration>15 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Rubén Cuesta-Barriuso, PhD</Name></ContactNames></Trial><Trial Id="204862"><Indications><Indication>Aneuploidy</Indication></Indications><CompaniesSponsor><Company>Clínica IVI Madrid</Company></CompaniesSponsor><Countries><Country>Spain</Country></Countries><DateChangeLast>2019-03-07T00:00:00Z</DateChangeLast><DateEnd>2012-12-31T00:00:00Z</DateEnd><DateStart>2010-07-31T00:00:00Z</DateStart><Identifiers><Identifier>MAD-FB-04-2010-01</Identifier><Identifier>NCT01164943</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>human FSH alone</Intervention><Intervention>recombinant follicle stimulating hormone alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>80</PatientCountEnrollment><Phase>Phase not specified</Phase><RecruitmentStatus>Terminated</RecruitmentStatus><ReasonForTrialDiscontinuation><Reason>Not Reported</Reason></ReasonForTrialDiscontinuation><Teaser>The aim of this study was to observe if there was a difference in aneuploidy rate and morphological oocyte parameters between different stimulation protocols.</Teaser><TrialCategories><Category>Biological</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Single Blind</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Infertility - Assessment of Oocytes</EndpointIndex><EndpointIndex>Infertility - Assessment of Pregnancy</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Healthy volunteers accepted</Term><Term>Young Adults (18-44 yrs)</Term></TermsPatientSelection><TitleDisplay>Aneuploidy Rate and Stimulation Protocol: recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH</TitleDisplay><PatientSegmentTerms><PatientSegment>Infertility - Subjects with Assisted Reproductive Technique(ART)</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Oocytes</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Actual">2012-12-31T00:00:00Z</PrimaryCompletionDate><TrialDuration>29 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>David Agudo</Name><Name>Eva Martinez</Name><Name>Fernando Bronet</Name></ContactNames></Trial></SearchResults></trialResultsOutput>